Quarterlytics / Healthcare / Biotechnology / Aktis Oncology, Inc.

Aktis Oncology, Inc.

akts · NASDAQ Healthcare
Claim this profile
Ticker akts
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Employees 79
← All annual reports
FY2017 Annual Report · Aktis Oncology, Inc.
Sign in to download
Loading PDF…
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K

(Mark One)
☒  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended June 30, 2017

or

☐  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________________ to ____________________

Commission file number: 001-38029

AKOUSTIS TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation or organization)

9805 Northcross Center Court, Suite H
Huntersville, NC
(Address of principal executive offices)

33-1229046
(IRS Employer Identification No.)

28078
(Postal Code)

Registrant’s telephone number, including area code:  1-704-997-5735

Securities registered under Section 12(b) of the Act:

Title of Each Class:  
Common Stock, $0.001 par value

Name of each exchange on which registered:  
The NASDAQ Stock Market LLC
(NASDAQ Capital Market)

Securities registered under Section 12(g) of the Act:
None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  ☐  No  ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act.  Yes  ☐  No  ☒

Indicate  by  check  mark  whether  the  registrant  (1)  has  filed  all  reports  required  to  be  filed  by  Section  13  or  15(d)  of  the  Exchange Act
during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days. Yes  ☒  No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter
period that the registrant was required to submit and post such files). Yes  ☒  No  ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be
contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this
Form 10-K or any amendment to this Form 10-K.  ☐

Indicate  by  check  mark  whether  the  registrant  is  a  large  accelerated  filer,  an  accelerated  filer,  a  non-accelerated  filer,  smaller  reporting
company,  or  an  emerging  growth  company.  See  the  definitions  of  “large  accelerated  filer,”  “accelerated  filer,”  “smaller  reporting
company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer ☐
Non-Accelerated Filer ☐
(Do not check if a smaller reporting company)
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Accelerated Filer  ☐
Smaller reporting company  ☒
Emerging growth company  ☒

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐  No  ☒

The  aggregate  market  value  of  the  registrant’s  common  stock,  par  value  $0.001  per  share  (“Common  Stock”),  held  by  non-affiliates  on
December  31,  2016  was  approximately  $52,512,000.  For  purposes  of  this  computation,  shares  of  Common  Stock  held  by  all  officers,

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
directors, and beneficial owners of 10% or more of the outstanding Common Stock were excluded because such persons may be deemed to
be  affiliates  of  the  registrant.  Such  determination  should  not  be  deemed  an  admission  that  such  persons  are,  in  fact,  affiliates  of  the
registrant.

As of September 8, 2017, there were 19,084,583 shares of Common Stock issued and outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

None.

 
 
 
 
TABLE OF CONTENTS

Item Number and Caption

Explanatory Note
Cautionary Note Regarding Forward-Looking Information

PART I

1.
1A.
1B.
2.
3.
4.

Business
Risk Factors
Unresolved Staff Comments
Properties
Legal Proceedings
Mine Safety Disclosures

PART II

5.
6.
7.
7A.
8.
9.
9A.
9B.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases Of Equity Securities  
Selected Financial Data
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Quantitative and Qualitative Disclosures About Market Risk
Financial Statements and Supplemental Data
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Controls and Procedures
Other Information

PART III

10.
11.
12.
13.
14.

Directors, Executive Officers, and Corporate Governance
Executive Compensation
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Certain Relationships and Related Transactions and Director Independence
Principal Accountant Fees and Services

PART IV

15.

Exhibits and Financial Statement Schedules

Financial Statements

i

Page

1
1

2

2
12
26
26
27
27

27

27
28
29
38
38
38
39
40

40

40
46
52
53
55

57

57

F-1

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This Annual  Report  on  Form  10-K  (this  “Report”)  contains  forward-looking  statements,  including,  without  limitation,  in  the  sections
captioned “Business,” “Risk Factors,” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and
elsewhere. Any  and  all  statements  contained  in  this  Report  that  are  not  statements  of  historical  fact  may  be  deemed  forward-looking
statements.  Terms  such  as  “may,”  “might,”  “would,”  “should,”  “could,”  “project,”  “estimate,”  “predict,”  “potential,”  “strategy,”
“anticipate,”  “attempt,”  “develop,”  “plan,”  “help,”  “believe,”  “continue,”  “intend,”  “expect,”  “future,”  and  terms  of  similar  import
(including the negative of any of the foregoing) may be intended to identify forward-looking statements. However, not all forward-looking
statements may contain one or more of these identifying terms. Forward-looking statements in this Report may include, without limitation,
statements  regarding  (i)  the  plans  and  objectives  of  management  for  future  operations,  including  plans  or  objectives  relating  to  the
development  of  commercially  viable  radio  frequency  filters,  (ii)  a  projection  of  income  (including  income/loss),  earnings  (including
earnings/loss)  per  share,  capital  expenditures,  dividends,  capital  structure  or  other  financial  items,  (iii)  our  future  financial  performance,
including any such statement contained in a discussion and analysis of financial condition by management or in the results of operations
included pursuant to the rules and regulations of the SEC, and (iv) the assumptions underlying or relating to any statement described in
points (i), (ii) or (iii) above.

The forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be
realized  because  they  are  based  upon  our  current  projections,  plans,  objectives,  beliefs,  expectations,  estimates  and  assumptions  and  are
subject to a number of risks and uncertainties and other influences, many of which are beyond our control. Actual results and the timing of
certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks
and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to
differ materially from expected or desired results may include, without limitation, our inability to obtain adequate financing, our limited
operating history, our inability to generate revenues or achieve profitability, the results of our research and development (R&D) activities,
our  inability  to  achieve  acceptance  of  our  products  in  the  market,  general  economic  conditions,  including  upturns  and  downturns  in  the
industry, our limited number of patents, failure to obtain, maintain and enforce our intellectual property rights, our inability to attract and
retain qualified personnel, our reliance on third parties to complete certain processes in connection with the manufacture of our products,
product  quality  and  defects,  existing  or  increased  competition,  our  ability  to  market  and  sell  our  products,  our  inability  to  successfully
integrate  our  STC-MEMS  Business  (as  defined  below  under  “Business  —  Recent  Developments  —  Business  Developments”)  in  our
business, our failure to innovate or adapt to new or emerging technologies, our failure to comply with regulatory requirements, results of
any  arbitration  or  litigation  that  may  arise,  stock  volatility  and  illiquidity,  our  failure  to  implement  our  business  plans  or  strategies,  our
failure to maintain effective internal control over financial reporting, and our failure to maintain the Trusted Foundry accreditation of our
New York fabrication facility. A description of the risks and uncertainties that could cause our actual results to differ materially from those
described by the forward-looking statements in this Report appears in the section captioned “Risk Factors” and elsewhere in this Report.   

Readers are cautioned not to place undue reliance on forward-looking statements because of the risks and uncertainties related to them and
to  the  risk  factors.  Except  as  may  be  required  by  law,  we  do  not  undertake  any  obligation  to  update  the  forward-looking  statements
contained in this Report to reflect any new information or future events or circumstances or otherwise.

When used in this Report, the terms, “we,” “Akoustis,” the “Company,” “our,” and “us” refers to Akoustis Technologies, Inc., a Delaware
corporation, and its wholly owned consolidated subsidiaries, Akoustis, Inc. and Akoustis Manufacturing New York, Inc., each of which are
Delaware corporations.

DEFINITIONS

1 

 
 
 
 
 
 
 
 
ITEM 1.          BUSINESS

Overview

PART I

Akoustis is an early stage company focused on developing, designing and manufacturing innovative radio frequency (RF) filter products
for the mobile wireless device industry. We use a patented fundamentally new piezoelectric resonator technology that we call BulkONE®
in the manufacturing of bulk acoustic wave (BAW) resonators, the building blocks of high selectivity “RF” filters required to route signals
in  a  smartphone  or  other  mobile  or  wearable  device,  cellular  infrastructure  and  WiFi  routers.  Filters  are  a  critical  component  of  the  RF
front-end (RFFE), and their use has multiplied with the launch and licensing of 4G/LTE, emerging 5G and WiFi frequency bands. They are
used to define the range of frequencies of radio signals that are transmitted (the “passband”) and simultaneously reject unwanted signals.

We plan to use single-crystal piezoelectric materials to develop a new class of BAW RF filters with a fundamental advantage to reduce
losses  over  existing  thin  film  RF  filter  technologies.  We  believe  our  technology  will  be  disruptive  to  the  RFFE  market  through  the
following expected advantages:

● Wider bandwidth coverage,

● Smaller filter supports higher level of integration and lower manufacturing costs,

● Lower insertion loss,

● Improved power compression and linearity,

● Reduced power amplifier cost, for the ultimate purpose of manufacturing our BAW RF filters,

● Reduced heat generation and reduced battery loading, and

● Reduced guard band between adjacent frequency bands.

Once  our  technology  is  qualified  for  mass  production,  we  expect  to  design  and  sell  single-crystal  BAW  RF  filter  products  using  our
BulkONE®  technology.  Our  product  focus  is  on  innovative  single-band  filter  products  for  the  growing  smartphone  and  RFFE  module
market,  which  can  be  used  to  make  duplexer  or  multiplexer  filter  products  necessary  for  the  mobile  market.  These  products  present  the
greatest  near-term  potential  for  commercialization  of  our  technology. According  to  a  Mobile  Experts  May  2016  report,  the  mobile  filter
market is expected to grow from $8.2 billion in 2017 to greater than $12 billion by 2021.

Recent Developments

Business Developments

In August 2016, we announced our first customer engagement when we entered into multiple non-exclusive agreements with a Chinese tier
one  RFFE  module  manufacturer  to  supply  it  with  our  premium  RF  filter  products  for  next-generation  high-band  RFFE  modules  for  4G,
emerging  4.5G  and  5G  mobile  -  targeting  the  China  and  India  OEM  markets.  In  December  2016,  we  announced  our  second  customer
engagement,  this  time  for  the  development  of  a  band-specific,  high-frequency  (above  3.5  GHz)  BAW  RF  filter  for  a  non-mobile
commercial application with a well-established OEM, specializing in non-mobile defense systems, with annual revenues of more than $1
billion.  In May 2017, we announced our third customer engagement, this time for the development of high-performance BAW duplexers
for non-mobile communication systems with a multi-billion dollar U.S. Fortune 500 company that provides systems, products and solutions
to government and commercial customers worldwide.

2 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
On March 23, 2017, we entered into an Asset Purchase Agreement and a Real Property Purchase Agreement (collectively, the “STC-MEMS
Agreements”)  with  The  Research  Foundation  for  the  State  University  of  New  York  (“RF-SUNY”)  and  Fuller  Road  Management
Corporation (“FRMC”), an affiliate of RF-SUNY (collectively, “Sellers”), respectively, to acquire certain specified assets, including STC-
MEMS,  a  semiconductor  wafer-manufacturing  and  microelectromechanical  systems  (MEMS)  operation  with  associated  wafer-
manufacturing  tools,  and  the  associated  real  estate  and  improvements  located  in  Canandaigua,  New  York  used  in  the  operation  of  STC-
MEMS  (the  assets  and  real  estate  and  improvements  referred  to  together  herein  as  the  “STC-MEMS  Business”).  Pursuant  to  the  STC-
MEMS Agreements,  the  Company  also  agreed  to  assume  post  acquisition  date  substantially  all  of  the  ongoing  obligations  of  the  STC-
MEMS Business incurred in the ordinary course of business.

We completed the acquisition of the STC-MEMS Business through our wholly-owned subsidiary, Akoustis Manufacturing New York, Inc.,
a Delaware corporation formed in connection with the acquisition, on June 26, 2017 for an aggregate purchase price of $2.8 million in cash.
The Company recorded net assets acquired of $6.3 million for purchase consideration of $4.6 million (includes $2.85 million of cash paid
at  closing  plus  $1.7m  real  estate  contingent  liability),  which  resulted  in  the  recording  of  a  bargain  purchase  gain  of  $1.7  million.  The
Company reviewed what factors might contribute to a bargain purchase to determine if it was reasonable for a bargain purchase to occur.
We determined the factors that contributed to the bargain purchase price were:

● The transaction was completed with a motivated seller who the Company believed was very hesitant to liquidate assets and lay-off

employees in the current political environment.

● The cash burn of the facility (approximately $3.0 million annually) was an economic burden to the sellers.

● The  Company,  the County  and  State  were  motivated  to  approve  the  transaction  without  significant  price  negotiation,  as  they
believed  it  would insure  the  employment  of  the  headcount  and  provide  the  opportunity  for  increased  headcount  and  increased
investment in the facility that would add to the tax base.  

Based upon these factors, the Company concluded that the occurrence of a bargain purchase was reasonable.

The  STC-MEMs  acquisition  allows  the  Company  to  internalize  manufacturing,  increase  capacity  and  control  its  wafer  supply  chain  for
single crystal BAW RF filters. We have now successfully transferred our R&D resonator filter process flow into the facility, and we plan
to utilize the facility to optimize our BulkONE® technology and to consolidate all aspects of wafer manufacturing for our disruptive and
patented high band BAW RF filters targeting the multi-billion dollar mobile and other wireless markets. This planned consolidation of the
Company’s  supply  chain  into  the  STC-MEMS  Business  started  on  June  26,  2017  and  is  expected  to  shorten  time-to-market  for  our  RF
products, greatly enhancing our ability to service customers upon completion of development and design specifications. Furthermore, we
believe that shorter time-to-market cycles provide us with the opportunity to increase the number of our potential customers.

In August  2017,  we  announced  our  first  shipment  of  premium  high-band  BAW  RF  filter  prototypes  manufactured  using  our  patented
single-crystal  BulkONE®  technology  to  the  aforementioned  Chinese  tier  one  customer.  The  shipment  included  high  performance,  LTE-
TDD Band 41, 2.6 GHz BAW RF filters that we believe will satisfy the challenging filter requirements in the high growth 4G LTE mobile
market in China. Shortly thereafter, we announced our first 3.5GHz RF filter shipments to our second customer for a key Radar application.

Organizational Developments

On August 11, 2016, we changed our fiscal year from a fiscal year ending on March 31 of each year to one ending on June 30 of each year,
effective for the fiscal year ended June 30, 2017. On October 31, 2016, we filed a transition report on Form 10-K for the transition period
from April 1, 2016 to June 30, 2016.

Following stockholder approval at our 2016 annual stockholders’ meeting, we changed our state of incorporation from the State of Nevada
to the State of Delaware on December 15, 2016.

Glossary

The following is a glossary of technical terms used herein:

● Acoustic wave — a mechanical wave that vibrates in the same direction as its direction of travel.

● AlGaN — Aluminum Gallium Nitride.

● AlN — Aluminum Nitride.

● Acoustic wave filter  —  an  electromechanical  device  that  provides  radio  frequency  control  and  selection,  in  which  an  electrical
signal is converted into a mechanical wave in a device constructed of a piezoelectric material and then back to an electrical signal.

3 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
● Band, channel or frequency band — a designated range of radio wave frequencies used to communicate with a mobile device.

● B u l k acoustic  wave  (BAW)  —  an  acoustic  wave  traveling  through  a  material  exhibiting  elasticity,  typically  vertical  or

perpendicular to the surface of a piezoelectric material.

● Digital baseband — the digital transceiver, which includes the main processor for the communication device.

● Duplexer — a bi-directional device that connects the antenna to the transmitter and receiver of a wireless device and simultaneously

filters both the transmit signal and receive signal.

● Filter —  a  series  of  interconnected  resonators  designed  to  pass  (or  select)  a  desired  radio  frequency  signal  and  block unwanted

signals.

● Group III element nitrides — a dielectric material comprised of group IIIA element, such as boron (B), aluminum (Al) or gallium
(Ga),  combined  with  group  5A  (or  VA  nitrogen  to  form  a  compound  semiconductor  nitride  such  as  BN,  AlN,  or  GaN.  For
resonators, the dielectric is typically chosen based upon the piezoelectric constant of the material in order to generate the  highest
electromechanical coupling.

● Insertion Loss —The power losses associated with inserting a BAW filter into a circuit.

● K-Squared — electromechanical coupling factor that determines the effective bandwidth of a filter.

● Lossy — resistive losses that result in heat generation.

● Metrology — techniques used to evaluate materials, devices and circuits.

● Monolithic topology — a description of an electrical circuit whereby all the elements of the circuit are fabricated at the same time

using the same process flow.

● Power Amplifier Duplexer (PAD) — an RF module containing a power amplifier and duplex filter components for the RFFE of a

smartphone.

● Piezoelectric materials  —  certain  solid  materials  (such  as  crystals  and  certain  ceramics)  that  produce  a  voltage  in  response  to

applied mechanical stress, or that deform when a voltage is applied to them.

● Quality factor,  or  Q  —  energy  stored  divided  by  the  energy  dissipated  per  cycle.  Higher  Q  represents  a  higher  caliber  of
resonance,  and  implies  mechanical  and  electrical  factors  responsible  for  energy  dissipation  are  minimal.  For  a  given  amount of
energy stored in a resonator, Q represents the number of cycles resonance will continue without additional input of energy into the
system.

● Resonator —  a  device  whose  impedance  sharply  changes  over  a  narrow  frequency  range  and  is  characterized  by  one  or  more
‘resonance frequency’ due to a standing wave across the resonator’s electrodes. The vibrations in a resonator can be characterized
by  mechanical  “acoustic”  waves  which  travel  without  a  characteristic  sound  velocity.  Resonators  are  the  building blocks  for  RF
filters used in mobile wireless devices.

● RF — radio frequency.

● RF front-end (RFFE) — the circuitries in a mobile device responsible for processing the analog radio signals; located between the

device’s antenna and the digital baseband.

● RF spectrum — a defined range of frequencies.

4 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
● Surface acoustic wave (SAW) — an acoustic sound wave traveling horizontally along the surface of a piezoelectric material.

● TDD LTE — Time Division Duplex- Long-Term Evolution or a wireless standard which shares the bandwidth between transmit

and receive.

● Tier one — a supplier or OEM with dominant market share.

● Tier two —  a supplier or OEM with an established but not dominant market share.

● Trusted Foundry— The Trusted Foundry Program was initiated by the Department of Defense in 2004 to ensure mission-critical
national  defense  systems  access  to  leading-edge  integrated  circuits  from  secure,  domestic  sources.  Defense  Microelectronics
Activity (DMEA) is the manager of the Trusted Foundry Program for the U.S. Department of Defense (DoD).  It is a joint DoD /
National Security Agency (NSA) program and is administered by the NSA’s Trusted Access Program Office (TAPO).

● Wafer — a thin slice of semiconductor material used in electronics for the fabrication of integrated circuits.

Our Technology

Current RF filters utilize a technology that is limited by the material properties of the base filter component. Existing BAW filters use an
“acoustic wave ladder” that is based on a monolithic topology approach using lossy polycrystalline materials. By contrast, our BulkONE®
technology  uses  a  single-crystal  material,  which  provides  30%  higher  piezoelectric  properties,  compared  to  conventional  polycrystalline
materials used in the industry today. We have fabricated R&D resonators that demonstrate the feasibility of our approach and believe our
technology will yield a new generation of filter products.

BulkONE®  technology  consists  of  novel  single-crystal  piezoelectric  materials,  which  are  fabricated  into  bulk-mode,  acoustic  wave
resonators and RF filters. Our patented piezoelectric materials contain high-purity Group III element nitride materials and possess a unique
signature, which can be detected by conventional material metrology tools. We utilize analytical modeling techniques to aid in the design of
our materials, and our raw material specifications are typically outsourced to a third party for manufacturing. Once our materials are ready
for processing, we supply our NY fabrication facility raw materials, a mask design file, and unique process sequence in order to fabricate
our resonators and filters. Our wafer process flow is compatible with wafer level packaging (WLP) that allows for low profile, cost effective
filters to be produced.

Challenges Facing the Mobile Device Industry

Rising consumer demand for always-on wireless broadband connectivity is creating an unprecedented need for high performance RFFE for
mobile devices. Mobile devices such as smartphones and tablets are quickly becoming the primary means of accessing the Internet, thereby
driving the Internet of Things (IoT). The rapid growth in mobile data traffic is testing the limits of existing wireless bandwidth. Carriers and
regulators have responded by opening new spectrums of RF frequencies, driving up the number of frequency bands in mobile devices. This
substantial increase in frequency bands has created a demand for more filters, as well as a demand for filters with higher selectivity. The
global transition to LTE and adoption of LTE-Advanced with more sophisticated carrier aggregation and multiple-input, multiple-output
(MIMO) techniques will continue to push the requirements for increased supply of high performance filters.

Furthermore, the new spectrum introduced by 4G/LTE and emerging 5G is driving spectrum licensing at higher frequencies than previous
3G smartphone models. For example, new TDD LTE frequencies allocated for 4G wireless cover frequencies nearly twice as high as those
covered  in  previous  generation  phones. As  a  result,  the  demand  for  filters  represents  the  single  largest  growth  opportunity  in  the  RFFE
industry  according  to  a  Mobile  Experts  May  2016  report.  For  traditional  “low  band”  frequencies,  SAW  filters  have  been  the  primary
choice, while high band solutions have utilized BAW filters due to their performance and yield. While there are multiple sources of supply
for SAW technology, the source of supply for BAW filters is more limited and essentially dominated by two manufacturers worldwide. See
“Competition” below.

5 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In addition, signal loss of current generation acoustic wave filters is excessively high, and up to half of the transmit power is wasted as heat,
which ultimately constrains battery life. Another challenge is that the allocated spectrum for  mobile  communication  bands  requires  high
bandwidth RF filters, which, in turn, requires wide bandwidth core resonator technology. In addition, filters with inferior selectivity either
reduce the available operating bands the mobile device can support or increase the noise in the operating bands. Each of these problems
negatively impacts the end-user’s experience when using the mobile device.

The  RFFE  must  meet  growing  data  demands  while  reducing  cost  and  improving  battery  life.  Our  solution  involves  a  new  approach  to
RFFE  component  manufacturing,  enabled  by  BulkONE®  technology.  We  expect  our  technology  to  produce  filters  that  will  reduce  the
overall system cost and improve performance of the RFFE.

Our Solutions

Our immediate focus is on the commercialization of wide bandwidth RF filters operating in the high frequency portion of the RFFE (called
high  band).  Using  our  BulkONE®  technology,  we  believe  these  filters  enable  new  PAD  module  or  RFFE  competition  for  high  band
modules as well as performance-driven low band applications. Initially, we expect to target select strategic RFFE market leaders as well as
tier  two  mobile  phone  original  equipment  manufacturers  (“OEMs”)  and/or  RFFE  module  suppliers.  Longer  term,  our  focus  will  be  to
expand  our  market  share  by  engaging  with  multiple  mobile  phone  OEMs  and  RFFE  module  manufacturers.  We  have  transitioned  our
technology to our Canandaigua, NY facility and continue to focus on the commercialization of our filters using our BulkONE® technology.
This will be the first in a series of R&D activities that will set the foundation for filter products that we believe can disrupt the high band
filter market. We will develop a series of filter designs to be used in the manufacturing of duplexers or more complex multiplexers targeting
the 4G/LTE and emerging 5G frequency bands. We believe our filter designs will create an alternative for, and replace, filters currently
manufactured using materials with fundamentally inferior performance. Figure 1 below illustrates characterization plots that represent the
high power, high bandwidth and high frequency capability of our single crystal materials.

Figure 1-Characteristics of our single crystal materials used to fabricate our BAW RF filters.

Single-Band Designs for Duplexers and Multiplexers

SAW filters have been preferred in modern RFFE because of their high performance, small size and low cost. However, traditional SAW
ladder designs do not perform well in high frequency bands or bands with closely spaced receive and transmit channels, typical of many
new  bands.  Therefore,  BAW  filters  are  needed  for  these  bands.  We  have  demonstrated  in  a  development  environment  our  ability  to
fabricate  BAW  resonators,  the  building  block  of  BAW  filters,  that  are  more  efficient  than  existing  available  BAW  resonators,  and  we
believe the improved efficiency will reduce the total cost of RFFE as well as reduce the battery demand for mobile devices. Additionally,
we believe that our BulkONE® filters will allow for a single manufacturing method that will support all of the BAW filter band range and
a significant portion of the SAW band range. Figure 2 below illustrates what we believe will be the frequency range of our BulkONE®
technology.

6 

 
 
 
 
 
 
 
 
 
 
Figure 2- The potential range of our technology

Pure-Play Filter Provider Enables New Module Competition

Given the high sound velocity in our piezoelectric materials, our technology allows for a wide range of frequency coverage, and we plan to
supply filters that will support 4G/LTE, emerging 5G and WiFi bands. We have successfully demonstrated resonators that will support the
design and fabrication of 4G/LTE filters, and our current focus is on completing the development required to transition this single-crystal
BAW  technology  to  high  volume  manufacturing.  We  will  be  a  pure-play  filter  supplier  that  will  address  the  increasing  RF  complexity
placed on RFFE manufacturers supporting 4G/LTE and WiFi. Figure 3 illustrates the historical growth in RF complexity.

Figure 3- Increase in Filter content in Mobile Phone Front End Modules (FEMs) from 2015 - 2021 (Source: Ericsson 2016)

 Commercialization

Our immediate focus is on the commercialization of wide bandwidth RF filters to address the RFFE with innovative single-band designs
using  our  BulkONE®  high  band  spectrum  technology.  We  are  currently  developing  our  first  commercial  single-band  filter  through  our
STC-MEMS Business wafer fabrication facility. We are focused on developing fixed-band filters because we believe these designs present
the greatest near-term potential for commercialization of our technology, and that once demonstrated, the STC-MEMS facility can be more
efficiently readied for production compared to alternative technologies.

7 

 
 
 
 
 
 
 
 
 
 
 
Our development plan contains the following milestones:

  ● Milestone 1  (Manufacturing  Gap  Analysis)  -  Validate  required  materials,  people,  process  and  equipment  are  present  for  volume

manufacturing.

  ● Milestone  2  (Process  Transfer  to  STC-MEMS  Business)  -  Design  of  filters,  technology  transfer  and  fabrication  on  high-volume

manufacturing equipment, achieve fully tested wafers, and delivery of RF filter product prototypes.

  ● Milestone  3  (Complete  Filter  Process  Capability)  -  Update  RF  filter  design  including  process  improvements,  fabricate  and  test
multiple wafers using the approved manufacturing process flow, calculate yields, and complete delivery of initial product prototypes.

  ● Milestone 4 (Production-Ready Filter Design) - Filter design complete and manufacturing process locked.

  ● Milestone 5 (Product Packaging and Ramp) - Product fully packaged and ready for production, focus shift to revenue generation from

filter sales.

Milestones 1, 2 and 3 are complete. We continue to make progress on Milestones 4 and 5. We expect to generate revenues from the sale of
our filters in the first half of the 2018 calendar year, after completion of Milestones 4 and 5.

8 

 
 
 
 
 
 
 
 
 
Research and Development

Since  inception,  the  Company’s  focus  has  been  on  developing  an  innovative  mobile-wireless  filter  technology  with  a  compelling  value
proposition  to  our  potential  customers  and  a  significant  and  noticeable  impact  to  the  end  user.  Whereas  today’s  polycrystalline  material
(used to manufacture RF resonators and filters) is sputtered on a metal-coated carrier, our patented BulkONE® technology employs high
quality,  single-crystal  resonator  films,  which  are  used  as  the  enabler  to  create  high  performance  BAW  RF  filters.  This  single-crystal
material  is  a  key  differentiator  when  compared  to  the  incumbent  amorphous  thin-film  technologies  because  it  increases  the  acoustic
velocity  and  the  electromechanical  coupling  coefficient  in  the  resonator,  which  results  in  higher  filter  efficiencies  and  lower  power
consumption, leading to simplified RFFEs, longer battery life, reduced tissue heating, and ultimately lower manufacturing costs. Research
and development expense totaled $ 4,425,778 for the year ended June 30, 2017 and $1,758,701 for the year ended June 30, 2016. These
R&D  activities  focused  on  single-crystal  material  development  and  resonator  demonstration.  Current  R&D  investments  include  single-
crystal materials advancement, technology transfer to our manufacturing partner and resonator development and filter design.

As a result of our efforts, we developed and recently published a measured filter designed for 3.5GHz to 3.9GHz applications. Our focus is
now on improving the electromechanical coupling and quality factor of our resonator technology and the performance of our fabricated
filters through design improvements and process optimization experiments.

In  addition,  we  are  developing  technology  for  filters  applications  at  frequencies  greater  than  5GHz.  The  performance  of  early  work  on
resonators resonating at 5.798GHz was presented at a technical conference showing an electromechanical coupling coefficient (k2eff ) of
6.5%, obtained after de-embedding resonator characteristics from measured data.

Figure 4- Akoustis’ single crystal undoped AIN piezoelectric technology based 3.7GHz filter performance. The plot shows measured
narrow band S21 and S11 for the fabricated 3.7GHz filter, showing minimum insertion loss of approximately 2.dB.

Raw Materials

Within  its  internal  manufacturing  operation, Akoustis  sources  raw  materials,  process  gases,  metals  and  other  miscellaneous  supplies  to
fabricate its BAW RF filter circuits.  Materials range from substrates (used to deposit key piezoelectric materials) to standard dielectric-
based laminates (used for packaging of the RF filter circuits). The Company sources at least two types of substrate materials for its BAW
process and the Company has more than one supplier for each material type. Multiple process gases are used for material synthesis, process
etching and wafer treatment.  While there is more than one supplier for most process gases, the purity levels of such gases may change by
source.    Hence,  either  purification  or  process  requalification  may  be  required,  as  purchase  from  a  second  source  is  required.   Akoustis
sources various high purity metals for electrode formation and interconnect layers for its RF circuits.  Such metals are available in various
purity levels and are available from more than one supplier.  Other process handling hardware common to the semiconductor industry is
available in abundance from multiple suppliers. Consistent with other semiconductor manufacturers, the Company may have to work with
all its suppliers to ensure adequate supply of raw materials, process gases and metals as the Company ramps from R&D into high volume
manufacturing.

9 

 
 
 
 
 
 
 
 
 
 
Intellectual Property

We  rely  on  a  combination  of  intellectual  property  rights,  including  patents  and  trade  secrets,  along  with  copyrights,  trademarks  and
contractual obligations and restrictions to protect our core technology and business.

In  the  United  States  and  internationally  we  have  fourteen  (14)  patents,  of  which  three  (3)  patents  are  the  subject  to  a  license  agreement
requiring further negotiation, in addition to sixteen (16) pending patent applications. Our intellectual property relates directly to our single-
crystal BAW technology, including materials and device designs, methods of manufacture, integrated circuit designs, wafer packaging, and
point of use (to include mobile applications). Our patents expire between 2031 and 2033. We intend to continue to innovate and expand our
patent portfolio, and when appropriate, we will look to purchase license(s) that grant access to additional intellectual property that enables,
enhances or further expands our technical capabilities and/or product.

We  believe  that  it  is  likely  that  Akoustis  will  have  competitive  advantages  from  rights  granted  under  our  patent  applications.  Some
applications, however, may not result in the issuance of any patents. In addition, any future patent may be opposed, contested, circumvented
or  designed  around  by  a  third  party  or  found  to  be  unenforceable  or  invalidated.  Others  may  develop  technologies  that  are  similar  or
superior to our proprietary technologies, duplicate our proprietary technologies or design around patents owned or licensed by us.

We  generally  control  access  to,  and  use  of,  our  confidential  information  through  the  use  of  internal  and  external  controls,  including
contractual protections with employees, contractors and customers. We rely in part on the United States and international copyright laws to
protect our intellectual property. All employees and consultants are required to execute confidentiality agreements in connection with their
employment and consulting relationships with us. We also require them to agree to disclose and assign to us all inventions conceived or
made in connection with the employment or consulting relationship.

Akoustis and BulkONE are trademarks of Akoustis, Inc.

Competition

The  RF  filter  market  is  controlled  by  a  relatively  small  number  of  RF  component  suppliers.  These  companies  include,  among  others,
Broadcom (previously known as Avago Technologies Ltd.), Murata Manufacturing Co., Ltd., Qorvo, Inc., Skyworks Solutions Inc., Taiyo
Yuden,  and  TDK  Epcos.  Broadcom  and  Qorvo,  Inc.  dominate  the  high  band  BAW  filter  market,  controlling  a  significant  portion  of  the
customer base and are increasing capacity to meet the growing RF filter demand of the 4G/LTE market.

Upon completion of our product development, we will compete directly with these companies to secure design slots inside RFFE modules
- targeting companies that procure filters or internally source filters. While many of our competitors have more resources than we have, we
believe that our filter designs will be superior in performance, and we will approach prospective customers as a pure-play filter supplier,
offering advantages in performance over the full frequency range at competitive costs. Our challenge will be to convince our customers
that we have a strong intellectual property position, we will be able to deliver in volume, that we will meet their price targets, and that we
can satisfy reliability and other requirements. For a list of other competitive factors, see “Item 1A. Risk Factors — We are still developing
our products, and they may not be accepted in the market.”

10 

 
 
 
 
 
 
 
 
 
 
 
Employees

We  place  an  emphasis  on  hiring  the  best  talent  at  the  right  time  to  enable  our  core  technology  and  business  growth.  This  includes
establishing  a  competitive  compensation  and  benefits  package,  thereby  enhancing  our  ability  to  recruit  experienced  personnel  and  key
technologists. We currently have a total of 58 full-time employees plus 5 part-time employees, including 33 full-time employees located in
the Canandaigua NY facility and 25 full-time and 5 part-time employees in our North Carolina facility. We will continue to hire specific
and targeted positions to further enable our technology and manufacturing capabilities as and when appropriate.

Government Regulations

Our business and products in development are subject to regulation by various federal and state governmental agencies, including the radio
frequency  emission  regulatory  activities  of  the  Federal  Communications  Commission  (“FCC”),  the  consumer  protection  laws  of  the
Federal Trade Commission, the import/export regulatory activities of the Department of Commerce, the product safety regulatory activities
of the Consumer Products Safety Commission, and the environmental regulatory activities of the Environmental Protection Agency.

The rules and regulations of the FCC limit the RF used by, and level of power emitting from, electronic equipment. Our RF filters, as a key
element enabling consumer electronic smartphone equipment, are required to comply with these FCC rules and may require certification,
verification or registration of our RF filters with the FCC. Certification and verification of new equipment requires testing to ensure the
equipment’s compliance with the FCC’s rules. The equipment must be labeled according to the FCC’s rules to show compliance with these
rules. Testing, processing of the FCC’s equipment certificate or FCC registration and labeling may increase development and production
costs  and  could  delay  the  implementation  of  our  BulkONE®  acoustic  wave  resonator  technology  for  our  RF  filters  and  the  launch  and
commercial productions of our filters into the U.S. market. Electronic equipment permitted or authorized to be used by us through FCC
certification or verification procedures must not cause harmful interference to licensed FCC users, and may be subject to RF interference
from licensed FCC users. Selling, leasing or importing non-compliant equipment is considered a violation of FCC rules and federal law,
and violators may be subject to an enforcement action by the FCC. Any failure to comply with the applicable rules and regulations of the
FCC  could  have  an  adverse  effect  on  our  business,  operating  results  and  financial  condition  by  increasing  our  compliance  costs  and/or
limiting our sales in the United States.

The semiconductor and electronics industries also have been subject to increasing environmental regulations. A number of domestic and
foreign jurisdictions seek to restrict the use of various substances, a number of which have been used in our products in development or
processes.  While  we  have  implemented  a  compliance  program  to  ensure  our  product  offering  meets  these  regulations,  there  may  be
instances where alternative substances will not be available or commercially feasible, or may only be available from a single source, or may
be significantly more expensive than their restricted counterparts. Additionally, if we were found to be non-compliant with any such rule or
regulation,  we  could  be  subject  to  fines,  penalties  and/or  restrictions  imposed  by  government  agencies  that  could  adversely  affect  our
operating results. Our cost to maintain compliance with existing environmental regulations is expected to be nominal based on our structure
in  which  we  outsource  a  majority  of  our  operations  to  suppliers  that  are  responsible  for  meeting  environmental  regulations.  We  will
continue to monitor our quality program and expand as required to maintain compliance and ability to audit our supply chain.

Noncompliance  with  applicable  regulations  or  requirements  could  subject  us  to  investigations,  sanctions,  mandatory  product  recalls,
enforcement actions, disgorgement of profits, fines, damages, civil and criminal penalties, or injunctions. An adverse outcome in any such
litigation  could  require  us  to  pay  contractual  damages,  compensatory  damages,  punitive  damages,  attorneys’  fees  and  costs.  These
enforcement actions could harm our business, financial condition and results of operations. If any governmental sanctions are imposed, or
if we do not prevail in any possible civil or criminal litigation, our business, financial condition and results of operations could be materially
adversely affected. In addition, responding to any action will likely result in a significant diversion of management’s attention and resources
and an increase in professional fees.

11 

 
 
 
 
 
 
 
 
 
ITEM 1A.       RISK FACTORS

An investment in shares of our Common Stock is highly speculative and involves a high degree of risk. We face a variety of risks that may
affect our operations or financial results, and many of those risks are driven by factors that we cannot control or predict. Before investing
in our Common Stock, you should carefully consider the following risks, together with the financial and other information contained in this
Report.  If  any  of  the  following  risks  actually  occurs,  our  business,  prospects,  financial  condition  and  results  of  operations  could  be
materially adversely affected. In that case, the trading price of our Common Stock would likely decline and you may lose all or a part of
your investment. Only those investors who can bear the risk of loss of their entire investment should invest in our Common Stock.

Prospective  investors  should  consider  carefully  whether  an  investment  in  the  Company  is  suitable  for  them  in  light  of  the  information
contained in this Report and the financial resources available to them. The risks described below do not purport to be all the risks to which
the  Company  or  the  Company  could  be  exposed.  This  section  is  a  summary  of  the  risks  that  we  presently  believe  are  material  to  the
operations of the Company. Additional risks of which we are not presently aware or which we presently deem immaterial may also impair
the Company’s business, financial condition or results of operations.

Risks Related to our Business and the Industry in Which We Operate

We have a limited operating history upon which investors can evaluate our business and future prospects.

We are an early stage company that has not yet begun any commercial operations. Historically, we were a shell company with no operating
history and no assets other than cash. Upon consummation of a merger with Akoustis, Inc. in May 2015, we redirected our business focus
towards  the  development  of  advanced  single-crystal  BAW  filter  products  for  RFFEs  for  use  in  the  mobile  wireless  device  industry.
Although Akoustis since its inception focused its activity on R&D of high efficiency acoustic wave resonator technology utilizing single-
crystal piezoelectric materials, this technology has not yet obtained marketing approval or been verified in commercial manufacturing, and
its RF filters have not generated any material level of sales.

Since our expectations of potential customers and future demand for our products are based on estimates of planned operations rather than
experience, it is difficult for our management and our investors to accurately forecast and evaluate our future prospects and our revenues.
Our  proposed  operations  are  therefore  subject  to  all  of  the  risks  inherent  in  light  of  the  expenses,  difficulties,  complications  and  delays
frequently encountered in connection with the formation of any new business and the development of a product, as well as those risks that
are specific to our business in particular. An investment in an early stage company such as ours involves a degree of risk, including the
possibility that your entire investment may be lost. The risks include, but are not limited to, our reliance on third parties to complete some
processes for the manufacturing of our product, the possibility that we will not be able to develop functional and scalable products, or that
although functional and scalable, our products and/or services will not be accepted in the market. To successfully introduce and market our
products at a profit, we must establish brand name recognition and competitive advantages for our products. There are no assurances that
the  Company  can  successfully  address  these  challenges.  If  it  is  unsuccessful,  the  Company  and  its  business,  financial  condition  and
operating results will be materially and adversely affected.

We may not generate revenues or achieve profitability.

We have incurred operating losses since our inception and expect to continue to have negative cash flow from operations. We have only
generated minimal revenues from shipment of product while our primary sources of funds have been R&D grants, private placements of
our equity, and debt. We have experienced net losses of approximately $15.8 million for the period from May 12, 2014 (inception) to June
30, 2017. Our future profitability will depend on our ability to create a sustainable business model and generate revenues, which is subject
to a number of factors, including our ability to successfully implement our strategies and execute our R&D plan, our ability to implement
our  improved  design  and  cost  reductions  into  manufacturing  of  our  RF  filters,  the  availability  of  funding,  market  acceptance  of  our
products, consumer demand for end products incorporating our products, our ability to compete effectively in a crowded field, our ability to
respond effectively to technological advances by timely introducing our new technologies and products, and global economic and political
conditions.

12 

 
 
 
 
 
 
 
 
 
 
 
Our future profitability also depends on our expense levels, which are influenced by a number of factors, including the resources we devote
to  developing  and  supporting  our  projects  and  potential  products,  the  continued  progress  of  our  research  and  development  of  potential
products, our ability to improve R&D efficiencies, license fees or royalties we may be required to pay, and the potential need to acquire
licenses to new technology, the availability of intellectual property for licensing or acquisition, or the use of our technology in new markets,
which could require us to pay unanticipated license fees and royalties in connection with these licenses.

Our  development  and  commercialization  efforts  may  prove  more  expensive  than  we  currently  anticipate,  and  we  may  not  succeed  in
increasing our revenues to offset higher expenses. These expenses, among other things, may cause our net income and working capital to
decrease.  If  we  fail  to  generate  revenue  and  manage  our  expenses,  we  may  never  achieve  profitability,  which  would  adversely  and
materially affect our ability to provide a return to our investors.

The industry and the markets in which the Company operates are highly competitive and subject to rapid technological change.

The markets in which we intend to compete are intensely competitive. We will operate primarily in the industry that designs and produces
semiconductor components for wireless communications and other wireless devices, which is subject to rapid changes in both product and
process technologies based on demand and evolving industry standards. The intended markets for our products are characterized by:

● rapid technological developments and product evolution,

● rapid changes in customer requirements,

● frequent new product introductions and enhancements,

● continuous demand for higher levels of integration, decreased size and decreased power consumption,

● short product life cycles with declining prices over the life cycle of the product, and

● evolving industry standards.

The continuous evolutions of these technologies and frequent introduction of new products and enhancements have generally resulted in
short  product  life  cycles  for  wireless  semiconductor  products,  in  general,  and  for  RFFEs,  in  particular.  Our  R&D  activity  and  resulting
products could become obsolete or less competitive sooner than anticipated because of a faster than anticipated change in one or more of
the above-noted factors. Therefore, in order for our RF filters to be competitive and achieve market acceptance, we need to keep pace with
rapid development of new process technologies, which requires us to:

● respond effectively to technological advances by timely introducing new technologies and products,

● successfully implement our strategies and execute our R&D plan in practice,

● improve the efficiency of our technology, and

● implement our improved design and cost reductions into manufacturing of our RF filters.

13 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We are still developing our products, and they may not be accepted in the market.

Although  we  believe  that  our  BulkONE®  acoustic  wave  resonator  technology  that  utilizes  single-crystal  piezoelectric  materials  will
provide  material  advantages  over  existing  RF  filters  and  are  currently  developing  various  methods  of  integration  suitable  for
implementation  of  this  technology  to  RF  filters,  we  cannot  be  certain  that  our  RF  filters  will  be  able  to  achieve  or  maintain  market
acceptance. While we have fabricated R&D resonators that demonstrate the feasibility of our BulkONE® technology, we are still in the
process of stabilizing this technology into our NY fabrication facility for manufacturing of our RF filters, and this technology is not verified
yet in practice or on a commercial scale. There are also no records that can demonstrate our ability to successfully overcome many of the
risks and uncertainties frequently encountered by companies in new and rapidly evolving fields. In addition to our limited operating history,
we will depend on a limited number of manufacturers and customers for a significant portion of our revenue in the future and we cannot
guarantee their acceptance of our products. Each of these factors may adversely affect our ability to implement our business strategy and
achieve our business goals.

The successful development of our BulkONE® technology and market acceptance of our RF filters will be highly complex and will depend
on the following principal competitive factors, including our ability to:

● comply with industry standards and effectively compete against current technology for producing RF acoustic wave filters,

● differentiate our  products  from  offerings  of  our  competitors  by  delivering  RF  filters  that  are  higher  in  quality,  reliability  and

technical performance,

● anticipate customer  and  market  requirements,  changes  in  technology  and  industry  standards  and  timely  develop  improved

technologies that meet high levels of satisfaction of our potential customers,

● maintain, grow and manage our internal teams to the extent we increase our operations and develop new segments of our business,

● develop and maintain successful collaborative, strategic, and other relationships with manufacturers, customers and contractors,

● protect, develop or otherwise obtain adequate intellectual property for our technology and our filters; and

● obtain strong financial, sales, marketing, technical and other resources necessary to develop, test, manufacture, commercialize and

market our filters.

If  we  are  unsuccessful  in  accomplishing  these  objectives,  we  may  not  be  able  to  compete  successfully  against  current  and  potential
competitors. As  a  result,  our  BulkONE®  technology  and  our  RF  filters  may  not  be  accepted  in  the  market  and  we  may  never  attain
profitability.

We will face intense competition, which may cause pricing pressures, decreased gross margins and loss of potential market share and
may materially and adversely affect our business, financial condition and results of operations.

We will compete with U.S. and international semiconductor manufacturers and mobile semiconductor companies of all sizes in terms of
resources and market share, some of whom have significantly greater financial, technical, manufacturing and marketing resources than we
do. We expect competition in our markets to intensify as new competitors enter the RF component market, existing competitors merge or
form alliances, and new technologies emerge. Our competitors may introduce new solutions and technologies that are superior to our BAW
technology, are verified on a commercial scale, and have achieved widespread market acceptance. Certain of our competitors may be able
to adapt more quickly than we can to new or emerging technologies and changes in customer requirements or may be able to devote greater
resources  to  the  development,  promotion  and  sale  of  their  products  than  we  can.  This  implementation  may  require  us  to  modify  the
manufacturing process for our filters, design new products to more stringent standards, and redesign some existing products, which may
prove difficult for us and result in delays in product deliveries and increased expenses.

14 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Increased competition could also result in pricing pressures, declining average selling prices for our RF filters, decreased gross margins and
loss  of  potential  market  share.  We  will  need  to  make  substantial  investments  to  develop  these  enhancements  and  technologies,  and  we
cannot  assure  investors  that  we  will  have  funds  available  for  these  investments  or  that  these  enhancements  and  technologies  will  be
successful. If a competing technology emerges that is, or is perceived to be, superior to our existing technology and we are unable to adapt
to these changes and to compete effectively, our market share and financial condition could be materially and adversely affected, and our
business, revenue, and results of operations could be harmed.

Changes in general economic conditions, together with other factors, cause significant upturns and downturns in the industry, and our
business, therefore, may also experience cyclical fluctuations in the future.

From time to time, changes in general economic conditions, together with other factors, may cause significant upturns and downturns in the
semiconductor industry. These fluctuations are due to a number of factors, many of which are beyond our control, including:

● levels of inventory in our end markets,

● availability and cost of supply for manufacturing of our RF filters using our design,

● changes in end-user demand for the products manufactured with our technology and sold by our prospective customers,

● industry production capacity levels and fluctuations in industry manufacturing yields,

● market acceptance of our future customers’ products that incorporate our RF filters,

● the gain or loss of significant customers,

● the effects of competitive pricing pressures, including decreases in average selling prices of our RF filters,

● new product and technology introductions by competitors,

● changes in the mix of products produced and sold, and

● intellectual property disputes.

As  a  result,  the  demand  for  our  products  can  change  quickly  and  in  ways  we  may  not  anticipate,  and  our  business,  therefore,  may  also
experience cyclical fluctuations in future operating results. In addition, future downturns in the electronic systems industry could adversely
impact our revenue and harm our business, financial condition and results of operations.

If we are unable to attract and retain qualified personnel to contribute to the development, manufacture and sale of our products, we
may not be able to effectively operate our business.

As the source of our technological and product innovations, our key technical personnel represent a significant asset. We believe that our
future success is highly dependent on the continued services of our current key officers, employees, and Board members, as well as our
ability to attract and retain highly skilled and experienced technical personnel. The loss of their services could have a detrimental effect on
our  operations.  Specifically,  the  loss  of  the  services  of  Jeffrey  Shealy,  our  President  and  Chief  Executive  Officer,  John  Kurtzweil,  our
Chief  Financial  Officer,  David Aichele,  our  Vice  President  of  Business  Development,  Richard  Ogawa,  our  Special  Legal Advisor,  any
major change in our Board or management, or our inability to attract, retain and motivate qualified personnel could have a material adverse
effect  on  our  ability  to  operate  our  business.  The  competition  for  management  and  technical  personnel  is  intense  in  the  wireless
semiconductor  industry,  and  therefore,  we  cannot  assure  you  that  we  will  be  able  to  attract  and  retain  qualified  management  and  other
personnel necessary for the design, development, manufacture and sale of our products.

15 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Product defects could adversely affect the results of our operations and may expose us to product liability claims.

The fabrication of RF filters is a complex and precise process. If we or any of our manufacturers fails to successfully manufacture wafers
that conform to our design specifications and the strict regulatory requirements of the FCC, it may result in substantial risk of undetected
flaws in components or other materials used by our manufacturers during fabrication of our filters and could lead to product defects and
costs to repair or replace these parts or materials. Any such failure would significantly impact our ability to develop and implement our
technology and to improve performance of our RF filters. Our inability to comply with such requirements could result in significant costs,
as well as negative publicity and damage to our reputation that could reduce demand for our products.

We also could be subject to product liability lawsuits if the wireless devices containing our RF filters cause injury. Recently interest groups
have requested that the FCC investigate claims that wireless communications technologies pose health concerns and cause interference with
airbags, hearing aids and medical devices. Any such product liability claims may include allegations of defects in manufacturing, defects in
design, a failure to warn of dangers inherent in the product or inadequate disclosure of risks related to the use of our product, negligence,
strict liability and a breach of warranties. Claims could also be asserted under state consumer protection acts.

If we are unable to establish effective marketing and sales capabilities or enter into agreements with third parties to market and sell our
RF filters, we may not be able to effectively generate product revenues.

We have limited experience selling, marketing or distributing products and currently have a small internal marketing and sales force. In
order  to  launch  and  commercialize  our  technology  and  our  RF  filters,  we  must  build  on  a  territory-by-territory  basis  marketing,  sales,
distribution, managerial and other non-technical capabilities or make arrangements with third parties to perform these services, and we may
not be successful in doing so. Therefore, we may choose to collaborate, either globally or on a territory-by-territory basis, with third parties
that have direct sales forces and established distribution systems, either to augment our own sales force and distribution systems or in lieu of
our own sales force and distribution systems. If so, our success will depend, in part, on our ability to enter into and maintain collaborative
relationships for such capabilities, such collaborator’s strategic interest in the products under development and such collaborator’s ability to
successfully market and sell any such products.

If  we  are  unable  to  enter  into  such  arrangements  when  needed  on  acceptable  terms  or  at  all,  we  may  not  be  able  to  successfully
commercialize our filters. Further, to the extent that we depend on third parties for marketing and distribution, any revenues we receive will
depend upon the efforts of such third parties, and there can be no assurance that such efforts will be successful. If we decide in the future to
establish  an  internal  sales  and  marketing  team  with  technical  expertise  and  supporting  distribution  capabilities  to  commercialize  our  RF
filters, it could be expensive and time consuming and would require significant attention of our executive officers to manage. We may also
not have sufficient resources to allocate to the sales and marketing of our filters. Any failure or delay in the development of sales, marketing
and distribution capabilities, either through collaboration with one or more third parties or through internal efforts, would adversely impact
the commercialization of any of our products that we obtain approval to market. As a result, our future product revenue would suffer and
we may incur significant additional losses.

Risks Related to Our Intellectual Property

If we fail to obtain, maintain and enforce our intellectual property rights, we may not be able to prevent third parties from using our
proprietary technologies.

Our long-term success largely depends on our ability to market technologically competitive products which, in turn, largely depends on our
ability  to  obtain  and  maintain  adequate  intellectual  property  protection  and  to  enforce  our  proprietary  rights  without  infringing  the
proprietary  rights  of  third  parties.  While  we  rely  upon  a  combination  of  our  patent  applications  currently  pending  with  the  United  State
Patent and Trademark Office (“USPTO”), our trademarks, copyrights, trade secret protection and confidentiality agreements to protect the
intellectual property related to our technologies, there can be no assurance that

16 

 
 
 
 
 
 
 
 
 
 
 
● our currently pending or future patent applications will result in issued patents,

● our limited patent portfolio will provide adequate protection to our core technology,

● we will succeed in protecting our technology adequately in all key jurisdictions, or

● we can prevent third parties from disclosure or misappropriation of our proprietary information which could enable competitors to
quickly  duplicate  or  surpass  our  technological  achievements,  thus  eroding  any  competitive  advantage  we  may  derive  from the
proprietary information.

In addition, we intend to expand our international presence, and effective patent, copyright, trademark and trade secret protection may not
be available or may be limited in foreign countries.

We have a limited number of patent applications, which may not result in issued patents or patents that fully protect our intellectual
property.

In the United States and internationally we have sixteen (16) pending patent applications; however, there is no assurance that any of the
pending applications or our future patent applications will result in patents being issued, or that any patents that may be issued as a result of
existing or future applications will provide meaningful protection or commercial advantage to us.

The process of seeking patent protection in the United States and abroad can be long and expensive. Since patent applications in the United
States and most other countries are confidential for a period of time after filing, we cannot be certain at the time of filing that we are the
first  to  file  any  patent  application  related  to  our  single-crystal  acoustic  wave  filter  technology.  In  addition,  patent  applications  are  often
published as part of the patent application process, even if such applications do not issue as patents. When published, such applications will
become publicly available, and proprietary information disclosed in the application will become available to others. While at present we are
unaware of competing patent applications, competing applications could potentially surface.

Even if all of our pending patent applications are granted and result in registration of our patents, we cannot predict the breadth of claims
that may be allowed or enforced, or that the scope of any patent rights could provide a sufficient degree of protection that could permit us to
gain or keep our competitive advantage with respect to these products and technologies. For example, we cannot predict:

● the degree and range of protection any patents will afford us against competitors, including whether third parties will find ways to

make, use, sell, offer to sell or import competitive products without infringing our patents;

● if and when patents will be issued;

● if third parties will obtain patents claiming inventions similar to those covered by our patents and patent applications;

● if third parties have blocking patents that could be used to prevent us from marketing our own patented products and practicing our

own technology; or

● whether we will need to initiate litigation or administrative proceedings (e.g. at the USPTO) in connection with patent rights, which

may be costly whether we win or lose.

As  a  result,  the  patent  applications  we  own  may  fail  to  result  in  issued  patents  in  the  United  States.  Third  parties  may  challenge  the
validity,  enforceability  or  scope  of  any  issued  patents  or  patents  issued  to  us  in  the  future,  which  may  result  in  those  patents  being
narrowed, invalidated or held unenforceable. Even if they are unchallenged, our patents and patent applications may not adequately protect
our  intellectual  property  or  prevent  others  from  developing  similar  products  that  do  not  infringe  the  claims  made  in  our  patents.  If  the
breadth  or  strength  of  protection  provided  by  the  patents  we  hold  or  pursue  is  threatened,  we  may  not  be  able  to  prevent  others  from
offering  similar  technology  and  products  in  the  RFFE  mobile  market  and  our  ability  to  commercialize  our  RF  filters  with  technology
protected by those patents could be threatened.

17 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
If  we  fail  to  obtain  issued  patents  outside  of  the  United  States,  our  ability  to  prevent  misappropriation  of  our  proprietary  information  or
infringement of our intellectual property rights in countries outside of the United States where our filters may be sold in the future may be
significantly limited. If we file foreign patent applications related to our pending U.S. patent applications or to our issued patents in the
United States, these applications may be contested and fail to result in issued patents outside of the United States or we may be required to
narrow  our  claims.  Even  if  some  or  all  of  our  patent  applications  are  granted  outside  of  the  United  States  and  result  in  issued  patents,
effective enforcement of rights granted by these patents in some countries may not be available due to the differences in foreign patent and
other laws concerning intellectual property rights, a relatively weak legal regime protecting intellectual property rights in these countries,
and  because  it  is  difficult,  expensive  and  time-consuming  to  police  unauthorized  use  of  our  intellectual  property  when  infringers  are
overseas. This failure to obtain or maintain adequate protection of our intellectual property rights outside of the United States could have a
materially adverse effect on our business, results of operations and financial conditions.

We may be involved in lawsuits to protect or enforce our patents, which could be expensive, time-consuming and unsuccessful.

Competitors may infringe our patents or the patents of our potential licensors. To attempt to stop infringement or unauthorized use, we may
need to file infringement claims, which can be expensive and time consuming and distract management.

If we pursue any infringement proceeding, a court may decide that a patent of ours or our licensors is not valid or is unenforceable, or may
refuse to stop the other party from using the relevant technology on the grounds that our patents do not cover the technology in question.
Additionally,  any  enforcement  of  our  patents  may  provoke  third  parties  to  assert  counterclaims  against  us.  Some  of  our  current  and
potential competitors have the ability to dedicate substantially greater resources to enforcing their intellectual property rights than we have.
Moreover, the legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, which
could reduce the likelihood of success of, or the amount of damages that could be awarded resulting from, any infringement proceeding we
pursue  in  any  such  jurisdiction. An  adverse  result  in  any  infringement  litigation  or  defense  proceedings  could  put  one  or  more  of  our
patents at risk of being invalidated, held unenforceable, or interpreted narrowly and could put our patent applications at risk of not issuing,
which could limit the ability of our filters to compete in those jurisdictions.

Interference proceedings could be provoked by third parties or brought by the USPTO to determine the priority of inventions with respect
to our patents or patent applications. An unfavorable outcome could require us to cease using the related technology or to attempt to license
rights to use it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially
reasonable terms, or at all.

We  need  to  protect  our  trademark  rights  and  disclosure  of  our  trade  secrets  to  prevent  competitors  from  taking  advantage  of  our
goodwill.

We  believe  that  the  protection  of  our  trademark  rights  is  an  important  factor  in  product  recognition,  protecting  our  brand,  maintaining
goodwill, and maintaining or increasing market share. We currently have two trademarks that we have filed to register with the USPTO —
the Akoustis  and  BulkONE®  marks  —  and  we  may  expend  substantial  cost  and  effort  in  an  attempt  to  register  new  trademarks  and
maintain and enforce our trademark rights. If we do not adequately protect our rights in our trademarks from infringement, any goodwill
that we have developed in those trademarks could be lost or impaired.

Third  parties  may  claim  that  the  sale  or  promotion  of  our  products,  when  and  if  we  have  any,  may  infringe  on  the  trademark  rights  of
others.  Trademark  infringement  problems  occur  frequently  in  connection  with  the  sale  and  marketing  of  products  in  the  RFFE  mobile
industry. If we become involved in any dispute regarding our trademark rights, regardless of whether we prevail, we could be required to
engage  in  costly,  distracting  and  time-consuming  litigation  that  could  harm  our  business.  If  the  trademarks  we  use  are  found  to  infringe
upon the trademark of another company, we could be liable for damages and be forced to stop using those trademarks, and as result, we
could lose all the goodwill that has been developed in those trademarks.

18 

 
 
 
 
 
 
 
 
 
 
In addition to the protection afforded by patents and trademarks, we seek to rely on copyright, trade secret protection and confidentiality
agreements  to  protect  proprietary  know-how  that  is  not  patentable,  processes  for  which  patents  are  difficult  to  enforce  and  any  other
elements of our processes that involve proprietary know-how, information or technology that is not covered by patents. For Akoustis, this
includes  chip  layouts,  circuit  designs,  resonator  layouts  and  implementation,  and  membrane  definition. Although  we  require  all  of  our
employees  and  certain  consultants  and  advisors  to  assign  inventions  to  us,  and  all  of  our  employees,  consultants,  advisors  and  any  third
parties who have access to our proprietary know-how, information or technology to enter into confidentiality agreements, our trade secrets
and  other  proprietary  information  may  be  disclosed  or  competitors  may  otherwise  gain  access  to  such  information  or  independently
develop  substantially  equivalent  information.  If  we  are  unable  to  prevent  material  disclosure  of  the  intellectual  property  related  to  our
technologies to third parties, we will not be able to establish or maintain the competitive advantage that we believe is provided by such
intellectual property, which would weaken our competitive market position, and materially adversely affect our business and operational
results.

Development of certain technologies with our manufacturers may result in restrictions on jointly-developed intellectual property.

In order to maintain and expand our strategic relationship with manufacturers of our filters, we may, from time to time, develop certain
technologies  jointly  with  these  manufacturers  and  file  for  further  intellectual  property  protection  and/or  seek  to  commercialize  such
technologies.  We  may  enter  into  joint  development  agreements  with  manufacturers  to  provide  for  joint  development  works  and  joint
intellectual property rights by us and by such manufacturer. Such agreements may restrict our commercial use of such intellectual property,
or may require written consent from, or a separate agreement with, that manufacturer. In other cases, we may not have any rights to use
intellectual property solely developed and owned by such manufacturer or another third party. If we cannot obtain commercial use rights
for such jointly-owned intellectual property or intellectual property solely owned by these manufacturers, our future product development
and commercialization plans may be adversely affected.

We may be subject to claims of infringement, misappropriation or misuse of third party intellectual property that, regardless of merit,
could result in significant expense and loss of our intellectual property rights.

The semiconductor industry is characterized by the vigorous pursuit and protection of intellectual property rights. We have not undertaken
a comprehensive review of the rights of third parties in our field. From time to time, we may receive notices or inquiries from third parties
regarding  our  products  or  the  manner  in  which  we  conduct  our  business  suggesting  that  we  may  be  infringing,  misappropriating  or
otherwise  misusing  patent,  copyright,  trademark,  trade  secret  and  other  intellectual  property  rights.  Any  claims  that  our  technology
infringes,  misappropriates  or  otherwise  misuses  the  rights  of  third  parties,  regardless  of  their  merit  or  resolution,  could  be  expensive  to
litigate  or  settle  and  could  divert  the  efforts  and  attention  of  our  management  and  technical  personnel,  cause  significant  delays  and
materially disrupt the conduct of our business. We may not prevail in such proceedings given the complex technical issues and inherent
uncertainties in intellectual property litigation. If such proceedings result in an adverse outcome, we could be required to:

● pay substantial damages, including treble damages if we were held to have willfully infringed;

● cease the manufacture, offering for sale or sale of the infringing technology or processes;

● expend significant resources to develop non-infringing technology or processes;

● obtain a license from a third party, which may not be available on commercially reasonable terms, or may not be available at all; or

● lose the opportunity to license our technology to others or to collect royalty payments based upon successful protection and assertion

of our intellectual property against others.

19 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In  addition,  our  agreements  with  prospective  customers  and  manufacturing  partners  may  require  us  to  indemnify  such  customers  and
manufacturing  partners  for  third  party  intellectual  property  infringement  claims.  Pursuant  to  such  agreements,  we  may  be  required  to
defend such customers and manufacturing partners against certain claims that could cause us to incur additional costs. While we endeavor
to include as part of such indemnification obligations a provision permitting us to assume the defense of any indemnification claim, not all
of  our  current  agreements  contain  such  a  provision  and  we  cannot  provide  any  assurance  that  our  future  agreements  will  contain  such  a
provision, which could result in increased exposure to us in the case of an indemnification claim.

Defense of any intellectual property infringement claims against us, regardless of their merit, would involve substantial litigation expense
and would be a significant diversion of resources from our business. In the event of a successful claim of infringement against us, we may
have to pay substantial damages, obtain one or more licenses from third parties, limit our business to avoid the infringing activities, pay
royalties  and/or  redesign  our  infringing  technology  or  alter  related  formulations,  processes,  methods  or  other  technologies,  any  or  all  of
which may be impossible or require substantial time and monetary expenditure. The occurrence of any of the above events could prevent us
from continuing to develop and commercialize our filters and our business could materially suffer.

Risks Related to our Financial Condition

We  have  a  history  of  losses,  will  need  substantial  additional  funding  to  continue  our  operations  and  may  not  achieve  or  sustain
profitability in the future.

Our operations have consumed substantial amounts of cash since inception. We have incurred losses since our incorporation and formation
in 2014. Although our newly acquired STC-MEMS Business has a potential revenue stream estimation of $1.5 million in the current fiscal
year, (which are not guaranteed), and although we plan to apply for additional grants in the calendar years 2017 and 2018, we do not expect
meaningful  revenues  from  our  resonator  technology  until  at  least  the  first  half  of  the  calendar  year  2018.  There  is  no  guarantee  that  the
grants  we  apply  for  will  be  awarded  to  us,  and  if  our  forecasts  for  the  Company  prove  incorrect,  the  business,  operating  results  and
financial condition of the Company will be materially and adversely affected. We anticipate that our operating expenses will increase in the
foreseeable future as we continue to pursue the development of our patent-pending single-crystal acoustic wave filter technology, invest in
marketing, sales and distribution of our RF filters to grow our business, acquire customers, commercialize our technology in the mobile
wireless market and continue the transition of our manufacturing to our STC-MEMS Business. These efforts may prove more expensive
than  we  currently  anticipate,  and  we  may  not  succeed  in  generating  sufficient  revenues  to  offset  these  higher  expenses.  In  addition,  we
expect to incur significant expenses related to regulatory requirements and our ability to obtain, protect, and defend our intellectual property
rights. 

We may also encounter unforeseen expenses, difficulties, complications, delays and other unknown factors that may increase our capital
needs and/or cause us to spend our cash resources faster than we expect. Accordingly, we will need to obtain substantial additional funding
in order to continue our operations.

To date, we have financed our operations through a mix of investments from private investors, the incurrence of debt, and grant funding,
and we expect to continue to utilize such means of financing for the foreseeable future. Additional funding from those or other sources may
not be available when or in the amounts needed, on acceptable terms, or at all. If we raise capital through the sale of equity, or securities
convertible into equity, it would result in dilution to our then existing stockholders, which could be significant depending on the price at
which we may be able to sell our securities. If we raise additional capital through the incurrence of indebtedness, we would likely become
subject to covenants restricting our business activities, and holders of debt instruments may have rights and privileges senior to those of our
equity investors. In addition, servicing the interest and principal repayment obligations under debt facilities could divert funds that would
otherwise be available to support research and development, or commercialization activities. If we are unable to raise capital when needed
or on attractive terms, we could be forced to delay, reduce or eliminate our R&D programs for our acoustic wave filter technology or any
future commercialization efforts. Any of these events could materially and adversely affect our business, financial condition and prospects,
and could cause our business to fail.

20 

 
 
 
 
 
 
 
 
 
Our independent registered public accounting firm has expressed doubt about our ability to continue as a going concern.

The  Company’s  historical  financial  statements  have  been  prepared  under  the  assumption  that  we  will  continue  as  a  going  concern.  Our
independent  registered  public  accounting  firm  has  issued  a  report  that  included  an  explanatory  paragraph  referring  to  our  recurring  net
losses and accumulated deficit and expressing substantial doubt in our ability to continue as a going concern. Our ability to continue as a
going  concern  is  dependent  upon  our  ability  to  obtain  additional  equity  financing  or  other  capital,  attain  further  operating  efficiencies,
reduce expenditures, and, ultimately, to generate revenue. Our financial statements do not include any adjustments that might result from
the  outcome  of  this  uncertainty.  However,  if  adequate  funds  are  not  available  to  us  when  we  need  them,  and  we  are  unable  to
commercialize our products giving us access to additional cash resources, we will be required to curtail our operations, which would, in
turn, further raise substantial doubt about our ability to continue as a going concern.

Risk Related to Managing Any Growth We May Experience

We  may  engage  in  future  acquisitions  that  could  disrupt  our  business,  cause  dilution  to  our  shareholders  and  harm  our  financial
condition and operating results.

While we currently have no specific plans to acquire any other businesses, we may, in the future, make acquisitions of, or investments in,
companies that we believe have products or capabilities that are a strategic or commercial fit with our current business or otherwise offer
opportunities for our company. In connection with these acquisitions or investments, we may:

● issue Common Stock or other forms of equity that would dilute our existing shareholders’ percentage of ownership,

● incur debt and assume liabilities, and

● incur amortization expenses related to intangible assets or incur large and immediate write-offs.

We may not be able to complete acquisitions on favorable terms, if at all. If we do complete an acquisition, we cannot assure you that it
will  ultimately  strengthen  our  competitive  position  or  that  it  will  be  viewed  positively  by  customers,  financial  markets  or  investors.
Furthermore, future acquisitions could pose numerous additional risks to our expected operations, including:

● problems integrating the purchased business, products or technologies,

● challenges in achieving strategic objectives, cost savings and other anticipated benefits,

● increases to our expenses,

● the assumption  of  significant  liabilities  that  exceed  the  limitations  of  any  applicable  indemnification  provisions  or  the  financial

resources of any indemnifying party,

● inability to maintain relationships with prospective key customers, vendors and other business partners of the acquired businesses,

● diversion of management’s attention from its day-to-day responsibilities,

21 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
● difficulty in maintaining controls, procedures and policies during the transition and integration,

● entrance into  marketplaces  where  we  have  no  or  limited  prior  experience  and  where  competitors  have  stronger  marketplace

positions,

● potential loss of key employees, particularly those of the acquired entity, and

● historical financial information may not be representative or indicative of our results as a combined company.

Our business and operations would suffer in the event of system failures, and our operations are vulnerable to interruption by natural
disasters, terrorist activity, power loss and other events beyond our control, the occurrence of which could materially harm our business.

Despite the implementation of security measures, our internal computer systems and those of our contractors and consultants are vulnerable
to damage from computer viruses, unauthorized access as well as telecommunication and electrical failures. While we have not experienced
any such system failure, accident or security breach to date, if such an event were to occur and cause interruptions in our operations, it could
result in a material disruption of our R&D. If any disruption or security breach resulted in a loss of or damage to our data or applications, or
inappropriate  disclosure  of  confidential  or  proprietary  information,  we  could  incur  liability  and/or  the  further  development  of  our
technology for RF filters could be delayed.

We are also vulnerable to accidents, electrical blackouts, labor strikes, terrorist activities, war and other natural disasters and other events
beyond our control, and we have not undertaken a systematic analysis of the potential consequences to our business as a result of any such
events and do not have an applicable recovery plan in place. We currently do not carry other business interruption insurance that would
compensate us for actual losses from interruptions of our business that may occur, and any losses or damages incurred by us could cause
our business to materially suffer.

We may be unable to successfully integrate the STC-MEMS Business with our current operations and strategic business plan.

We will be required to devote significant management attention and resources, including expenses to integrating the STC-MEMS Business
with  our  current  operations  and  to  developing  the  integrated  operations  in  accordance  with  our  strategic  business  plan.  There  is  no
guarantee that we will maintain existing customer/other relationships or the revenue stream of the STC-MEMS Business. We may fail to
realize some or all of the anticipated benefits of the acquisition of the STC-MEMS Business if the integration and development process
takes longer than expected or is costlier than expected.  Such failure may have a material adverse effect on our stock price, business, plan
of operation, and results of operations.

Risks Related to Regulatory Requirements

We could fail to maintain our Trusted Foundry accreditation in our New York Fabrication Facility.

Although  our  New  York  fabrication  facility  has  not  generated  any  revenue  to  date  from  its  Trusted  Foundry  accreditation,  a  failure  to
maintain  that  accreditation  in  the  future  could  hamper  our  ability  to  generate  product  and  foundry  services  revenue  related  to  potential
Aerospace and Defense customers.

22 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We may incur substantial expenses in connection with regulatory requirements, and any regulatory compliance failure could cause our
business to suffer.

The wireless communications industry is subject to ongoing regulatory obligations and review. See “Business — Government Regulations”
above. Maintaining compliance with these requirements may result in significant additional expense to us, and any failure to maintain such
compliance could cause our business to suffer.

Noncompliance with applicable regulations or requirements could also subject us to investigations, sanctions, mandatory product recalls,
enforcement actions, disgorgement of profits, fines, damages, civil and criminal penalties, or injunctions. An adverse outcome in any such
litigation  could  require  us  to  pay  contractual  damages,  compensatory  damages,  punitive  damages,  attorneys’  fees  and  costs.  These
enforcement actions could harm our business, financial condition and results of operations. If any governmental sanctions are imposed, or
if we do not prevail in any possible civil or criminal litigation, our business, financial condition and results of operations could be materially
adversely affected. In addition, responding to any action will likely result in a significant diversion of management’s attention and resources
and an increase in professional fees.

Compliance with regulations regarding the use of “conflict minerals” could limit the supply and increase the cost of certain metals used
in manufacturing our products.

Regulations in the United States require that we determine whether certain materials used in our products, referred to as conflict minerals,
originated in the Democratic Republic of the Congo or adjoining countries, or originated from recycled or scrap sources. We anticipate that
we  will  first  be  required  to  comply  with  the  SEC’s  conflict  minerals  rules  for  the  2017  calendar  year,  and  we  expect  to  incur  costs
associated with implementing policies and procedures to comply with the applicable rules and due diligence procedures. In addition, the
verification  and  reporting  requirements  could  affect  the  sourcing  and  availability  of  minerals  that  are  used  in  the  manufacture  of  our
products, and we may face reputational and competitive challenges if we are unable to sufficiently verify the origins of all conflict minerals
used in our products. We may also face challenges with government regulators, potential customers, suppliers and manufacturers if we are
unable to sufficiently verify that the metals used in our products are conflict free.

There could be an adverse change or increase in the laws and/or regulations governing our business.

We and our operating subsidiary are subject to various laws and regulations in different jurisdictions, and the interpretation and enforcement
of laws and regulations are subject to change. We also will be subject to different tax regulations in each of the jurisdictions where we will
conduct our business or where our management or the management of our operating subsidiary is located. We expect that the scope and
extent of regulation in these jurisdictions, as well as regulatory oversight and supervision, will generally continue to increase. There can be
no  assurance  that  future  regulatory,  judicial  and  legislative  changes  in  any  jurisdiction  will  not  have  a  material  adverse  effect  on  us  or
hinder  us  in  the  operation  of  our  business.  In  addition,  we  may  incur  substantial  costs  in  order  to  comply  with  current  or  future
environmental, health and safety laws and regulations applicable to us.

These current or future laws and regulations may impair our research, development or production efforts or impact the research activities
we pursue. Our failure to comply with these laws and regulations also may result in substantial fines, penalties or other sanctions, which
could cause our financial condition to suffer.

23 

 
 
 
 
 
 
 
 
 
 
Investment Risks

You could lose all of your investment.

An investment in our securities is speculative and involves a high degree of risk. Potential investors should be aware that the value of an
investment in the Company may go down as well as up. In addition, there can be no certainty that the market value of an investment in the
Company will fully reflect its underlying value. You could lose your entire investment.

Our stock trades in low volumes, which may make it more difficult for investors to sell their shares quickly.

Our Common Stock trades on the Nasdaq Capital Market, but it trades in low volumes, which may make it more difficult for investors to
sell  their  shares  quickly.  This  situation  may  be  attributable  to  a  number  of  factors,  including  but  not  limited  to  the  fact  that  we  are  a
development-stage company that is relatively unknown to stock analysts, stock brokers, institutional investors, and others in the investor
community. In addition, investors may be risk averse to investments in development-stage companies. As a consequence, it may be more
difficult for investors to sell their shares quickly and our stock price may be more sensitive to sales of our Common Stock in the market.
The low trading volume is outside of our control and may not increase or, if it increases, may not be maintained.

You  may  experience  dilution  of  your  ownership  interests  because  of  the  future  issuance  of  additional  shares  of  our  common  or
preferred stock or other securities that are convertible into or exercisable for our common or preferred stock, including as a result of
triggering price protection rights held by certain investors.

In the future, we may issue our authorized but previously unissued equity securities, resulting in the dilution of the ownership interests of
our  stockholders.  The  Company  is  authorized  to  issue  an  aggregate  of  45,000,000  shares  of  Common  Stock  and  5,000,000  shares  of
preferred stock. We may issue additional shares of our Common Stock or other securities that are convertible into or exercisable for our
Common  Stock  in  connection  with  hiring  or  retaining  employees,  future  acquisitions,  future  sales  of  our  securities  for  capital  raising
purposes,  or  for  other  business  purposes.  In  addition,  as  of  September  8,  2017,  warrants  and  options  to  purchase  602,632  and  160,000
shares,  respectively,  of  our  Common  Stock  remained  outstanding.  In  addition,  investors  in  the  2017  Offering  (as  defined  under
“Management’s Discussion and Analysis — Liquidity and Capital Resources — Financing Activities” below) have certain price protection
rights. Pursuant to such rights, if we issue shares of our Common Stock (subject to customary exceptions, including issuances of awards
under Company employee stock incentive programs and certain issuances in connection with credit arrangements) at a price less than $9.00
per share, investors in the 2017 Offering will be entitled to receive (for no additional consideration) additional shares of our Common Stock
in an amount such that, when added to the number of shares of Common Stock they initially purchased in the 2017 Offering, will equal the
number  of  shares  of  Common  Stock  that  their  investment  in  the  2017  Offering  would  have  purchased  at  the  lower  purchase  price.  The
future issuance of additional shares of our Common Stock may create downward pressure on the trading price of the Common Stock. We
will need to raise additional capital in the near future to meet our working capital needs, and there can be no assurance that we will not be
required  to  issue  additional  shares,  warrants  or  other  convertible  securities  in  the  future  in  conjunction  with  these  capital  raising  efforts,
including at a price (or exercise prices) below the price you paid for your stock.

The ability of our Board of Directors to issue additional stock may prevent or make more difficult certain transactions, including a sale
or merger of the Company.

Our Board of Directors is authorized to issue up to 5,000,000 shares of preferred stock with powers, rights and preferences designated by it.
Shares  of  voting  or  convertible  preferred  stock  could  be  issued,  or  rights  to  purchase  such  shares  could  be  issued,  to  create  voting
impediments or to frustrate persons seeking to effect a takeover or otherwise gain control of the Company. The ability of the Board to issue
such additional shares of preferred stock, with rights and preferences it deems advisable, could discourage an attempt by a party to acquire
control of the Company by tender offer or other means. Such issuances could therefore deprive stockholders of benefits that could result
from such an attempt, such as the realization of a premium over the market price for their shares in a tender offer or the temporary increase
in market price that such an attempt could cause. Moreover, the issuance of such additional shares of preferred stock to persons friendly to
the Board of Directors could make it more difficult to remove incumbent managers and directors from office even if such change were to
be favorable to stockholders generally.

We do not anticipate paying dividends on our Common Stock.

Cash dividends have never been declared or paid on our Common Stock, and we do not anticipate such a declaration or payment for the
foreseeable future. We expect to use future earnings, if any, to fund business growth. Therefore, stockholders will not receive any funds
absent a sale of their shares of Common Stock. If we do not pay dividends, our Common Stock may be less valuable because a return on
your investment will only occur if our stock price appreciates. We cannot assure stockholders that our stock price will appreciate or that
they will receive a positive return on their investment if and when they sell their shares.

24 

 
 
 
 
 
 
 
 
 
 
 
 
 
We  are  an  emerging  growth  company,  and  the  reduced  disclosure  requirements  applicable  to  emerging  growth  companies  will  make
our Common Stock less attractive to investors.

We are an emerging growth company under the JOBS Act. For as long as we continue to be an emerging growth company, we intend to
take advantage of certain exemptions from various reporting requirements that are applicable to other public companies including, but not
limited to, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, exemptions from
the requirements of holding a nonbinding advisory stockholder vote on executive compensation and  any  golden  parachute  payments  not
previously  approved,  exemption  from  the  requirement  of  auditor  attestation  in  the  assessment  of  our  internal  control  over  financial
reporting and exemption from any requirement that may be adopted by the Public Company Accounting Oversight Board. If we do, the
information that we provide stockholders may be different than what is available with respect to other public companies. We cannot predict
if  investors  will  find  our  Common  Stock  less  attractive  because  we  will  rely  on  these  exemptions.  If  some  investors  find  our  Common
Stock less attractive as a result, there may be a less active trading market for our Common Stock and our stock price may be more volatile.

Under  the  JOBS  Act,  emerging  growth  companies  can  delay  adopting  new  or  revised  accounting  standards  until  such  time  as  those
standards apply to private companies. We have irrevocably elected to take advantage of this extended transition period. Since we will not
be required to comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for
other  public  companies,  our  financial  statements  may  not  be  comparable  to  the  financial  statements  of  companies  that  comply  with  the
effective dates of those accounting standards.

We will remain an emerging growth company until the earliest of (1) the end of the fiscal year in which the market value of our Common
Stock that is held by non-affiliates exceeds $700 million as of the end of the second fiscal quarter, (2) the end of the fiscal year in which we
have total annual gross revenues of $1.07 billion or more during such fiscal year, (3) the date on which we issue more than $1 billion in
non-convertible debt in a three-year period or (4) June 30, 2019, the end of the fiscal year following the fifth anniversary of the date of the
first  sale  of  our  common  stock  pursuant  to  an  effective  registration  statement  filed  under  the  Securities Act  of  1933,  as  amended  (the
“Securities Act”). Decreased disclosures in our SEC filings due to our status as an “emerging growth company” may make it harder for
investors to analyze our results of operations and financial prospects.

Even  after  we  no  longer  qualify  as  an  emerging  growth  company,  we  may  still  qualify  as  a  “smaller  reporting  company,”  which  would
allow us to take advantage of many of the same exemptions from disclosure requirements, including not being required to comply with the
auditor  attestation  requirements  of  Section  404  of  the  Sarbanes-Oxley  Act  and  reduced  disclosure  obligations  regarding  executive
compensation. Some investors may find our Common Stock less attractive because we rely on these exemptions, there may be a less active
trading market for our Common Stock and our stock price may be more volatile.

Being a public company is expensive and administratively burdensome.

As a public reporting company, we are subject to the information and reporting requirements of the Securities Exchange Act of 1934, as
amended  (the  “Exchange Act”),  and  other  federal  securities  laws,  rules  and  regulations  related  thereto,  including  compliance  with  the
Sarbanes-Oxley Act. Complying with these laws and regulations requires the time and attention of our Board of Directors and management,
and increases our expenses. Among other things, we are required to:

● maintain and evaluate a system of internal control over financial reporting in compliance with the requirements of Section 404 of the

Sarbanes-Oxley Act and the related rules and regulations of the SEC and the Public Company Accounting Oversight Board;

● maintain policies relating to disclosure controls and procedures;

● prepare and distribute periodic reports in compliance with our obligations under federal securities laws;

● institute a more comprehensive compliance function, including with respect to corporate governance; and

25 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
● involve, to a greater degree, our outside legal counsel and accountants in the above activities.

The costs of preparing and filing annual and quarterly reports, proxy statements and other information with the SEC and furnishing audited
reports  to  stockholders  is  expensive  and  much  greater  than  that  of  a  privately-held  company,  and  compliance  with  these  rules  and
regulations may require us to hire additional financial reporting, internal controls and other finance personnel, and will involve a material
increase in regulatory, legal and accounting expenses and the attention of management. There can be no assurance that we will be able to
comply with the applicable regulations in a timely manner, if at all. In addition, being a public company makes it more expensive for us to
obtain director and officer liability insurance. In the future, we may be required to accept reduced coverage or incur substantially higher
costs to obtain this coverage. These factors could also make it more difficult for us to attract and retain qualified executives and members
of our Board of Directors, particularly directors willing to serve on the Audit Committee of our Board of Directors.

If  we  fail  to  remediate  the  identified  material  weakness  and  maintain  effective  controls  and  procedures,  we  may  not  be  able  to
accurately report our financial results, which could have a material adverse effect on our operations, financial condition, and the price
of our Common Stock.

We are required to maintain disclosure controls and procedures and internal control over financial reporting. Section 404 of the Sarbanes-
Oxley Act of 2002 requires us to include in our annual reports on Form 10-K an assessment by management of the effectiveness of our
internal  control  over  financial  reporting. As  disclosed  in  Item  9A  of  this  Report,  our  management  identified  a  material  weakness  in  our
internal control over financial reporting, causing our disclosure controls and procedures and our internal control over financial reporting to
be  ineffective  as  of  June  30,  2017. A  material  weakness  is  a  deficiency,  or  combination  of  deficiencies,  such  that  there  is  a  reasonable
possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.
Remediation of the material weakness will require management attention and cause the Company to incur additional expenses. If we fail to
remediate  the  material  weakness,  or  if  we  are  unable  to  maintain  effective  controls  and  procedures  in  the  future,  our  ability  to  record,
process, summarize, and report financial information accurately and within the time periods specified in the rules and forms of the SEC
could be adversely affected, we could lose investor confidence in the accuracy and completeness of our financial reports, and we may be
subject  to  investigation  or  sanctions  by  the  SEC. Any  such  consequence  or  other  negative  effect  could  adversely  affect  our  operations,
financial condition, and the price of our Common Stock.

In  addition,  at  such  time,  if  any,  as  we  are  no  longer  a  smaller  reporting  company  or  an  emerging  growth  company,  our  independent
registered public accounting firm will have to attest to and report on management’s assessment of the effectiveness of our internal control
over  financial  reporting.  If  and  when  we  are  required  to  have  our  independent  registered  public  accounting  firm  attest  to  management’s
assessment of the effectiveness of our internal control over financial reporting, if our independent registered public accounting firm is not
satisfied with the adequacy of our internal control over financial reporting, or if the independent auditors interpret the requirements, rules,
or regulations differently than we do, then they may decline to attest to management’s assessment or may issue a report that is qualified.
Any of these events could result in a loss of investor confidence in the reliability of our financial statements, which could negatively affect
the price of our Common Stock.

ITEM 1B.        UNRESOLVED STAFF COMMENTS

None.

ITEM 2.           PROPERTIES

Our current headquarters in Huntersville, NC, is a 4,800-square foot facility that we lease for base rent of $4,700 per month, with a term
expiring in April 2018; however, due to increased headcount hired to support business operations in North Carolina, we have executed a
new 60-month lease for an adjoining facility which is expected to commence on or about November 1, 2017. The new facility is 10,400
square feet, and its base rent is $9,800 per month. The current 4,800-square foot facility will be vacated at the commencement of the new
lease. On June 26, 2017, the Company acquired a 120,000 square foot MEMS fabrication facility in Canandaigua, New York. The current
NY  facility  houses  approx.  35  employees  and  is  only  15%  utilized.  The  Company  believes  the  new  10,400-square  foot  facility  in
Huntersville,  NC,  once  occupied,  along  with  the  recently  acquired  facility  in  New  York  will  be  suitable  and  sufficient  to  meet  the
Company’s needs for the next three to five years.

26 

 
 
 
 
 
 
 
 
 
 
 
 
ITEM 3.           LEGAL PROCEEDINGS

From  time  to  time,  we  may  become  involved  in  various  lawsuits  and  legal  proceedings  that  arise  in  the  ordinary  course  of  business.
Litigation  is  subject  to  inherent  uncertainties,  and  an  adverse  result  in  any  such  matters  may  arise  from  time  to  time  that  may  have  an
adverse effect on our business, financial condition, results of operations and prospects.

We  are  currently  not  aware  of  any  material  pending  legal  proceedings  to  which  we  are  a  party  or  of  which  any  of  our  property  is  the
subject, nor are we aware of any such proceedings that are contemplated by any governmental authority.

ITEM 4.           MINE SAFETY DISCLOSURES

Not applicable.

PART II

ITEM 5.           MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER
PURCHASES OF EQUITY SECURITIES

Market Information and Holders

Our Common Stock is currently traded on the NASDAQ Capital Market under the symbol “AKTS.” Prior to March 13, 2017, our Common
Stock was quoted on the OTC Market (OTCQB) under the same symbol. There has been limited trading in our Common Stock to date.

As  of  September  8,  2017,  19,084,583  shares  of  our  Common  Stock  were  issued  and  outstanding  and  were  held  by  approximately  151
stockholders of record.

The following table sets forth the high and low sales prices (or closing bid prices with respect to periods prior to March 13, 2017) for our
Common Stock for the fiscal quarters indicated, as reported on NASDAQ (or on OTC Markets with respect to closing bids for periods prior
to March 13, 2017). OTC Market quotations for periods prior to March 13, 2017 reflect inter-dealer prices, without retail mark-up, mark-
down or commission and may not represent actual transactions.

Period

Quarter ended September 30, 2015
Quarter ended December 31, 2015
Quarter ended March 31, 2016
Quarter ended June 30, 2016
Quarter ended September 30, 2016
Quarter ended December 31, 2016
Quarter ended March 31, 2017
Quarter ended June 30, 2017

Dividends

    $

High

Low

5.00    $
4.15     
2.00     
4.40     
4.49     
5.85     
12.90     
12.21     

2.75 
1.55 
1.50 
1.90 
3.50 
3.91 
5.44 
8.40 

We  have  never  paid  any  dividends  on  our  capital  stock  and  do  not  anticipate  paying  any  cash  dividends  on  our  Common  Stock  in  the
foreseeable  future.  We  intend  to  retain  future  earnings  to  fund  ongoing  operations  and  future  capital  requirements.  Any  future
determination to pay dividends will be at the discretion of our Board of Directors and will be dependent upon financial condition, results of
operations, capital requirements and such other factors as the Board of Directors deems relevant.

27 

 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
 
 
     
     
 
     
     
     
     
     
     
     
 
 
 
Warrants and Options

As of June 30, 2017, there were outstanding warrants and options to purchase 612,165 shares of our Common Stock and 160,000 shares of
our Common Stock, respectively. There are no other outstanding convertible securities of the Company.

Equity Compensation Plan Information

The following table provides information as of June 30, 2017, relating to our equity compensation plans, under which grants of options,
restricted stock, and other equity awards may be made from time to time:

Plan category

Equity compensation plans approved by security holders
Equity compensation plans not approved by security

holders

Total

Number of
securities to be
issued upon
exercise of
outstanding
options, warrants
and rights
(a)

Weighted-
average exercise
price of
outstanding
options,
warrants and
rights
(b)

Number of securities
remaining available for
future issuance under
equity compensation
plans (excluding
securities reflected in
column (a)
(c)

160,000(1)  $

— 

160,000(1)   

1.50     

—     

2,728,000(2)

— 

2,728,000(2)

(1) The 160,000  shares  of  Common  Stock  to  be  issued  upon  the  exercise  of  outstanding  options  are  issuable  under  the  Company’s 2015

Equity Incentive Plan (the “2015 Plan”).

(2) As of June 30, 2017, 2,728,000 additional shares of Common Stock remained available for future issuance under the Company’s 2016
Stock Incentive Plan. No additional grants will be made under the Company’s 2014 Stock Plan (the “2014 Plan”) or the 2015 Plan.

Recent sales of unregistered securities

We have not sold any equity securities during the fiscal year ended June 30, 2017 that were not registered under the Securities Act, other
than as previously reported in our Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K filed with the SEC.

Purchases of Equity Securities

Unvested restricted stock grants awarded under the 2014 Plan and the 2015 Plan are subject to Company repurchase options upon certain
terminations of the recipient’s service with the Company. As of June 30, 2017, 1,352,265, shares of restricted stock remained subject to
repurchase  options,  which  are  scheduled  to  expire  between  January  2018  and  December  2020.  We  did  not  repurchase  any  of  our  equity
securities pursuant to these repurchase options or otherwise during the fiscal year ended June 30, 2017.

Transfer Agent

The transfer agent for our Common Stock is Globex Transfer, LLC. The transfer agent’s address is 780 Deltona Blvd., Suite 202, Deltona,
FL 32725 and its telephone number is 813-344-4490.

ITEM 6.           SELECTED FINANCIAL DATA

Not applicable to a smaller reporting company.

28 

 
 
 
  
 
 
 
 
 
   
 
 
 
 
 
   
 
   
   
   
 
   
  
   
      
  
   
      
 
 
 
 
 
 
 
 
 
 
 
ITEM  7.                    MANAGEMENT’S  DISCUSSION  AND  ANALYSIS  OF  FINANCIAL  CONDITION  AND  RESULTS  OF
OPERATIONS

The following management’s discussion and analysis should be read in conjunction with the historical financial statements and the related
notes thereto contained in this Report. See also the “Cautionary Note Regarding Forward-Looking Information” on page 1 of this Report.

The following discussion highlights the results of operations and the principal factors that have affected our financial condition, as well as
our  liquidity  and  capital  resources  for  the  periods  described,  and  provides  information  that  management  believes  is  relevant  for  an
assessment and understanding of the statements of financial condition and results of operations presented herein. The following discussion
and  analysis  are  based  on  the  audited  financial  statements  contained  in  this  Report,  which  we  have  prepared  in  accordance  with  United
States generally accepted accounting principles. You should read the discussion and analysis together with such financial statements and
the related notes thereto.

29 

 
 
 
 
 
Overview

Akoustis  is  an  early-stage  company  focused  on  developing,  designing  and  manufacturing  innovative  RF  filter  products  for  the  mobile
wireless  device  industry,  including  for  products  such  as  smartphones  and  tablets,  cellular  infrastructure  equipment  and  WiFi  premise
equipment.  Located  between  the  device’s  antenna  and  its  digital  backend,  the  RFFE  is  the  circuitry  that  performs  the  analog  signal
processing and contains components such as amplifiers, filters and switches. To construct the resonators that are the building blocks for the
RF filter, we have developed a fundamentally new single-crystal acoustic materials and device technology that we refer to as BulkONE®.
Filters are critical in selecting and rejecting signals, and their performance enables differentiation in the modules defining the RFFE. 

We believe owning the core resonator technology and manufacturing our designs is the most direct and effective means of delivering our
solutions to the market. Furthermore, our technology is based upon bulk-mode resonance, which is superior to surface-mode resonance for
high  band  applications  4G/LTE,  emerging  5G  and  WiFi  5GHz  frequency  bands.  While  our  target  customers  utilize  or  make  the  RFFE
module, several customers lack access to critical high band technology to compete in high band applications and other traditional surface-
mode  solutions  where  higher  power  performance  is  required.  We  intend  to  design,  manufacture  and  market  our  RF  filter  products  to
multiple  mobile  phone  OEM,  cellular  infrastructure  and  WiFi  router  customers  and  enable  broader  competition  among  the  front-end
module manufacturers. We plan to operate as a “pure-play” RF filter supplier and align with the front-end module manufacturers who seek
to acquire high performance filters to grow their module business.

We have built prototype resonators using our proprietary single-crystal materials. We are currently optimizing our BulkONE® technology
in our 120,000 sq. ft. wafer-manufacturing plant located in Canandaigua, New York. We leverage both federal and state level, non-dilutive
R&D grants to support development and commercialization of our technology. We are developing resonators for 4G/LTE, emerging 5G and
WiFi  bands  and  the  associated  proprietary  models  and  design  kits  required  to  design  our  RF  filters.  Once  we  have  stabilized  the  wafer
process technology, we plan to engage with strategic customers to evaluate first our resonators and then our filter prototypes. Our initial
designs  will  target  high  band  4G/LTE,  emerging  5G  and  WiFi  frequency  bands.  Since Akoustis  owns  its  core  technology  and  controls
access  to  its  intellectual  property,  we  can  offer  several  ways  to  engage  with  potential  customers.  First,  we  can  engage  with  the  mobile
wireless market, providing filters that we design and offer as a standard catalog component to multiple customers. Second, we can start with
a customer-supplied filter specification, which we design and fabricate for a specific customer. Finally, we can offer our models and design
kits for our customers to design their own filter into our proprietary technology.

In December 2014, Akoustis, Inc. was awarded its first small business innovative research (“SBIR”) R&D grant with the National Science
Foundation  (“NSF”).  The  NSF  program,  which  increases  the  incentive  and  opportunity  for  startups  and  small  businesses  to  undertake
cutting-edge,  high-quality  scientific  research  and  development,  requires  that  the  grantee  have  full  responsibility  for  the  conduct  of  the
project or activity supported and the adherence to the award conditions. Total funds received from the NSF and matching funds from North
Carolina Science, Technology & Innovation Department of Commerce since inception through September 8, 2017 total $892,000.

Our  partnership  with  NSF  has  strengthened  since  the  start  of  our  engagement,  and  its  support  has  accelerated  our  technology
commercialization as well as funded technical jobs. We have additional opportunities for new grants and matching funds from our current
small business program partnership with NSF including the Phase IIb award.

We have earned minimal revenue from operations since inception, and our operations have been funded with capital contributions, grants
and debt. We have incurred losses totaling approximately $15.8 million from inception through June 30, 2017. These losses are primarily
the result of material and material processing costs associated with developing and commercializing our technology as well as personnel
costs, professional fees (primarily accounting and legal) as well as other general and administrative expenses offset by the $1.7 million gain
from  the  bargain  acquisition  of  the  STC-MEMS  Business  in  June  2017.  We  expect  to  continue  to  incur  substantial  costs  for
commercialization  of  our  technology  on  a  continuous  basis  because  our  business  model  involves  materials  and  solid-state  device
technology development as well as engineering of catalog and custom filter designs.

As of September 8, 2017, the Company had $6.7 million of cash and cash equivalents.  The Company believes this is sufficient to cover our
cost  of  operations  including  anticipated  capital  expenditures  through  December  31,  2017. As  a  result,  we  will  need  to  obtain  additional
capital through the sale of additional equity securities, debt and additional grants, or otherwise, to fund operations past that date.  There is
no assurance that the Company’s projections and estimates are accurate. These matters raise substantial doubt about the Company’s ability
to continue as a going concern.

30 

 
 
 
 
 
 
 
 
 
 
Plan of Operation

We plan to commercialize our technology by designing and manufacturing single-band and multi-band BAW RF filter from our NY wafer
fabrication facility. Our filter solutions address problems (such as loss, bandwidth, power handling and isolation) created by the growing
number  of  frequency  bands  in  the  RFFE  of  mobile  devices  to  support  4G/LTE,  emerging  5G  and  WiFi.  We  have  prototyped  our  first
single-band  low-loss  BAW  filter  designs  for  4G/LTE  frequency  bands,  which  are  dominated  by  competitive  BAW  solutions  and
historically cannot be addressed with low band, lower power handling SAW technology. During the second half of calendar 2017, we plan
to sample filter product prototypes to prospective customers that cover LTE-Band 41, Radar, and 5GHz WiFi frequency bands.

In order to succeed, we must convince mobile phone OEMs, RFFE module manufacturers, cellular infrastructure OEMs and WiFi router
OEMs to use our BulkONE® technology in their systems and modules. However, since there are only two dominant BAW filter suppliers
in the industry that have high band technology, and both utilize such technology as a competitive advantage at the module level, we expect
customers that lack access to high band filter technology will be open to engage with our pure-play filter company.

Once we complete customer validation of our technology, we expect to complete qualification of our BulkONE® process technology in the
second half of calendar 2017 to support a product family of 4G/LTE filter solutions. Once we have stabilized our process technology in a
manufacturing environment, we will complete a production release of our high band filter products in the frequency range from 2.5GHz to
6.0GHz.  The  target  frequency  bands  will  be  prioritized  based  upon  customer  priority.  We  expect  this  will  require  recruiting  and  hiring
additional personnel and capital investments.

We plan to pursue filter design and R&D development agreements and potentially joint ventures with target customers and other strategic
partners. These types of arrangements may subsidize technology development costs and qualification, filter design costs, as well as offer
complementary  technology  and  market  intelligence  and  other  avenues  to  revenue.  However,  we  intend  to  retain  ownership  of  our  core
technology,  intellectual  property,  designs  and  related  improvements.  We  expect  to  pursue  development  of  catalog  designs  for  multiple
customers, and offer such catalog products in multiple sales

We  have  successfully  transferred  our  BulkONE®  wafer  process  to  our  STC-MEMS  Business.  The  BulkONE®  process  uses  a  range  of
single-crystal  group  III-nitride  piezoelectric  materials,  which  were  fabricated  into  BAW  resonators  and  characterized  at  cellular
communication  frequencies  to  determine  their  bandwidth.  On  May  23,  2016,  we  announced  an  experimental,  3.4  GHz  BAW  two-port
series-configured  resonator  device  with  a  high  K-squared  of  12.5%,  which  was  modeled  near  resonance  frequency  and  was  constructed
from single-crystal undoped aluminum nitride (AlN) material. On August 8, 2016, we announced improvements to our single-crystal BAW
resonator design and process technology to achieve a quality factor (Q) of 2090, which is suitable for BAW RF filters targeting 4G/LTE,
WIFI and emerging 5G and 5G WIFI mobile wireless applications. These resonators, which are the core building blocks enabling BAW RF
filters,  were  fabricated  using  our  patented  BulkONE®  process.  Technology  development  efforts  continue  on  wafer  and  process
optimization, specifically, through targeted activities for Q-factor improvements.

As referenced in the Business section, in August 2016, Akoustis announced its first customer engagement signing multiple non-exclusive
agreements with a Chinese tier one RF front end (RFFE) module manufacturer to supply the Company’s premium RF filter products for
next-generation  high-band  RFFE  modules  for  4G,  emerging  4.5G  and  5G  mobile  -  targeting  the  China  and  India  OEM  markets.  In
December 2016, the Company announced its second customer engagement, for the development of a band-specific, high-frequency (above
3.5 GHz) BAW RF filter for a non-mobile commercial application with a well-established OEM specializing in non-mobile communication
systems  with  annual  revenue  of  more  than  $1  Billion.    In  May  2017,  the  Company  announced  its  third  customer  engagement  for  the
development  of  high-performance  BAW  diplexers  for  non-mobile  communication  systems  with  a  multi-billion  dollar,  Fortune  500  U.S.
company, which provides systems, products and solutions to government and commercial customers worldwide. 

31 

 
 
 
 
 
 
 
 
 
In August  2017,  the  Company  announced  its  first  shipment  of  premium  high-band  BAW  RF  filter  prototypes  manufactured  using  its
patented single-crystal BulkONE® technology to the aforementioned Chinese tier one customer. The shipment included high performance,
LTE-TDD  Band  41,  2.6  GHz  BAW  RF  filters  that  will  satisfy  the  challenging  filter  requirements  in  the  high  growth  4G  LTE  mobile
market in China.

We  will  continue  discussions  with  additional  prospective  customers,  although  these  discussions  may  not  result  in  any  agreements.  We
expect to proceed with our plan to develop a family of standard catalog filter designs regardless of the outcome of these discussions.

As of September 8, 2017, we had approximately $6.7 million of cash and cash equivalents to fund a majority of the foregoing milestones,
for  product  development  to  commercialize  our  technology,  research  and  development,  the  development  of  our  patent  strategy  and
expansion  of  our  patent  portfolio,  as  well  as  for  working  capital  and  other  general  corporate  purposes.  These  funds  are  expected  to  be
sufficient to fund our activities through December 2017. However, there is no assurance that the Company’s projections and estimates are
accurate.  Our  anticipated  costs  include  employee  salaries  and  benefits,  compensation  paid  to  consultants,  capital  costs  for  research  and
other equipment, costs associated with development activities including travel and administration, legal expenses, sales and marketing costs,
general  and  administrative  expenses,  and  other  costs  associated  with  an  early  stage,  publicly-traded  technology  company.  We  anticipate
increasing the number of employees by approximately 15 to 20 employees in the next twelve months; however, this is highly dependent on
the nature of our development efforts, our success in commercialization, and our ability to raise additional funding. We anticipate adding
employees  for  research  and  development  in  both  our  New  York  and  North  Carolina  facilities,  as  well  as  general  and  administrative
functions, to support our efforts. We expect to incur consulting expenses related to technology development and other efforts as well as
legal  and  related  expenses  to  protect  our  intellectual  property.  We  expect  capital  expenditures  to  be  approximately  $7.5  million  for  the
purchase  of  equipment  and  software  during  the  next  12  months  and  are  currently  investigating  the  feasibility  of  using  debt  facilities,
equipment leases, or government grants to fund all or part of the purchase of the equipment.

The amounts we actually spend for any specific purpose may vary significantly and will depend on a number of factors including, but not
limited  to,  the  pace  of  progress  of  our  commercialization  and  development  efforts,  actual  needs  with  respect  to  product  testing,  R&D,
market conditions, and changes in or revisions to our marketing strategies. In addition, we may use a portion of any net proceeds to acquire
complementary products, technologies or businesses; however, we do not have plans for any acquisitions at this time.

Commercial  development  of  new  technology  is,  by  its  nature,  unpredictable.  Although  we  will  undertake  development  efforts  with
commercially reasonable diligence, there can be no assurance that our current cash position will be sufficient to enable us to commercialize
our technology to the extent needed to create future sales to sustain operations as contemplated herein. If our current cash is insufficient for
these  purposes,  or  the  Company  does  not  receive  anticipated  proceeds  from  research  grants  or  such  grant  payments  are  delayed,  or  the
Company experiences costs in excess of estimates to continue its research and development plan, it is possible that the Company would not
have  sufficient  resources  to  continue  as  a  going  concern  for  the  next  year,  and  we  will  consider  other  options  to  continue  our  path  to
commercialization,  including,  but  not  limited  to,  additional  financing  through  follow-on  stock  offerings,  debt  financing,  co-development
agreements,  curtailment  of  operations,  suspension  of  operations,  sale  or  licensing  of  developed  intellectual  or  other  property,  or  other
alternatives.

If we are unable to obtain the funds that we believe are needed to develop our technology and enable future sales, we may be required to
scale back our development plans by reducing expenditures for employees, consultants, business development and marketing efforts, and
other envisioned expenditures. This could reduce our ability to commercialize our technology or require us to seek further funding earlier,
or on less favorable terms.

We cannot assure you that our technology will be accepted, that we will ever generate revenues sufficient to support our operations, or that
we  will  ever  be  profitable.  Furthermore,  since  we  have  no  committed  source  of  financing,  there  is  no  assurance  that  we  will  be  able  to
obtain sufficient capital as and when we need it to continue our operations. If we cannot obtain sufficient capital as and when we need it,
we may be required to severely curtail, or even to cease, our operations.

32 

 
 
 
 
 
 
  
 
 
Critical Accounting Policies

The following discussion and analysis of our financial condition and results of operations is based upon our financial statements, which
have  been  prepared  in  conformity  with  accounting  principles  generally  accepted  in  the  United  States  of  America  (“GAAP”).  Certain
accounting  policies  and  estimates  are  particularly  important  to  the  understanding  of  our  financial  position  and  results  of  operations  and
require  the  application  of  significant  judgment  by  our  management  or  can  be  materially  affected  by  changes  from  period  to  period  in
economic factors or conditions that are outside of our control. As a result, they are subject to an inherent degree of uncertainty. In applying
these  policies,  our  management  uses  its  judgment  to  determine  the  appropriate  assumptions  to  be  used  in  the  determination  of  certain
estimates.  Those  estimates  are  based  on  our  historical  operations,  our  future  business  plans  and  projected  financial  results,  the  terms  of
existing contracts, our observance of trends in the industry, information provided by our customers and information available from other
outside sources, as appropriate.

Derivative Liability

The Company evaluates its options, warrants and other contracts, if any, to determine if those contracts or embedded components of those
contracts  qualify  as  derivatives  to  be  separately  accounted  for  in  accordance  with  paragraph  815-10-05-4  and  Section  815-40-25  of  the
FASB Accounting  Standards  Codification.  The  result  of  this  accounting  treatment  is  that  the  fair  value  of  the  embedded  derivative  is
marked-to-market  each  balance  sheet  date  and  recorded  as  either  an  asset  or  a  liability.  The  change  in  fair  value  is  recorded  in  the
consolidated statement of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the
instrument is marked to fair value at the date of conversion, exercise or cancellation and then the related fair value is reclassified to equity.

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other
embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are
accounted for as a single, compound derivative instrument.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed
at  the  end  of  each  reporting  period.  Equity  instruments  that  are  initially  classified  as  equity  that  become  subject  to  reclassification  are
reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in
the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12
months of the balance sheet date.

The Company adopted Section 815-40-15 of the FASB Accounting Standards Codification (“Section 815-40-15”) to determine whether an
instrument (or an embedded feature) is indexed to the Company’s own stock.  Section 815-40-15 provides that an entity should use a two-
step  approach  to  evaluate  whether  an  equity-linked  financial  instrument  (or  embedded  feature)  is  indexed  to  its  own  stock,  including
evaluating the instrument’s contingent exercise and settlement provisions.

The Company utilizes a binomial option pricing model to compute the fair value of the derivative and to mark to market the fair value of
the derivative at each balance sheet date. The Company records the change in the fair value of the derivative as other income or expense in
the consolidated statements of operations.

Fair Value of Financial Instruments

The  carrying  amounts  of  cash  and  cash  equivalents  and  accounts  payable  approximate  fair  value  due  to  the  short-term  nature  of  these
instruments.

The Company measures the fair value of financial assets and liabilities based on the guidance of ASC 820, “Fair Value Measurements and
Disclosures,”  which  defines  fair  value,  establishes  a  framework  for  measuring  fair  value,  and  expands  disclosures  about  fair  value
measurements. 

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the
principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement
date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the
use of unobservable inputs when measuring fair value.

33 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value measurements are categorized using a valuation hierarchy for disclosure of the inputs used to measure fair value, which prioritize
the inputs into three broad levels:

Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in
which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable
as of the reported date, and include those financial instruments that are valued using models or other valuation methodologies.

Level 3 - Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with
internally developed methodologies that result in management’s best estimate of fair value.

Equity-based compensation

The  Company  recognizes  compensation  expense  for  all  equity–based  payments  in  accordance  with ASC  718  “Compensation  –  Stock
Compensation".  Under  fair  value  recognition  provisions,  the  Company  recognizes  equity–based  compensation  net  of  an  estimated
forfeiture rate and recognizes compensation cost only for those shares expected to vest over the requisite service period of the award.

Restricted  stock  awards  are  granted  at  the  discretion  of  the  Company.  These  awards  are  restricted  as  to  the  transfer  of  ownership  and
generally vest over the requisite service periods, typically over a four-year period (vesting on a straight–line basis). The fair value of a stock
award is equal to the fair market value of a share of Company stock on the grant date.

The fair value of an option award is estimated on the date of grant using the Black–Scholes option valuation model. The Black–Scholes
option  valuation  model  requires  the  development  of  assumptions  that  are  inputs  into  the  model.  These  assumptions  are  the  value  of  the
underlying  share,  the  expected  stock  volatility,  the  risk–free  interest  rate,  the  expected  life  of  the  option,  the  dividend  yield  on  the
underlying stock and the expected forfeiture rate. Expected volatility is benchmarked against similar companies in a similar industry over
the expected option life and other appropriate factors. Risk–free interest rates are calculated based on continuously compounded risk–free
rates for the appropriate term. The dividend yield is assumed to be zero as the Company has never paid or declared any cash dividends on
its  Common  Stock  and  does  not  intend  to  pay  dividends  on  its  Common  Stock  in  the  foreseeable  future.  The  expected  forfeiture  rate  is
estimated based on management’s best estimate.

Determining  the  appropriate  fair  value  model  and  calculating  the  fair  value  of  equity–based  payment  awards  requires  the  input  of  the
subjective  assumptions  described  above.  The  assumptions  used  in  calculating  the  fair  value  of  equity–based  payment  awards  represent
management’s best estimates, which involve inherent uncertainties and the application of management’s judgment. As a result, if factors
change  and  the  Company  uses  different  assumptions,  our  equity–based  compensation  could  be  materially  different  in  the  future.  In
addition, the Company is required to estimate the expected forfeiture rate and recognize expense only for those shares expected to vest. If
the Company’s actual forfeiture rate is materially different from its estimate, the equity–based compensation could be significantly different
from what the Company has recorded in the current period. 

The Company accounts for share–based payments granted to non–employees in accordance with ASC 505-40, “Equity Based Payments to
Non–Employees”. The Company determines the fair value of the stock–based payment as either the fair value of the consideration received
or the fair value of the equity instruments issued, whichever is more reliably measurable. If the fair value of the equity instruments issued
is used, it is measured using the stock price and other measurement assumptions as of the earlier of either (1) the date at which a
commitment for performance by the counterparty to earn the equity instruments is reached, or (2) the date at which the counterparty’s
performance is complete. The fair value of the equity instruments is re-measured each reporting period over the requisite service period.

34 

 
 
 
 
 
 
 
 
 
 
 
 
Results of Operations

Our  results  of  operations  are  presented  for  the  year  ended  June  30,  2017  compared  to  the  year  ended  June  30,  2016.  Our  results  of
operations for the year ended June 30, 2017 include five days of operations of our STC-MEMS Business, which we acquired on June 26,
2017.

Year Ended June 30, 2017 Compared to Year Ended June 30, 2016

The Company recorded revenue of $486,000 for the year-ended June 30, 2017 as compared to $255,000 for the year ended June 30, 2016.
The revenue for the fiscal year ended June 30, 2017 was made up primarily of grant revenue from the National Science Foundation for the
Phase II grant. The revenue recorded in the comparative fiscal year was also made up primarily of grant revenue from the National Science
Foundation ($50,000 from Phase I and $192,000 for Phase II).

R&D  expenses  consist  of  costs  for  technical  and  engineering  personnel,  travel  expense  for  R&D  personnel  and  costs  to  develop  and
commercialize  our  technology  including  materials,  material  processing,  and  contractors.  R&D  expenses  were  $4.4  million  for  the  year-
ended June 30, 2017 and were $2.7 million, or 151.6%, higher than the prior year. The year-over-year increase was due to the ramp up of
R&D activity in the Company’s third year of operations. The increased expenditures occurred primarily in areas of R&D personnel, stock-
based compensation, and material costs. Personnel costs were $1.4 million compared to $717,000 in the comparative period, an increase of
$654,000 or 91%. The increase included five days of costs associated with the New York foundry personnel (approximately $ 127,000),
costs for the addition of technical and engineering hires in the North Carolina facility in the 2017 fiscal year, and the full year effect of N.C.
new hires made in the prior fiscal year. Stock-based compensation of $1.3 million for the year ended June 30, 2017 was $1.1 million, or
566%, higher than the year ended June 30, 2016 due to new restricted stock awards made to R&D personnel and the change in the fair
market value of awards made to technical and engineering contractors in prior periods. In addition, material and material process costs were
$1.4 million as compared to $670,000 in the comparative period ended June 30, 2016 which was an increase of $681,000, or 102.0%. The
year-over-year  cost  increase  was  due  to  the  ramp  of  raw  material  purchases  and  material  processing  costs  for  product  development
activities.

General  and  administrative  (“G&A”)  costs  include  salaries  and  wages  for  executive  and  administrative  staff,  stock-based  compensation,
professional  fees,  insurance  costs  and  other  general  costs  associated  with  the  administration  of  our  business.  General  and  administrative
expenses for the year ended June 30, 2017 were $6.0 million versus $2.9 million for the comparative period. The increase of $3.1 million,
or 105.0%, was associated mainly with increases in personnel costs, professional fees, insurance expense, stock-based compensation and
travel. Personnel costs of $1.4 million were higher by $231,000, or 20.1%, due to the increase in the number of administrative personnel,
while professional fees of $1.2 million, associated with legal, accounting and investor relations, were higher by $645,000, or 113%. The
legal, accounting and investor relations fees incurred in the year ended June 30, 2017 ramped up as the result of Company’s second year of
being a public reporting company; first on the OTC Market and then on NASDAQ. Stock-based compensation for the year ended June 30,
2017 was $2.6 million and higher by $1.9 million, or 295%, as a result of the issuance of new awards for G&A personnel granted after
June 2016 and the recording of the change in the fair market value of stock grants issued to investor relations consultants.

Other income and expense for the year ended June 30, 2017 was $850,000 and included a $1.7 million gain on bargain purchase related to
the acquisition of the STC-MEMS Business, offset by an $877,000 loss on the fair value of derivatives for placement agent warrants issued
in connection with private placements in 2015 and 2016. These warrants were amended in December 2016 and January 2017 to remove the
derivative feature and are now classified as equity. Other expense was $967,000 for the year ended June 30, 2016 and was primarily related
to the loss on fair value of derivatives recorded for the placement agent warrants referenced above.

The Company recorded a net loss of $9.1 million for the year ended June 30, 2017, compared to a net loss of $5.4 million for the year
ended June 30, 2016. The year-over-year incremental loss of $3.7 million, or 68%, was driven by higher material costs due to the ramp up
of research and development activities, higher professional fees due to the costs associated with the Company’s second year of being a
public reporting company, higher personnel costs for both R&D and administrative headcount, including increased costs for stock-based
compensation, offset by the $1.7 million gain on bargain purchase price recorded due to the acquisition of the STC-MEMS Business.

35 

 
  
 
 
 
  
 
 
 
 
Liquidity and Capital Resources

Financing Activities

We have earned minimal revenue from operations since inception, and our operations have been funded with capital contributions, private
placements of stock, grants and debt.

36 

 
 
 
 
 
On March 10, 2016, we held a closing of a private placement offering (the “March 2016 Offering”) in which we sold 494,125 shares of our
Common  Stock  to  accredited  investors  at  a  fixed  purchase  price  of  $1.60  per  share  (the  “2016  Offering  Price”),  for  aggregate  gross
proceeds of $790,600 (before deducting expenses of the March 2016 Offering). On April 14, 2016, we held a closing of a private placement
offering (the “April 2016 Offering,” and together with the March 2016 Offering, the “2016 Offering”) in which we sold 1,741,185 shares of
our Common Stock at the “2016 Offering Price, for aggregate gross proceeds of $2.8 million (before deducting expenses of the April 2016
Offering).

With closings in each of November and December 2016 and January and February 2017, the Company sold a total of 2,142,000 shares of
Common Stock in a private placement offering (the “2016-2017 Offering”) at a fixed purchase price of $5.00 per share (the “2016-2017
Offering Price”). Aggregate gross proceeds were $10.7 million (before deducting commissions and expenses of the offering).

In May 2017, the Company held a closing of a private placement offering (the “2017 Offering”) in which it sold an aggregate of 663,000
shares of Common Stock at a fixed purchase price of $9.00 per share to accredited investors, for aggregate gross proceeds of $5,967,000
(before deducting commissions and expenses of the offering).

Since inception through June 2017, we received $892,000 in funds from NSF/SBIR grants and NC matching funds.

The  Company  estimates  the  $6.7  million  of  cash  on  hand  as  of  September  8,  2017  will  fund  its  operations,  including  current  capital
expense commitments through December 2017. As a result, we will need to obtain additional capital through the sale of additional equity
securities, debt and additional grants, or otherwise, to fund operations past that date. There is no assurance that the Company’s projections
and  estimates  are  accurate. Although  the  Company  is  actively  managing  and  controlling  the  Company’s  cash  outflows  to  mitigate  these
risks, these matters raise substantial doubt about the Company’s ability to continue as a going concern.

Balance Sheet and Working Capital

June 30, 2017 Compared to June 30, 2016

As of June 30, 2017, the Company had current assets of $10.0 million made up primarily of cash on hand of $9.6 million. As of June 30,
2016, current assets were $4.3 million comprised primarily of cash on hand of $4.2 million. The $5.54 million increase in cash year over
year was due to net proceeds from private placement offerings of $15.3 million offset by the cash expended for operations of $5.59 million
and  the  investment  in  machinery  and  equipment  of  $1.6  million  as  well  as  the  $2.8  million  cash  paid  at  the  June  2017  closing  of  the
acquisition for the STC-MEMS Business. The Company also saw a year over year increase in inventory of $145,000, mainly due to the
purchase of inventory ($96,000) associated with the STC-MEMS acquisition, an increase in prepaid expenses of $103,000 due to the annual
service fee payment for NASDAQ ($35,000) and new license fees for Cornell University for $45,000.

Property, Plant and Equipment was $7.9 million as of June 30, 2017 as compared to a balance of $207,000 as of the year ended June 30,
2016. The approximate $7.6 million year-over-year increase is due to the purchase of equipment, building and land acquired with the STC-
MEMS Business (cumulative recorded value of $6.1 million) as well as an additional investment of $1.7 million in fixed assets, primarily
equipment for research and development.

Total assets as of June 30, 2017 and June 30, 2016 were $18.1 million and $4.5 million, respectively.

Current liabilities as of June 30, 2017 were $1.4 million and increased year-over-year by $816,000. We saw an increase in accounts payable
and  accrued  expenses  of  $793,000  due  mainly  to  the  ramp  up  of  both  R&D  activities  and  administrative  and  support  costs  including
additional personnel, material spend, and professional fees. 

Long-term liabilities totaled $1.7 million as of June 30, 2017, compared to $1.3 million for the prior year period. The increase of $408,000
was due to the decrease in the derivative liability recorded for warrants issued to placement agents in connection with private placements in
2015 and the 2016 Offering. During December 2016 and January 2017, the Company amended these warrant agreements to eliminate the
derivative feature, and as a result, the liability was fully reclassed to stockholder’s equity in the year ended June 30, 2017. This decrease in
long-term  liability  was  offset  by  an  increase  of  $1.7  million,  which  was  a  long-term  contingent  real  estate  liability  associated  with  the
acquisition of the STC-MEMS Business that closed on June 26, 2017.

37 

 
 
 
 
 
 
 
 
 
 
  
 
 
 
Stockholders’ equity was $15.0 million as of June 30, 2017, compared to $2.7 million as of June 30, 2016.

Additional  paid-in-capital  (“APIC”)  was  $30.8  million  as  of  June  30,  2017  and  increased  by  $21.4  million.  The  year-over-year  increase
was  due  to:  (1)  an  increase  from  proceeds  of  $15.4  million  for  the  issuance  of  Common  Stock  in  the  2016-2017  Offering  and  the  2017
Offering,  less  $992,000  for  the  fair  value  of  warrants  issued  to  placement  agents  for  a  total  of  291,000  shares  of  Common  Stock,  (2)
increase of $4.8 million of APIC recorded due to the vesting of restricted stock agreements granted to employees and contractors in lieu of
cash compensation, and (3) an increase due to the release of derivative liabilities associated with warrants issued in 2015 and 2016 offering
for $2.2 million after the warrant agreements were amended to eliminate the derivative feature in December and January 2017. The $21.4
million increase in stockholder’s equity was reduced by the $9.1 million net loss recorded for the year ended June 30, 2017.

Working capital as of June 30, 2017 was $8.7 million, compared to $3.7 million as of June 30, 2016.

Cash Flow Analysis

Year Ended June 30, 2017 Compared to the Year Ended June 30, 2016

Operating activities used cash of $5.5 million during the year ended June 30, 2017 and $3.3 million for the 2016 comparative period. The
$2.2 million year-over-year increase in cash used was attributable to higher operating expenses associated with the ramp up of development
and  commercialization  activities  (primarily  R&D  personnel  and  material  costs),  higher  spend  on  G&A  costs  for  support  personnel  and
professional fees.

Investing activities used cash of $4.5 million for the year ended June 30, 2017 compared to $204,000 for the comparative year ended June
30, 2016. The year-over-year increase was due to the $2.8 million cash paid at closing for the acquisition of the STC-MEMS Business, as
well as increased spend on R&D equipment (higher by $1.5 million).

Financing activities provided cash of $15.6 million for the year ended June 30, 2017 versus $3.3 million for the 2016 comparative period.
The $12.3 million increase was from funds raised in the 2016-2017 Offering and the 2017 Offering.

Off-Balance Sheet Transactions

The Company did not engage in any “off-balance sheet arrangements” (as that term is defined in Item 303(a)(4)(ii) of Regulation S-K) as
of June 30, 2017.

ITEM 7A.        QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not applicable to a smaller reporting company.

ITEM 8.           FINANCIAL STATEMENTS AND SUPPLEMENTAL DATA

Our audited consolidated financial statements as of and for the fiscal years ended June 30, 2017 and June 30, 2016 are included beginning
on Page F-1 immediately following the signature page to this Report. See Item 15 for a list of the financial statements included herein.

ITEM  9.                      CHANGES  IN AND  DISAGREEMENTS  WITH ACCOUNTANTS  ON ACCOUNTING AND  FINANCIAL
DISCLOSURE

None.

38 

 
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
 
ITEM 9A.        CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rules 13a-
15(e) and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports that we
file  or  submit  under  the  Exchange  Act  is  recorded,  processed,  summarized  and  reported,  within  the  time  periods  specified  in  the
Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure
that  information  required  to  be  disclosed  by  an  issuer  in  the  reports  that  it  files  or  submits  under  the  Exchange Act  is  accumulated  and
communicated to the issuer’s management, including its principal executive officer and principal financial officer, or persons performing
similar functions, as appropriate to allow timely decisions regarding required disclosure.

We  conducted  an  evaluation  under  the  supervision  and  with  the  participation  of  our  Chief  Executive  Officer  and  our  Chief  Financial
Officer  of  the  effectiveness  of  the  design  and  operation  of  our  disclosure  controls  and  procedures  as  of  June  30,  2017.  Based  on  that
evaluation,  our  Chief  Executive  Officer  and  Chief  Financial  Officer  concluded  that  our  disclosure  controls  and  procedures  were  not
effective as of such date due to the material weakness described below with respect to our internal control over financial reporting.

39 

 
 
 
 
 
 
Management’s Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Our
management assessed the effectiveness of our internal control over financial reporting as of June 30, 2017. In making this assessment, our
management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal
Control Integrated Framework (2013). Based on that evaluation under this framework, our management concluded that our internal control
over  financial reporting was not effective.

During its assessment of internal control over financial reporting, management identified a material weakness in the design of controls over
it acquisition accounting and reporting practices as it relates to the acquisition of the STC-MEMS Business.  The effectiveness of controls
surrounding  the  acquisition  accounting  processing,  review  of  external  advisors  work  and  subsequent  compilation  and  reporting  has  the
potential, when taken together, to represent a more than remote likelihood that a material misstatement could occur and not be prevented or
detected.   Therefore, management has determined this has risen to the level of a material weakness.   To remediate this material weakness,
management intends to increase the size and capabilities of its accounting department and place less reliance on external consultants.

Because of its inherent limitations, a system of internal control over financial reporting can provide only reasonable assurance and may not
prevent or detect misstatements. Also, projections of any evaluation of effectiveness as to future periods are subject to risk that controls
may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Further,  because  of  changes  in  conditions,  effectiveness  of  internal  control  over  financial  reporting  may  vary  over  time.  Our  system
contains self-monitoring mechanisms, and actions are taken to correct deficiencies as they are identified.

This  Report  does  not  include  an  attestation  report  of  the  Company’s  registered  public  accounting  firm  regarding  internal  control  over
financial  reporting.  Management’s  report  was  not  subject  to  attestation  by  the  Company’s  registered  public  accounting  firm  pursuant  to
rules of the Securities and Exchange Commission that permit the Company (as a smaller reporting company) to provide only management’s
report in this annual report.

Changes in Internal Control over Financial Reporting

Except for the material weakness described above, there have been no changes in our internal control over financial reporting during the
quarter ended June 30, 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial
reporting.

ITEM 9B.        OTHER INFORMATION

None.

PART III

ITEM 10.         DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE

Directors and Executive Officers

Below are the names of, and certain information regarding, our current executive officers and directors.

Name

Age

Position

Date Named to Board
of Directors/as
Executive Officer

Arthur E. Geiss
Jerry D. Neal

Jeffrey B. Shealy

John T. Kurtzweil
David M. Aichele

Cindy C. Payne
Steven P. DenBaars
Jeffrey K. McMahon
Steven P. Miller
Suzanne B. Rudy

  64
  73

  48

  61
  51

  57
  55
  46
  69
  62

    Co-Chairman of the Board
    Co-Chairman of the Board

President and Chief Executive Officer;
Director
Chief Financial Officer and Chief
Accounting Officer

    Vice President of Business Development
Vice President of Finance, Corporate
Controller, and Treasurer

    Director
    Director
    Director
    Director

40 

  May 22, 2015
  May 22, 2015

  May 22, 2015
July 14, 2017

  May 22, 2015

  May 22, 2015
  May 22, 2015
  May 22, 2015
  July 14, 2017
  July 14, 2017

 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
   
   
 
 
 
 
 
 
   
 
   
 
 
 
   
 
 
 
 
 
Directors are elected to serve until their successors are elected and qualified. Directors are elected by a plurality of the votes  cast  at  the
meeting of stockholders at which they are elected and hold office until the expiration of the term for which he or she was elected or until a
successor has been elected and qualified.

A  majority  of  the  authorized  number  of  directors  constitutes  a  quorum  of  the  Board  of  Directors  for  the  transaction  of  business.  The
directors must be present at the meeting to constitute a quorum. However, any action required or permitted to be taken by  the  Board  of
Directors may be taken without a meeting if all members of the Board of Directors individually or collectively consent in writing to the
action.

Executive officers are appointed by the Board of Directors and serve at its pleasure.

The principal occupation and business experience during the past five years for our executive officers and directors is as follows:

Arthur E. Geiss, Co-Chairman of the Board, founded AEG Consulting, LLC in 2003 and currently serves as its Owner and CEO. AEG
Consulting offers guidance concerning manufacturing, operations, and process development to technology companies. Prior to establishing
AEG Consulting, Mr. Geiss served as Vice President of Wafer Fab Operations at RF Micro Devices, Inc. (“RFMD”) (now Qorvo, Inc.).
He was responsible for the start-up and operations of Gallium Arsenide epitaxial-growth and  wafer-fabrication.  Previous  to  RFMD,  Mr.
Geiss  held  management  positions  with Alpha  Industries,  Inc.  (purchased  by  Skyworks  Solutions,  Inc.)  and  before  that  at  ITT  Gallium
Arsenide Technology Center (purchased by Cobham plc). At both companies, he was responsible for process and device development and
wafer fabrication operations. Prior to these, Mr. Geiss held a research position at the Xerox Palo Alto Research Center (now PARC, Inc.).
At PARC he investigated the structure of vitreous materials and amorphous thin-films using Raman spectroscopy. Mr. Geiss has served as
a Member of the Executive Committee of the IEEE GaAs IC Symposium (now CSICS) and as a Member of the Executive Committee of
the  GaAs  Manufacturing  Technology  Conference  (now  CS  Mantech).  He  has  numerous  patents  and  publications  on  electronic  devices,
processing, and manufacturing. Mr. Geiss earned a B.S. degree at Lafayette College and M.S. and Ph.D. degrees at Brown University, all in
physics. We believe that Mr. Geiss adds value to our Board of Directors based on his extensive experience with technology companies, his
executive leadership and management experience and his research background.

Jerry  D.  Neal,  Co-Chairman  of  the  Board,  founded  RFMD  (now,  Qorvo,  Inc.)  in  1991  and  served  as  its  Executive  Vice  President  of
Marketing and Strategic Development from January 2002 to May 31, 2012. Dr. Neal served as a Vice President of Marketing of RFMD,
from May 1991 to January 2000 and its Executive Vice President of Sales, Marketing and Strategic Development from January 2000 to
January  2002.  Prior  to  joining  RFMD,  he  was  employed  for  10  years  with  Analog  Devices,  Inc.,  including  as  Marketing  Engineer,
Marketing  Manager  and  Business  Development  Manager.  Dr.  Neal  also  founded  Moisture  Control  Systems  for  the  production  of  his
patented electronic sensor for measurement of soil moisture for research, which was later sold to Hancor, Inc. He has been a Director of
Jazz Semiconductor, Inc. since November 2002. Dr. Neal served as a Director of RFMD from February 1992 to July 1993. He also held
various positions at Hewlett-Packard. Dr. Neal received his Associate’s Degree in Electrical Engineering from Gaston Technical Institute
and North Carolina State University and his doctor of business management degree from Southern Wesleyan University. We believe that
Dr.  Neal  adds  value  to  our  Board  of  Directors  based  on  his  extensive  executive  leadership  and  management  experience  and  his  sales,
marketing and product development background.

41 

 
 
 
 
 
 
 
 
Jeffrey B. Shealy is our President and Chief Executive Officer, as well as one of our directors. He has over 20 years of experience in the
RF/Wireless industry focused on building businesses around solid-state materials and electron device innovation. He held the position of
Vice President and General Manager at RFMD from 2001 until 2014. Mr. Shealy is a Howard Hughes Doctoral Fellow and spent 7 years
with Hughes Electronics at Hughes Research Labs (now HRL Labs) and Hughes Network Systems (now Hughes). He previously founded
RF Nitro, a RF Power Amplifier high-tech venture, which was acquired by RFMD in 2001. Mr. Shealy holds an MBA degree from Wake
Forest University, Master of Science and Doctorate degrees in Electrical and Computer Engineering from University of California at Santa
Barbara  (UCSB),  and  a  Bachelor’s  of  Science  degree  in  Electrical  and  Computer  Engineering  from  North  Carolina  State  University
(NCSU).  We  believe  that  Mr.  Shealy  adds  value  to  our  Board  of  Directors  based  on  his  intimate  knowledge  of  our  business  plans  and
strategies, his experience with high tech startup ventures and his years of experience in the RF/Wireless industry.

John T. Kurtzweil, has served as our Chief Financial Officer and Chief Accounting Officer since July 14, 2017, and he served as a director
on the Board from January 12, 2017 to July 14, 2017. He served as VP Finance of Cree, Inc., a company that develops, manufactures, and
sells  lighting-class  light  emitting  diode,  lighting,  and  semiconductor  products  for  power  and  radio-frequency  applications,  and  Chief
Financial Officer of Wolfspeed, a Cree Company, from 2015 until March 2017. He is currently providing consulting services to a limited
number of businesses. Prior to his employment at Cree, Mr. Kurtzweil was an independent consultant beginning in 2014. From 2012 until
2014,  Mr.  Kurtzweil  served  as  Senior  Vice  President,  Chief  Financial  Officer  and  Special Advisor  to  the  Chief  Executive  Officer  of
Extreme  Networks,  Inc.,  a  provider  of  high-performance,  open  networking  innovations  for  enterprises,  services  providers,  and  Internet
exchanges, and also served as its Chief Accounting Officer. From 2006 to 2012, Mr. Kurtzweil served as Executive Vice President, Finance
and  as  Chief  Financial  Officer  and  Treasurer  of  Cree,  Inc.  From  2004  to  2006,  Mr.  Kurtzweil  was  Senior  Vice  President  and  Chief
Financial  Officer  at  Cirrus  Logic,  Inc.,  a  fabless  semiconductor  company.  Mr.  Kurtzweil  currently  serves  as  a  director  of  Axcelis
Technology, Inc., and was appointed Chairman of its Audit Committee in February 2017. Mr. Kurtzweil served as a board member for Meru
Networks, Inc. for a portion of 2015 prior to its sale.

David M. Aichele is Vice President of Business Development responsible for leading the sales and marketing efforts of the Company. Mr.
Aichele joined the company in May 2015, bringing over 20 years of international sales, business development, and marketing experience
with him. Prior to Akoustis, Mr. Aichele was EVP Sales & Marketing for T1Visions, a high-tech software startup company ranking among
the 2014 INC 500 fastest growing private companies in the U.S from 2013 to May 2015. Mr. Aichele held director positions at RFMD from
2005 to 2015, where he was responsible for the business development and launch of new RF semiconductor products targeting the cellular
market, and senior management positions at Tessera and TE Connectivity, where he led business development and sales teams. Mr. Aichele
holds a BSEE from Ohio University and an MBA from the Leeds School of Business at the University of Colorado.

Cindy  C.  Payne has  served  as  our  Vice  President  of  Finance,  Corporate  Controller,  and  Treasurer  since  July  14,  2017.  Ms.  Payne
previously served as our Chief Financial Officer and Treasurer from 2015 to July 14, 2017. Ms. Payne brings to the Company over 20 years
of  experience  in  financial  management.  Prior  to  joining Akoustis,  Ms.  Payne  most  recently  served  as  the  CFO  for Amerock  LLC  from
2014-2015, a private equity owned hardware distributor in Mooresville, NC. Prior to joining Amerock, Ms. Payne held the position of CFO
for Tolt Service Group, a private equity owned technology services provider, from 2010 until the company’s sale in 2014. Her experience
prior  to  Tolt  included  the  role  of  Director  of  Financial  Planning  and Analysis  in  the  Soft  Trim  Division  of  International Automotive
Components,  a  Tier  I  supplier  to  the  automotive  industry  and  the  role  of  Controller  of  NewBold  Corporation.  NewBold  Corporation,
located  in  the  Roanoke,  Virginia  area,  offers  both  manufactured  products  and  technology  services  to  retail  and  healthcare  markets.  Ms.
Payne  graduated  Magna  Cum  Laude  from  Western  Carolina  University  with  a  Bachelor  of  Science  in  Business Administration  and  is  a
Certified Public Accountant, licensed in the Commonwealth of Virginia.

42 

 
 
 
 
 
 
Steven P. DenBaars  is  a  Professor  of  Materials  and  Co-Director  of  the  Solid-State  Lighting  Center  at  University  of  California  at  Santa
Barbara. Professor DenBaars joined UCSB in 1991 and currently holds the Mitsubishi Chemical Chair in Solid State Lighting and Displays.
He  is  also  a  co-founder  and  current  board  member  of  two  privately  held  GaN  startup  companies,  Soraa  Inc.  and  Soraa  Laser  Inc.  Dr.
DenBaars has been in the LED business for over 25 years starting with his prior work at Hewlett-Packard Optoelectronics division in 1988
and involvement in more than two LED companies and one laser diode company. Professor DenBaars’ specific research interests include
growth  of  wide-band  gap  semiconductors  (GaN  based),  and  their  application  to  Blue  LEDs  and  lasers  and  energy  efficient  solid-state
lighting. This research has led to over 750 scientific publications and over 160 U.S. patents on electronic materials and devices. He has been
awarded a NSF Young Investigator award, Young Scientist Award of the ISCS, IEEE Aron Kressel Award, and he is an IEEE Fellow and a
Visiting Professor at the Institute for Advanced Studies (IAS) HKUST. He was recently elected to the National Academy of Engineering
(2012), and elected Fellow of the National Academy of Inventors (2014). We believe that Professor DenBaars adds value to our Board of
Directors based on his years of experience in the LED industry and his extensive research involving wide-based gap semiconductors and
their application to high power electronic devices.

Jeffrey K. McMahon has been employed by North Highland, a global management consulting firm, since 2003. He has held the position
of Managing Director since 2014 and is the current Market Lead for North Highland’s largest market. He has an extensive background in
business and information technology consulting in the financial services, energy, and telecommunications industries.  He  has  20  years  of
experience helping Fortune 100 companies drive revenue, optimize processes, improve customer experience and manage risk. His areas of
expertise include marketing, strategy articulation and realization, strategic execution, business process management and merger integration.
Prior to joining North Highland, Mr. McMahon was a Manager in Accenture’s process practice area. Mr. McMahon received a Bachelor of
Science  degree  in  Civil  Engineering  from  North  Carolina  State  University.  We  believe  that  Mr.  McMahon  adds  value  to  our  Board  of
Directors based on his extensive experience in business and technology consulting and his marketing and strategizing expertise.

Steven P. Miller served as a Board Advisor to the Board from January 2017 to June 2017. He is the President of Via Capri Inc., the general
partner of Via Capri Investment L.P., a limited partnership formed by Mr. Miller in 1996. Mr. Miller is also the President of Sawmill Inc.,
the general partner of Sawmill Investment L.P., another limited partnership formed by Mr. Miller in 1996. From 2001 to 2003, Mr. Miller
served as a director for TriQuint Semiconductor, Inc. (TriQuint), then a leading supplier of high-performance components and modules for
communications applications before merging with RFMD to form Qorvo, Inc. in 2015. Prior to that, Mr. Miller held several positions at
Sawtek Inc. from 1979 until his retirement in 1999, including Co-Founder, President, Chief Executive Officer, and Chairman of Sawtek’s
Board of Directors. Sawtek Inc. merged with TriQuint in 2001. Prior to co-founding Sawtek Inc. in 1979, Mr. Miller was Manager of the
SAW Development Laboratory in the Defense Group at Texas Instruments Incorporated. Mr. Miller brings to the Board familiarity with
the Company, its operations, finances, and strategic plan through his experience as a Board Advisor, as well as industry expertise, public
company leadership experience, and his experience and skills in strategic growth and business development, including capital formation.

Suzanne  Rudy most  recently  served  as  Vice  President  of  Tax  &  Corporate  Treasurer,  Compliance  Officer  and Assistant  Secretary  of
Qorvo,  Inc.,  a  publicly-traded  company  and  leading  supplier  of  semiconductor  solutions  for  the  wireless  communications  market,  until
November 2015. In addition to her treasury and compliance duties, Ms. Rudy served as a director for various subsidiaries of Qorvo, Inc.
Prior to joining Qorvo, Inc. predecessor, RMFD, in 1999, Ms. Rudy was the Controller for Precision Fabrics Group, Inc., a textile spin-off
of the Fortune 500 Company, Burlington Industries. In addition, she spent six years as a Certified Public Accountant and Manager for BDO
Seidman,  LLP,  an  international  accounting  firm.  From  2012  to  2016,  Ms.  Rudy  served  as  a  director  for  Delta Apparel,  Inc.,  a  publicly-
traded  apparel  manufacturer,  where  she  served  on  the Audit  and  Compensation  Committees.  From  2008  to  2011,  Ms.  Rudy  served  as  a
director  for  First  National  Bank  United  Corporation,  serving  as  Chair  of  the Audit  Committee  and  the Assets  and  Liability  Committee.
Since  2006,  Ms.  Rudy  has  served  on  the  Board  of  Visitors  for  Guilford  College.  She  was  also  a  Board  Leadership  Fellow  in  2013,  as
designated  by  the  National Association  of  Corporate  Directors.  Ms.  Rudy  brings  to  our  Board  extensive  expertise  in  public  company
financial, compliance, and related strategic matters.

43 

 
 
 
 
 
 
Director Independence

Our Board has determined that Ms. Rudy and Messrs. Geiss, Neal, DenBaars, McMahon, and Miller are independent directors under the
applicable  standards  of  The  NASDAQ  Stock  Market.  In  reaching  this  determination,  the  Board  considered  Mr.  Geiss’  relationship  with
AEG Consulting, a firm owned and operated by Mr. Geiss, which provides consulting services to the Company, as discussed below under
“Certain Relationships and Related Person Transactions.” After consideration, the Board determined that this relationship did not impact
Mr. Geiss’ ability to serve as an independent director.

Family Relationships

There are no family relationships among our directors or executive officers.

Involvement in Certain Legal Proceedings

None of our directors or executive officers has been involved in any of the following events, or any of the other events specified in Item
401(f) of Regulation S-K, during the past ten years:

● any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the

time of the bankruptcy or within two years prior to that time;

● any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other

minor offenses);

● being  subject  to  any  order,  judgment,  or  decree,  not  subsequently  reversed,  suspended  or  vacated,  of  any  court  of  competent
jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his or her involvement in any type of
business, securities or banking activities; or

● being found by a court of competent jurisdiction (in a civil action), the SEC or the Commodity Futures Trading Commission to have

violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.

Board Committees

The Board maintains three standing committees: the Audit Committee, the Compensation Committee and the Nominating Committee. Each
committee operates under a written charter and reports regularly to the Board. A copy of each of these committee charters is available in the
“Investors” section of our website under the heading “Governance Documents” at http://www.akoustis.com and may also be obtained by
submitting  the  “Contact  Us”  form  at  the  website  address  set  forth  above.  Each  member  of  the  Audit  Committee,  the  Compensation
Committee and the Nominating Committee must satisfy membership requirements imposed by the applicable committee charter and, where
applicable, NASDAQ listing standards and SEC rules and regulations. Each of the members of the Audit Committee, the Compensation
Committee  and  the  Nominating  Committee  has  been  determined  by  the  Board  to  be  independent  under  applicable  NASDAQ  listing
standards and, in the case of the Audit Committee and the Compensation Committee, under the independence requirements established by
the SEC. A brief description of the responsibilities of each of these committees and their current membership follows.

Audit Committee 

The Audit  Committee  is  a  separately-designated  standing Audit  Committee  established  in  accordance  with  Section  3(a)(58)(A)  of  the
Exchange Act. The Audit Committee is appointed by the Board to assist the Board in its duty to oversee our accounting, financial reporting
and internal control functions and the audit of our financial statements. The current members of the Audit Committee are Suzanne Rudy
(Chair), Jerry Neal and Jeffrey McMahon, each of whom is independent under existing NASDAQ listing standards and SEC requirements.
The Board has examined the SEC’s definition of “audit committee financial expert” and determined that Ms. Rudy is an audit committee
financial expert.

44 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compensation Committee

The Compensation Committee is appointed by the Board to assist the Board in overseeing and reviewing information from management
regarding  compensation  and  human  capital  issues  within  the  Company.  The  Compensation  Committee  also  has  specific  responsibilities
regarding performance reviews and compensation of the Company’s executive officers. The Compensation Committee regularly consults
with  members  of  our  executive  management  team  regarding  our  executive  compensation  program.  The  current  members  of  the
Compensation  Committee  are  Messrs.  McMahon  (Chairman)  and  Neal  and  Ms.  Rudy,  each  of  whom  is  independent  under  existing
NASDAQ listing standards, SEC requirements, and the requirements of Section 162(m) of the Internal Revenue Code (the “Code”).

Nominating Committee

The  Nominating  Committee  is  appointed  by  the  Board  to  assist  the  Board  in  identifying  individuals  qualified  to  become  Board  and
committee members and to recommend to the Board director nominees. The current members of the Nominating Committee are Messrs.
Neal (Chairman) and DenBaars and Ms. Rudy.

Other Committees

Our Board of Directors may designate from among its members one or more other committees in the future, and in July 2017, our Board
designated  a  Technology  Committee  to  assist  the  Board  and  the  Company’s  senior  management  in  overseeing  technology  development
initiatives and to advise the Board regarding new technology development and execution of technology initiatives. The current members of
the Technology Committee are Messrs. Geiss, DenBaars, and Miller.

Compensation Committee Interlocks and Insider Participation

The current members of the Compensation Committee are Messrs. McMahon (Chairman) and Neal and Ms. Rudy. Mr. Geiss also served as
a  member  of  the  Compensation  Committee  for  a  portion  of  the  fiscal  year  ended  June  30,  2017.  No  member  of  the  Compensation
Committee  has  ever  served  as  an  officer  or  employee  of Akoustis  or  had  any  relationship  during  the  fiscal  year  ended  June  30,  2017
required  to  be  disclosed  pursuant  to  Item  404  of  Regulation  S-K,  other  than  consulting  fees  paid  to AEG  Consulting,  LLC,  Mr.  Geiss’
consulting  firm.  No  executive  officer  of  the  Company  has  served  as  a  director  or  member  of  the  Compensation  Committee  (or  other
committee serving an equivalent function) of any other entity, one of whose executive officers served as director of the Company during
the year ended June 30, 2017.

Code of Ethics

The  Company  has  adopted  a  Code  of  Ethics  and  Conduct  that  applies  to  our  directors,  officers,  and  employees. A  copy  of  the  Code  of
Ethics and Conduct is posted on the Company’s website  at  www.akoustis.com.  In  the  event  that  we  amend  any  of  the  provisions  of  the
Code  of  Ethics  and  Conduct  that  requires  disclosure  under  applicable  law  or  SEC  rules,  we  intend  to  disclose  such  amendment  on  our
website. Any waiver of the Code of Ethics and Conduct must be approved by the Board of Directors. Any waivers granted to our CEO or
CFO will be disclosed on our website within four business days.

Stockholder Communications with the Board

Stockholders may communicate with the Board of Directors, members of particular committees or individual directors, by sending a letter
to such persons in care of our Chief Executive Officer at our principal executive offices. The Chief Executive Officer has the authority to
disregard  any  inappropriate  communications  or  to  take  other  appropriate  actions  with  respect  to  any  inappropriate  communications.  If
deemed an appropriate communication, the Chief Executive Officer will submit the correspondence to the Chairman of the Board or to any
committee or specific director to whom the correspondence is directed. Please note that all such communications must be accompanied by a
statement of the type and amount of our securities that the person holds; any special interest, meaning an interest that is not derived from the
proponent’s capacity as a shareholder, of the person in the subject matter of the communication; and the address, telephone number and e-
mail address, if any, of the person submitting the communication.

45 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Section 16(a) Beneficial Ownership Reporting Compliance

Section  16  of  the  Exchange Act  requires  the  directors,  certain  officers,  and  beneficial  owners  of  more  than  10%  of  a  class  of  securities
registered under Section 12 of the Exchange Act to file reports with the SEC indicating their holdings of and transactions in such securities
and to provide copies of such reports to the issuer of such securities. Based solely upon a review of the copies of the reports furnished to the
Company, the Company believes all such reporting persons complied with such reporting obligations during the fiscal year ended June 30,
2017, except for a Form 3 filed on March 13, 2017 by Mark N. Tompkins.

ITEM 11.         EXECUTIVE COMPENSATION

Summary Compensation Table

On August 11, 2016, we changed our fiscal year from a fiscal year ending on March 31 of each year to a fiscal year ending on June 30 of
each year, effective for the fiscal year ended June 30, 2017. Accordingly, the following table sets forth information concerning the total
compensation awarded to, earned by or paid to our named executive officers during (i) the fiscal year ended June 30, 2017; (ii) the three-
month transition period (“TP”) from April 1, 2016 to June 30, 2016; and (iii) the year ended March 31, 2016 (our prior fiscal year).

Name and
Principal 
Position

Jeffrey Shealy,
CEO

Mark
Boomgarden,
VP of Operations
(5)

Fiscal
Year

Salary
($)

Bonus
($)

Stock
Awards
($) (3)

All Other
Compensation
($)(4)

Total
($)

2017 (1) 
TP 2016 
  2016 (2)

2017 (1) 
TP 2016 

154,327 

42,484      
150,000     

139,923
36,615     

92,700

—     
30,000     

42,024

—     

151,200

—     
—     

84,000

—     

 9,801
2,815     
5,077     

6,631
2,009     

407,938
45,299  
185,077 

272,578
38,624 

  2016 (2)

117,692     

13,600     

67,450     

17,653     

216,395 

2017 (1) 
Cindy Payne,
TP 2016 
VP of Finance (6)   2016 (2)

149,183
39,038     
114,327     

44,805

—     
13,775     

126,000

—     
217,500     

7,760
2,113     
4,462     

327,748
41,151 
350,064 

Dave Aichele,

VP of Business
Development

2017 (1) 
TP 2016 
  2016 (2)

139,923
37,143     
121,876     

42,024

—     
13,600     

84,000

—     
165,000     

7,278
2,009     
4,603     

273,225
39,152 
305,079 

(1)

 (2)

Bonus amount reflected for FY 2017 was earned during the bonus period of April 1, 2016 to March 31, 2017 but paid in May 2017.

Bonus amount reflected for FY 2016 was earned during the bonus period of April 1, 2015 to March 31, 2016 but paid in May 2016.

46 

 
 
 
 
 
 
 
 
 
   
   
   
   
 
 
   
 
    
    
    
    
  
 
   
   
 
   
   
      
      
      
      
  
 
   
   
 
   
   
      
      
      
      
  
 
   
   
 
   
   
      
      
      
      
  
   
   
      
      
      
      
  
 
   
   
 
 
 
(3)

See  Note  10  to  the  Consolidated  Financial  Statements  included  in  this  Report  for  a  discussion  of  the  assumptions  made  in  the
valuation of stock awards.

(4)

Other compensation is presented by each executive below:

Fiscal
Year

401K
Contribution
($) (a)

Contractor
Compensation  

Total ($)

Jeffrey Shealy,
CEO

Mark Boomgarden,
VP of Operations

Cindy Payne,
VP Finance

David Aichele,
VP of Business
Development

2017
TP 2016

  2016

2017
TP 2016

  2016

2017
TP 2016

  2016

2017
TP 2016

  2016

9,801
2,815 
5,077 

6,631
2,009 
4,603 

7,760
2,113 
4,462 

7,278
2,009 
4,603 

13,050 

9,801
2,815 
5,077 

6,631
2,009 
17,653 

7,760
2,113 
4,462 

7,278
2,009 
4,603 

(a)

Effective June 1, 2015, we established a 401(k)-retirement savings plan, with an employer matching contribution, for all
employees. We have no other plans in place and have never maintained any other plans that provide for the payment of
retirement benefits or benefits that will be paid primarily following retirement including, but not limited to, tax qualified
deferred benefit plans, supplemental executive retirement plans, tax-qualified deferred contribution plans and nonqualified
deferred contribution plans.

(5)

(6)

Mr. Boomgarden served as our Vice President of Operations until his resignation, effective September 15, 2017.

Ms. Payne served as our Chief Financial Officer until July 14, 2017 when she voluntarily resigned and transitioned into the position
of Vice President of Finance.  Effective July 14, 2017, John T. Kurtzweil now serves as our Chief Financial Officer.

Except as indicated below under “Employment Agreements,” we have no contracts, agreements, plans or arrangements, whether written or
unwritten, that provide for payments to the named executive officers listed above.

47 

 
 
 
 
 
 
 
   
 
 
 
   
   
    
 
  
 
   
  
   
  
 
   
   
  
  
  
 
   
  
   
 
   
   
  
  
  
 
   
  
   
  
 
   
   
  
  
  
 
   
  
   
  
  
 
 
 
 
 
Outstanding Equity Awards at Fiscal 2017 Year-End

We have equity awards outstanding under three compensation plans approved by our stockholders: the 2014 Stock Plan, the 2015 Equity
Incentive Plan (the “2015 Plan”) and the 2016 Stock Incentive Plan (the “2016 Plan). However, no further grants will be made under the
2014  Plan  or  the  2015  Plan.  The  following  table  provides  information  about  outstanding  equity  awards  held  by  our  named  executive
officers as of June 30, 2017.

Name

Jeffrey Shealy, CEO

Mark Boomgarden, VP of Operations (5)

Cindy Payne, VP of Finance (6)

David Aichele, VP of Business Development

Stock Awards

Grant Date
(1)

Number of shares or
units of stock that have
not vested (#)

Market value of shares
or units of stock that
have not vested ($) (2)

  8/11/2016 (3)  

  6/16/2014 (4)  
    9/9/2014 (4)  
  10/5/2015 (3)  
  8/11/2016 (3)  

  10/5/2015 (3)  
  8/11/2016 (3)  

  10/5/2015 (3)  
  8/11/2016 (3)  

36,000 

16,204 
72,918 
38,000 
20,000 

145,000 
30,000 

110,000 
20,000 

314,640

141,623
637,303
332,120
174,800

1,267,300
262,200

961,400
174,800

(1)

(2)

(3)

(4)

(5)

(6)

The grant date is determined in accordance with Topic 718.

Based upon the $8.74 closing price of our Common Stock, as reported by NASDAQ on June 30, 2017, multiplied by the number of
shares that had not yet vested.

The shares granted on this date are subject to a repurchase option by the Company if the named executive officer’s employment
with the Company is terminated by the Company without cause, by the named executive officer for good reason, or upon the named
executive officer’s permanent disability.  The shares will be released from the repurchase option as follows:  50%  on  the  second
anniversary of the grant date and 25% on each of the third and fourth anniversaries of the grant date.

The shares granted on this date are subject to a repurchase option by the Company if the named executive officer’s employment
with  the  Company  is  terminated  for  any  reason.  The  remaining  unvested  shares  will  be  released  from  the  repurchase  option  as
follows: sufficient shares such that an aggregate 75% of the original shares granted shall have vested on the third anniversary of the
grant date and the remaining 25% on the fourth anniversary of the grant date.

Mr. Boomgarden served as our Vice President of Operations until his resignation, effective September 15, 2017.

Ms. Payne served as our Chief Financial Officer until July 14, 2017 when she voluntarily resigned and transitioned into the position
of Vice President of Finance.  Effective July 14, 2017, John T. Kurtzweil now serves as our Chief Financial Officer.

Employment Agreements

Jeffrey B. Shealy

On June 15, 2015, we entered into a three-year employment agreement with our Chief Executive Officer, Jeffrey B. Shealy. After the initial
three-year term, the agreement will be automatically renewed for successive one-year periods unless terminated by either party on at least
30  days’  written  notice  prior  to  the  end  of  the  then-current  term.  Mr.  Shealy’s  annual  base  salary  was  $150,000,  subject  to  increase  or
decrease annually as determined by our Board of Directors. Effective July 4, 2016 the Board increased Mr. Shealy’s salary to $154,500.
Mr. Shealy’s base salary was further increased to $163,770, effective September 11, 2017. Mr. Shealy is eligible, at the discretion of our
Board of Directors, to receive an annual cash bonus of up to 100% of his annual base salary, which may be based on us achieving certain
operational, financial or other milestones (the “Milestones”) that may be established by our Board of Directors. Mr. Shealy is entitled to
receive stock options or other equity incentive awards under the 2016 Plan as and when determined by the Board, and is entitled to receive
perquisites  and  other  fringe  benefits  that  may  be  provided  to,  and  is  eligible  to  participate  in  any  other  bonus  or  incentive  program
established by us for, our executives. Mr. Shealy and his dependents are also entitled to participate in any of our employee benefit plans
subject  to  the  same  terms  and  conditions  applicable  to  other  employees.  Mr.  Shealy  will  be  entitled  to  be  reimbursed  for  all  reasonable
travel,  entertainment  and  other  expenses  incurred  or  paid  by  him  in  connection  with,  or  related  to,  the  performance  of  his  duties,
responsibilities  or  services  under  his  employment  agreement,  in  accordance  with  policies  and  procedures,  and  subject  to  limitations,
adopted by us from time to time.

48 

 
 
 
  
 
   
 
 
 
 
 
   
 
  
 
 
   
 
  
 
 
 
 
 
   
 
  
 
 
 
   
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
In the event that Mr. Shealy is terminated by us without Cause (as defined in his employment agreement) or he resigns for Good Reason (as
defined  in  his  employment  agreement)  during  the  term  of  his  employment,  Mr.  Shealy  would  be  entitled  to  (x)  an  amount  equal  to  his
annual  base  salary  then  in  effect  (payable  in  accordance  with  the  Company’s  normal  payroll  practices)  for  a  period  of  24  months
commencing  on  the  effective  date  of  his  termination  (the  “Severance  Period”)  (in  the  case  of  termination  by  the  executive  for  Good
Reason, reduced by any cash remuneration paid to him because of any other employment or self-employment during the Severance Period),
(y) if and to the extent the Milestones are achieved for the annual bonus for the year in which the Severance Period commences (or, in the
absence of Milestones, our Board of Directors has, in its sole discretion, otherwise determined an amount of Mr. Shealy’s annual bonus for
such  year),  an  amount  equal  to  such  annual  bonus  pro-rated  for  the  portion  of  the  performance  year  completed  before  Mr.  Shealy’s
employment terminated, and (z) any unvested stock options, restricted stock or similar incentive equity instruments will vest immediately.
For  the  duration  of  the  Severance  Period,  Mr.  Shealy  will  also  be  eligible  to  participate  in  our  benefit  plans  or  programs,  provided  Mr.
Shealy was participating in such plan or program immediately prior to the date of employment termination, to the extent permitted under
the terms of such plan or program (collectively, the “Termination Benefits”). If Mr. Shealy’s employment is terminated during the term by
us  for  Cause,  by  Mr.  Shealy  for  any  reason  other  than  Good  Reason  or  due  to  his  death,  then  he  will  not  be  entitled  to  receive  the
Termination Benefits, and shall only be entitled to the compensation and benefits that shall have accrued as of the date of such termination
(other  than  with  respect  to  certain  benefits  that  may  be  available  to  Mr.  Shealy  as  a  result  of  a  Permanent  Disability  (as  defined  in  his
employment agreement)).

John T. Kurtzweil

On July 14, 2017, the Board named John T. Kurtzweil as our new Chief Financial Officer who would also serve as the Company’s Chief
Accounting Officer, effective as of the same day. In connection with the election of the new Chief Financial Officer of the Company, the
Company entered into an employment agreement, dated July 14, 2017 (the “CFO Agreement”), with the Chief Financial Officer, pursuant
to which Mr. Kurtzweil will receive an annual base salary of $151,000, monthly living expenses of $1,600, three weeks of paid vacation
each year, and reimbursement of all reasonable business, promotional, travel, and entertainment expenses incurred in the performance of
his duties. In addition, Mr. Kurtzweil is also eligible to earn a target annual bonus each fiscal year equal to 70% of his annual base salary,
based on certain Company operation, financial, and other milestones set by the Board and/or its Compensation Committee. Mr. Kurtzweil is
also entitled to participate in any employee benefit plans and programs generally provided by the Company to its senior executives from
time  to  time.  In  addition,  as  an  inducement  to  employment,  Mr.  Kurtzweil  will  receive  a  restricted  stock  award  for  100,000  shares  of
Common Stock and options for 75,000 shares of Common Stock during the Company’s next open trading window. These awards will be
granted under the 2016 Plan and will vest 25% on each of the first four anniversaries of the grant date, subject to Mr. Kurtzweil’s continued
employment and the terms and conditions of the 2016 Plan and the applicable award agreements.

The term of the CFO Agreement extends through July 31, 2018, and the CFO Agreement will automatically renew for successive one-year
periods unless either party gives at least 30 days written notice of non-renewal to the other party prior to the end of the then applicable
term.

49 

 
 
 
 
 
 
If Mr. Kurtzweil’s employment is terminated by the Company without “cause” or by Mr. Kurtzweil for “good reason” (each as defined in
the CFO Agreement), Mr. Kurtzweil will be entitled to receive: (1) continued payment of his base salary, payable in bi-weekly installments,
for 12 months; (2) his annual bonus for the preceding year, if and to the extent earned and not already paid; (3) any other compensation and
benefits accrued through the date of termination; and (4) reimbursement for one year after the date of termination for the cost of committed
living  allowance  expenses  and  any  COBRA  continuation  of  health  coverage  if  he  elects  such  coverage. Any  unvested  stock  options,
restricted stock awards, or other equity awards granted by the Company to Mr. Kurtzweil will vest or be forfeited in accordance with the
terms of the applicable award agreement(s).

If Mr. Kurtzweil’s employment is terminated due to his death or “disability” (as defined in the CFO Agreement), if the Company terminates
Mr.  Kurtzweil’s  employment  for  “cause,”  or  if  Mr.  Kurtzweil  voluntarily  terminates  his  employment  without  “good  reason,”  Mr.
Kurtzweil,  his  designated  beneficiary,  or  his  estate,  as  applicable,  will  be  entitled  to  receive  his  base  salary  accrued  through  the  date  of
termination. In the case of termination due to “disability” or Mr. Kurtzweil’s voluntary termination of employment, he will also be entitled
to receive his annual bonus for the preceding year, if and to the extent earned and not already paid. Any unvested stock options, restricted
stock awards, or other equity awards granted by the Company to Mr. Kurtzweil will vest or be forfeited in accordance with the terms of the
applicable award agreement(s).

Other

On  June  15,  2015,  the  Company  also  entered  into  two-year  employment  agreements  with  each  of  the  Vice  President  of  Business
Development,  the  Vice  President  of  Operations,  and  the  then  Chief  Financial  Officer.  Each  of  these  employment  agreements  had
substantially the same terms as that of the CEO described above. These agreements expired on June 15, 2017, and each of these officers
continue  to  serve  in  their  respective  positions,  with  the  exception  of  Ms.  Payne  who  now  serves  as  Vice  President  of  Finance,  effective
upon her voluntary resignation from the Chief Financial Officer position on July 14, 2017.

Each named executive officer’s salary is subject to increase or decrease annually as determined by our Board of Directors. Effective June
15,  2017  the  Board  increased  the  salaries  of  Mr.  Aichele,  Mr.  Boomgarden  and  Ms.  Payne  to  $141,080,  $141,080  and  $150,350,
respectively.  Effective  September  11,  2017,  Mr. Aichele’s  and  Ms.  Payne’s  base  salaries  were  increased  to  $148,134  and  $154,860.50,
respectively.

Change in Control Arrangements

2015 Plan

In the event of a merger or change in control of the Company, the treatment of each outstanding restricted stock award granted under the
2015 Plan will be determined by the administrator of the 2015 Plan, including whether each such award will be assumed or an equivalent
option  or  right  substituted  by  the  successor  corporation.  The  administrator  will  not  be  required  to  treat  all  awards  similarly  in  the
transaction. In the event that the successor corporation does not assume or substitute the awards, all restrictions on the awards will lapse.

2016 Plan

Under the terms of the 2016 Plan, the following provisions will apply to the restricted stock awards granted under the 2016  Plan  in  the
event of a change of control (except to the extent, if any, otherwise required under Code Section 409A):

● To the extent that the successor or surviving company in the change of control event does not assume or substitute for an award
(or in which the Company is the ultimate parent corporation and does not continue the award) on substantially similar terms or
with substantially equivalent economic benefits as awards outstanding under the 2016 Plan (as determined by the administrator
of  the  2016  Plan), any  restrictions  will  be  deemed  to  have  been  met,  and  such  awards  will  become  fully  vested,  earned  and
payable to the fullest extent of the original grant of the applicable award.

50 

 
 
 
 
 
 
  
 
 
 
 
 
 
 
● In  addition,  in the  event  that  an  award  is  substituted,  assumed  or  continued,  the  award  will  become  vested  in  full  and  any
restrictions will be deemed to have been met and such awards will become fully vested, earned and payable to the fullest extent
of the original award, if the employment or service of the participant is terminated within two years after the effective date of a
change of control if such termination of employment or service (i) is by the Company without cause or (ii) is by the participant
for good reason.

● Further, if a named executive officer has entered into an employment agreement or other similar arrangement as of the effective
date of the 2016 Plan, the officer is entitled to the greater of the benefits provided upon a change of control of the Company
under  the  2016 Plan  or  the  respective  employment  agreement  or  other  similar  arrangement  as  in  effect  on  the  2016  Plan’s
effective  date, and such employment agreement or other similar arrangement will not be construed to  reduce  in  any  way  the
benefits otherwise provided to the officer upon a change of control as defined in the 2016 Plan.

Director Compensation

We do not have a formal director compensation program, and our directors have historically received compensation at the discretion of the
Board in the form of equity awards granted under the 2015 Plan and the 2016 Plan. We also reimburse our directors for reasonable out-of-
pocket  expenses  related  to  their  role  on  our  Board.  We  intend  for  our  director  compensation  to  align  the  interests  of  our  non-employee
directors with the interests of our stockholders and plan to implement a formal director compensation program for the fiscal year ending
June 30, 2018.

The  table  below  summarizes  all  compensation  received  by  each  of  the  Company’s  non-employee  directors  for  services  as  a  director
performed during the fiscal year ended June 30, 2017.

Name

Arthur E. Geiss (1)(2)

Jerry D. Neal (1)

Steven P. DenBaars (1)

Jeffrey K. McMahon (1)

John Kurtzweil (3)

Stock 
awards
($)(1)

All other
compensation
($)

Total
($)

92,400     

16,995     

109,395 

92,400     

—     

92,400 

92,400     

—     

92,400 

92,400     

—     

92,400 

126,500     

—     

126,500 

 (1)

(2)

(3)

Messrs. Geiss,  Neal,  DenBaars  and  McMahon  each  received  a  restricted  stock  grant  under  the  2015  Plan  for  22,000  shares  of
Common Stock for Board service on August 11, 2016, with 50% of such shares scheduled to vest on the second anniversary of the
grant date and 25% of such shares to vest on each of the third and fourth anniversaries of the grant dates. Valuation is based on the
closing bid price of $4.20 on the grant date.

Mr. Geiss received $15,195 in compensation for consulting services provided by his consulting firm, AEG Consulting, for the year
ended June 30, 2017.

Mr. Kurtzweil received a restricted stock grant under the 2016 Plan for 22,000 shares of common stock for Board service effective
January 25, 2017, with 25% of such shares scheduled to vest on each of the first four anniversaries of the grant date. The grant is
valued at the closing bid price of $5.65 on the grant date. Mr. Kurtzweil resigned from the Board of Directors on July 14, 2017 in
connection with his transition to the role of the Company’s Chief Financial Officer. His restricted  stock award will continue to vest
on schedule.  

51 

 
 
 
 
 
 
 
 
 
 
   
   
 
 
   
   
      
 
   
 
   
      
      
  
   
 
   
      
      
  
   
 
   
      
      
  
   
 
   
      
      
  
   
 
  
 
  
 
 
ITEM  12.                SECURITY  OWNERSHIP  OF  CERTAIN  BENEFICIAL  OWNERS AND  MANAGEMENT AND  RELATED
STOCKHOLDER MATTERS

Beneficial ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect
to securities. In accordance with SEC rules, shares of our Common Stock that may be acquired upon exercise of stock options or warrants
that are currently exercisable or that become exercisable within 60 days after September 8, 2017 (the “Determination Date”) are deemed
beneficially owned by the holders of such options and warrants and are deemed outstanding for the purpose of computing the percentage of
ownership of such person, but are not treated as outstanding for the purpose of computing the percentage of ownership of any other person.
Subject to community property laws, where applicable, the persons or entities named in the tables below have sole voting and investment
power with respect to all shares of our Common Stock indicated as beneficially owned by them.

The following table sets forth information with respect to the beneficial ownership of our Common Stock as of the Determination Date by
(i) each stockholder known by us to be the beneficial owner of more than 5% of our Common Stock (our only class of voting securities),
(ii) each of our directors and executive officers, and (iii) all of our directors and executive officers as a group. To our knowledge, none of
the shares listed below are held under a voting trust or similar agreement, except as noted.

Name and address of beneficial owner 

Jeffrey B. Shealy, Chief Executive Officer, Director (4)
David M. Aichele, Vice President of Business Development (5)
Mark Boomgarden, Vice President of Operations (6)
Cindy C. Payne, VP Finance(7)
Steven P. DenBaars, Director(8)(9)
Arthur E. Geiss, Director, Co-Chairman of the Board(8)(10)
Jeffrey K. McMahon, Director(8) (11)
Jerry D. Neal, Director, Co-Chairman of the Board(8) (11)
John T. Kurtzweil, Chief Financial Officer  (12)
Suzanne Rudy, Director
Steven Miller, Director
All directors and executive officers as a group (11 persons)(13)

Mark Tompkins
App 1, Via Guidino 23
Lugano 6900, Switzerland

*Less than 1%

Amount and
nature of
beneficial
ownership (1)
(2)

Percent of 
class (3)

3,300,725     
134,250     
178,441     
184,375     
285,858     
76,306     
551,888     
367,000     
22,000     
30,000     
50,000     
5,180,843     

17.3%
* 
* 
1.0%
1.5%
* 
2.9%
1.9%
* 
* 
* 

27.12%

2,349,906     

12.3%

 (1) Unless  otherwise indicated  in  the  table,  the  address  for  each  person  named  in  the  table  is  c/o Akoustis  Technologies,  Inc.,  9805

Northcross Center Court, Suite H, Huntersville, NC 28078.

 (2) Unless otherwise indicated in the table, the shares are held directly by the beneficial owner.

 (3) Applicable percentage ownership is based on 19,084,583 shares of Common Stock outstanding as of the Determination Date, together
with  securities exercisable  for  or  convertible  into  shares  of  Common  Stock  within  60  days  after  the  Determination  Date,  for  each
shareholder.

52 

 
 
 
 
 
 
   
 
 
 
    
  
   
   
   
   
   
   
   
   
   
   
   
   
 
   
      
  
   
      
  
   
      
  
   
 
 
 
 
 
(4)

Includes 36,000 restricted shares that are subject to a repurchase option.

(5)

Includes 130,000 restricted shares that are subject to a repurchase option.

(6)

Includes 123,626 restricted shares that are subject to a repurchase option. Mr. Boomgarden resigned from the Company, effective
September 15, 2017.

(7)

Includes 175,000 restricted shares that are subject to a repurchase option.

(8)

Includes 20,000 shares of Common Stock issuable upon exercise of options.

(9)

Includes 38,204 restricted shares that are subject to a repurchase option.

(10)

Includes 30,914 restricted shares that are subject to a repurchase option.

(11)

Includes 22,000 restricted shares that are subject to a repurchase option.

(12)

Includes 22,000 restricted shares that are subject to a repurchase option.

(13)

Includes 599,744 restricted shares that are subject to a repurchase option

ITEM 13.         CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

SEC rules require us to disclose any transaction or currently proposed transaction in which the Company is a participant and in which any
related person has or will have a direct or indirect material interest involving the lesser of $120,000.00 or one percent (1%) of the average
of the Company’s total assets as of the end of last two completed fiscal years. A related person is any executive officer, director, nominee
for director, or holder of 5% or more of the Company’s Common Stock, or an immediate family member of any of those persons. Set forth
below is a description of such related-party transactions that occurred during the transition period.

Certain of our directors and officers participated in the 2016-2017 Offering. Specifically:

●

●

●

●

●

Our CEO, Jeffrey Shealy, purchased 20,000 shares of Common Stock for an aggregate purchase price of $100,000 in the 2016-2017
Offering.

Mark Boomgarden, our Vice President of Operations (until his resignation, effective September 15, 2017), purchased 2,000 shares
of Common Stock for an aggregate purchase price of $10,000 in the 2016-2017 Offering.

Jerry Neal, one of our directors and Co-Chairman of our Board of Directors, purchased 200,000 shares  of  Common  Stock  for  an
aggregate purchase price of $1,000,000 in the 2016-2017 Offering.

Arthur Geiss, one of our directors and Co-Chairman of our Board of Directors, purchased 2,000 shares  of  Common  Stock  for  an
aggregate purchase price of $10,000 in the 2016-2017 Offering.

Rohan Houlden, our Divisional Vice President of Product Engineering, purchased 20,000 shares  of Common Stock for an aggregate
purchase price of $100,000 in the 2016-2017 Offering.

In addition, James R. Shealy, brother of our Chief Executive Officer, purchased 14,000 shares of Common Stock for an aggregate purchase
price of $70,000 in the 2016-2017 Offering. Michael J. Shealy, a second brother of our Chief Executive Officer, purchased 20,000 shares
of Common Stock for an aggregate purchase price of $100,000 in the 2016-2017 Offering.

AEG Consulting, a firm owned and operated by Arthur Geiss, Co-Chairman of the Board, received $15,195 for consulting fees for the year
ended June 30, 2017.

53 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Steve Miller, one of our directors, served as a Board Advisor to the Board from January 2017 through June 2017, prior to joining the Board
in  July  2017.  In  connection  with  his  service  as  a  Board Advisor,  the  Board  has  approved  a  restricted  stock  award  for  11,000  shares  of
Common Stock to be granted to Mr. Miller during the next open trading window.

The Board of Directors considered the above transactions in reaching its determination regarding the independence of our directors, See
“Director Independence” under “Item 10-Directors, Executive Officers and Corporate Governance.”

54 

 
 
 
 
ITEM 14.         PRINCIPAL ACCOUNTANT FEES AND SERVICES

Fees

The  aggregate  fees  billed  to  us  by  Marcum  LLP,  our  independent  registered  principal  accounting  firm,  for  services  rendered  for  (i)  the
fiscal year ended June 30, 2017; (ii) the transition period from April 1, 2016 to June 30, 2016; and (iii) our prior fiscal year ended March
31, 2016 are set forth in the table below:

Fee Category

Audit fees (2)
Audit-related fees (3)
Tax fees (4)
All other fees

Total fees

Fiscal Year
ended June 30,
2017

Transition Period
ended June 30,
2016(1)

Fiscal year
ended March 31,
 2016

  $

121,495    $
40,757     
10,341     
—     

65,611    $
13,692     
16,276     
—     

109,458 
26,583 
34,037 
— 

  $

172,593    $

95,579    $

170,078 

(1)

Fees included in the Transition period ended June 30, 2016 include the fees for the audit of the three-month transition period as well as
the audit of the year ended June 30, 2016.

(2) Audit fees consist of fees incurred for professional services rendered for the audit of consolidated financial statements, for reviews of
our  interim  consolidated  financial  statements  included  in  our  quarterly  reports  on  Forms  10-Q  and  for  services  that  are  normally
provided in connection with statutory or regulatory filings or engagements.

(3)

For the fiscal year ended June 30, 2017, audit-related fees are related to the review of the selling stockholder registration statement
related to the 2016-2017 Offering and 2017 Offering and review of the registration statement on Form S-8 for the 2016 Plan. For our
prior  fiscal  year  ended  March  31,  2016,  audit-related  fees  are  related  to  the  review  of  the  selling  stockholder  registration  statement
related to a private placement in 2015 and review of the Form 8-K filing associated with our May 2015 merger.

(4)

Tax fees consist of fees billed for tax return preparation.

Pre-Approval Practice

The  Board  established  an Audit  Committee  in  February  2017.  The Audit  Committee’s  responsibilities  include  establishing  policies  and
procedures  for  the  review  and  pre-approval  by  the  Audit  Committee  of,  and  approving  or  pre-approving,  all  auditing  services  and
permissible  non-audit  services  to  be  performed  by  the  independent  registered  public  accounting  firm,  and  any  non-audit  services  to  be
performed by any other accounting firm. Our Audit Committee has adopted procedures for the pre-approval of services to be performed by
the independent public accountants. Pursuant to this pre-approval policy, the Audit Committee considers, at least annually, and approves
the terms of the audit engagement. At each regularly scheduled Audit Committee meeting, the committee members review both a report
summarizing  the  services,  provided  or  anticipated  to  be  provided  by  the  auditor  and  the  related  fees  and  costs,  and  a  listing  of  newly
requested services subject to pre-approval since its last regularly scheduled meeting. Any proposed engagement relating to permissible non-
audit services must be presented to the Audit Committee and pre-approved on a case-by-case basis, prior to the performance of the auditor.
In addition, particular categories of permissible non-audit services that are recurring may be pre-approved by the Audit Committee subject
to preset fee limits. The Audit Committee reviews requests for the provision of audit and non-audit services by the Company’s independent
public accountants and determines if they should be approved. Such requests could be approved either at a meeting of the Audit Committee
or upon approval by an independent director, if such responsibility has been delegated by the Audit Committee and if approval is needed
between Audit Committee meetings. Any such interim approvals must be reported to the Audit Committee at its next scheduled meeting.
Prior to approving any services, the Audit Committee considers whether the provision of such services is consistent with the SEC’s and the
PCAOB’s rules on auditor independence and is compatible with maintaining the independence of the Company’s public accountants.

55 

 
 
 
 
 
 
   
   
 
 
   
   
 
     
 
   
   
   
 
   
      
      
  
 
 
 
 
 
 
 
All fees related to audit, audit-related, tax, and other permitted non-audit services were pre-approved by the Audit Committee (or the Board
of Directors if prior to the establishment of the Audit Committee).

56 

 
 
 
ITEM 15.         EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

Financial Statement Schedules

PART IV

The consolidated financial statements of Akoustis Technologies, Inc., and its subsidiaries are listed on the Index to Financial Statements on
this annual report on Form 10-K beginning on page F-1.

All  financial  statement  schedules  are  omitted  because  they  are  not  applicable  or  the  required  information  is  shown  in  the  financial
statements or notes thereto.

Exhibits

The exhibits listed in the accompanying Exhibit Index are filed as a part of this Annual Report on Form 10-K.

57 

 
 
 
 
 
 
 
 
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly authorized.

SIGNATURES

Dated:  September 19, 2017

AKOUSTIS TECHNOLOGIES, INC.

By:

/s/ Jeffrey B. Shealy
Jeffrey B. Shealy
President and Chief Executive Officer

In  accordance  with  the  Exchange Act,  this  report  has  been  signed  below  by  the  following  persons  on  behalf  of  the  registrant  and  in  the
capacities and on the dates indicated.

SIGNATURE 

TITLE

DATE

/s/ Jeffrey B. Shealy
Jeffrey B. Shealy

/s/ John T. Kurtzweil

John T. Kurtzweil

/s/ Arthur E. Geiss

Arthur E. Geiss

/s/ Jerry D. Neal
Jerry D. Neal

/s/ Steven P. DenBaars

Steven P. DenBaars

/s/ Jeffrey K. McMahon
Jeffrey K. McMahon

/s/ Steven P. Miller
Steven P. Miller

/s/ Suzanne B. Rudy

Suzanne B. Rudy

  Chief Executive Officer (Principal
  Executive Officer), Director

  September 19, 2017

  Chief Financial Officer and Chief Accounting

Officer (Principal 

  Financial and Accounting Officer)

September 19, 2017

  Co-Chairman of the Board

  September 19, 2017

  Co-Chairman of the Board

  September 19, 2017

  Director

  Director

  Director

  Director

58 

  September 19, 2017

  September 19, 2017

  September 19, 2017

  September 19, 2017

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
   
 
 
 
   
 
   
 
 
 
   
 
 
   
 
 
 
   
 
 
   
 
 
 
   
 
 
   
 
 
 
   
 
 
   
 
 
 
   
 
 
   
 
 
 
   
   
 
 
 
 
 
INDEX TO FINANCIAL STATEMENTS

Report of Independent Registered Public Accounting Firm

Consolidated Balance Sheets as of June 30, 2017 and June 30, 2016

Consolidated Statements of Operations for the years ended June 30, 2017 and 2016

Consolidated Statement of Changes in Stockholders’ Equity for the years ended June 30, 2017 and 2016

Consolidated Statements of Cash Flows for the years ended June 30, 2017 and 2016

Notes to Consolidated Financial Statements

 F-1

  Page

  F-2

  F-3

  F-4

  F-5

  F-6

  F-7

 
 
 
 
 
 
   
 
   
 
   
 
   
 
   
 
   
 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Audit Committee of the
Board of Directors and Shareholders
of Akoustis Technologies, Inc.

We  have  audited  the  accompanying  consolidated  balance  sheets  of Akoustis  Technologies,  Inc.  and  Subsidiaries  (the  “Company”)  as  of
June 30, 2017 and 2016, and the related consolidated statements of operations, changes in stockholders’ equity and cash flows for the years
then ended. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on
these financial statements based on our audits.

We  conducted  our  audits  in  accordance  with  the  standards  of  the  Public  Company Accounting  Oversight  Board  (United  States).  Those
standards  require  that  we  plan  and  perform  the  audit  to  obtain  reasonable  assurance  about  whether  the  financial  statements  are  free  of
material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting.  Our  audit  included  consideration  of  internal  control  over  financial  reporting  as  a  basis  for  designing  audit  procedures  that  are
appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control
over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting
the  amounts  and  disclosures  in  the  financial  statements,  assessing  the  accounting  principles  used  and  significant  estimates  made  by
management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for
our opinion.

In  our  opinion,  the  financial  statements  referred  to  above  present  fairly,  in  all  material  respects,  the  consolidated  financial  position  of
Akoustis Technologies, Inc. and Subsidiaries, as of June 30, 2017 and 2016, and the consolidated results of its operations and its cash flows
for the years then ended in conformity with accounting principles generally accepted in the United States of America.

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As
discussed  in  Note  2  to  the  consolidated  financial  statements,  the  Company  has  not  generated  any  revenue,  and  has  incurred  losses  since
inception.  These  conditions  raise  substantial  doubt  about  the  Company’s  ability  to  continue  as  a  going  concern.  Management’s  plans
regarding these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result
from the outcome of this uncertainty.

/s/Marcum llp

Marcum llp
New York, NY
September 19, 2017

 F-2

 
 
 
 
 
 
 
 
 
 
Akoustis Technologies, Inc.
Consolidated Balance Sheets

Assets

Assets:
Cash and cash equivalents
Inventory
Prepaid expenses
Other current assets
Total current assets

Property and equipment, net

Intangibles, net

Other assets
Total Assets

Liabilities and Stockholders' Equity

Current Liabilities:
Accounts payable and accrued expenses
Deferred revenue
Total current liabilities

Long-term Liabilities:
Contingent real estate liability
Derivative liabilities
Total long-term liabilities

Total Liabilities

Commitments and contingencies

Stockholders' Equity
Preferred Stock, par value $0.001: 5,000,000 shares authorized; none issued and outstanding
Common stock, $0.001 par value; 45,000,000 shares authorized; 19,075,050 and 15,375,981 shares

issued and outstanding at June 30, 2017 and June 30, 2016, respectively

Additional paid in capital
Accumulated deficit
Total Stockholders' Equity
Total Liabilities and Stockholders' Equity

June 30,
2017

June 30,
2016

  $

9,631,520    $
188,476   
158,457   
42,808   
10,021,261   

4,155,444 
43,544 
54,818 
— 
4,253,806 

7,853,814   

206,985 

206,527   

71,233 

10,715   

  $ 18,092,317    $

10,715 
4,542,739 

  $

1,336,368    $
14,500   
1,350,868   

543,646 
— 
543,646 

1,730,542   
—   
1,730,542   

— 
1,322,729 
1,322,729 

3,081,410   

1,866,375 

—   

— 

19,075   
30,774,885   
(15,783,053)  
15,010,907   

  $ 18,092,317    $

15,376 
9,335,801 
(6,674,813)
2,676,364 
4,542,739 

The accompanying notes are an integral part of these consolidated financial statements

 F-3

 
 
 
 
 
   
 
 
 
   
 
 
 
 
   
 
 
 
 
    
 
  
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Akoustis Technologies, Inc.
Consolidated Statements of Operations

For the Year
Ended

June 30, 2017    

For the Year
Ended
June 30, 2016  

Contract research and government grants

  $

469,532    $

254,834 

Revenue

Total revenue

Operating expenses
Research and development
General and administrative expenses
Total operating expenses

Loss from operations

Other income (expense)
Other income
Interest income
Bargain purchase
Change in fair value of derivative liabilities
Total other income (expense)
Net loss

Net loss per common share - basic and diluted

16,964   

— 

486,496   

254,834 

4,425,778   
6,019,285   
10,445,063   

1,758,701 
2,935,299 
4,694,000 

(9,958,567)  

(4,439,166)

—   
1,936   
1,725,881   
(877,490)  
850,327   
(9,108,240)   $

500 
1,339 

(968,840)
(967,001)
(5,406,167)

(0.54)   $

(0.40)

  $

  $

Weighted average common shares outstanding -basic and diluted

16,990,536   

13,349,482 

The accompanying notes are an integral part of these consolidated financial statements

 F-4

 
 
 
 
 
 
 
 
   
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
    
 
  
 
 
 
 
Akoustis Technologies, Inc.
Consolidated Statement of Changes in Stockholders’ Equity
For the Years Ended June 30, 2017 and June 30, 2016

Common Stock

  Additional

  Accumulated  

Shares

Amount

Paid In
Capital

Deficit

Stockholders’
Equity

Balance, July 1, 2015

12,469,084    $

12,469    $

5,441,260    $

(1,268,646)   $

4,185,083 

Common stock issued for cash, net

of issuance costs

2,240,000   

2,240   

3,330,343   

Warrants issued to underwriter

—   

—   

(165,719)  

Common stock issued for services  

660,231   

660   

702,950   

Common stock issued for exercise

of warrants

Transfer of warrants from liability

to equity classification

Net loss

6,666   

7   

9,993   

—   

—   

—   

—   

16,974   

—   

(5,406,167)  

(5,406,167)

Balance, June 30, 2016

15,375,981    $

15,376    $

9,335,801    $

(6,674,813)   $

2,676,364 

Common stock issued for cash, net

of issuance costs

2,805,000   

2,805   

15,381,966   

Warrants issued to underwriter

—   

—   

(991,767)  

Common stock issued for services  

783,000   

783   

4,242,314   

Common stock issued for exercise

of warrants

111,069   

Vesting of restricted shares

Transfer of warrants from liability

to equity classification

Net loss

—   

—   

—   

111   

—   

—   

—   

171,649   

434,703   

2,200,219   

Balance, June 30, 2017

19,075,050    $

19,075    $

30,774,885    $ (15,783,053)   $

15,010,907 

The accompanying notes are an integral part of these consolidated financial statements

 F-5

—   

(9,108,240)  

(9,108,240)

—   

—   

—   

—   

—   

3,332,583 

(165,719)

703,610 

10,000 

16,974 

—   

—   

—   

—   

—   

—   

15,384,771 

(991,767)

4,243,097 

171,760 

434,703 

2,200,219 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
   
 
   
 
   
 
 
 
 
 
 
 
    
 
    
 
    
 
    
 
  
 
 
 
 
 
 
 
 
 
    
 
    
 
    
 
    
 
  
 
 
 
 
 
 
 
 
 
    
 
    
 
    
 
    
 
  
 
 
 
 
 
 
 
 
    
 
    
 
    
 
    
 
  
 
 
 
 
 
 
 
 
 
    
 
    
 
    
 
    
 
  
 
 
 
 
 
 
 
 
 
    
 
    
 
    
 
    
 
  
 
 
 
 
 
 
 
 
 
    
 
    
 
    
 
    
 
  
 
 
 
 
 
    
 
    
 
    
 
    
 
  
 
 
 
 
 
 
 
 
 
    
 
    
 
    
 
    
 
  
 
 
 
 
 
 
 
 
 
    
 
    
 
    
 
    
 
  
 
 
 
 
 
 
 
 
    
 
    
 
    
 
    
 
  
 
 
 
 
 
 
 
 
 
    
 
    
 
    
 
    
 
  
 
 
 
 
 
 
 
 
 
    
 
    
 
    
 
    
 
  
 
 
 
 
 
 
 
 
 
    
 
    
 
    
 
    
 
  
 
 
 
 
 
 
 
 
 
    
 
    
 
    
 
    
 
  
 
 
 
 
Akoustis Technologies, Inc.
Consolidated Statements of Cash Flows

CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:

Depreciation
Amortization of intangibles
Share-based compensation
Change in fair value of derivative liabilities
Bargain purchase

Changes in operating assets and liabilities:

Inventory
Prepaid expenses
Other current asset
Accounts payable and accrued expenses
Deferred revenue

Net Cash Used In Operating Activities

CASH FLOWS FROM INVESTING ACTIVITIES:
Cash paid for machinery and equipment
Cash paid for acquisition of STC-MEMS
Cash paid for intangibles

Net Cash Used In Investing Activities

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock
Proceeds from exercise of warrants

Net Cash Provided By Financing Activities

Net Increase (Decrease) in Cash

Cash - Beginning of Period

Cash - End of Period

SUPPLEMENTARY CASH FLOW INFORMATION:
Cash Paid During the Period for:

Income taxes
Interest

SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING

ACTIVITIES:

Stock compensation payable
Warrants issued for stock issuance costs
Reclassification of derivative liability to additional paid in capital
Contingent liability

For the Year
Ended
June 30, 2017    

For the Year
Ended
June 30, 2016  

  $

(9,108,240)   $

(5,406,167)

102,876   
7,208   
3,906,111   
877,490   
(1,725,881)  

(48,883)  
(103,639)  
(42,808)  
572,644   
14,500   
(5,548,622)  

(1,625,055)  
(2,846,049)  
(60,729)  
(4,531,833)  

34,828 
3,339 
849,625 
968,840 
— 

(43,544)
4,994 
— 
275,116 
— 
(3,312,969)

(160,172)
— 
(43,495)
(203,667)

15,384,771   
171,760   
15,556,531   

3,332,584 
10,000 
3,342,584 

5,476,076   

(174,052)

4,155,444   

4,329,496 

  $

9,631,520    $

4,155,444 

  $
  $

  $
  $
  $
  $

—    $
—    $

— 
— 

654,781    $
991,767    $
2,200,219    $
1,730,542    $

146,016 
165,719 
— 
— 

The accompanying notes are an integral part of these consolidated financial statements

 F-6

 
 
 
 
 
   
 
 
 
 
 
 
   
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
 
    
 
  
 
 
    
 
  
 
 
    
 
  
 
 
 
    
 
  
 
 
    
 
  
 
 
 
    
 
  
 
 
Note 1. Organization

AKOUSTIS TECHNOLOGIES, INC.
Notes to the Consolidated Financial Statements

Akoustis Technologies, Inc. (formerly known as Danlax, Corp.) (“the Company”) was incorporated under the laws of the State of Nevada,
U.S. on April 10, 2013. Effective December 15, 2016, the Company changed its state of incorporation from the State of Nevada to the State
of  Delaware.  Through  its  subsidiaries, Akoustis,  Inc.  and Akoustis  Manufacturing  New  York,  Inc.  (each  a  Delaware  corporation),  the
Company,  headquartered  in  Huntersville,  North  Carolina,  is  focused  on  developing,  designing  and  manufacturing  innovative  radio
frequency  filter  products  for  the  mobile  wireless  device  industry.  The  mission  of  the  Company  is  to  commercialize  and  manufacture  its
patented BulkONE® acoustic wave technology to address the critical frequency-selectivity requirements in today’s mobile smartphones -
improving the efficiency and signal quality of mobile wireless devices and enabling the Internet of Things.

On August 11, 2016, the Company changed its fiscal year from the period beginning on April 1 and ending on March 31 of each year to the
period beginning on July 1 and ending on June 30 of each year, effective for the fiscal year ended June 30, 2017.

On March 10, 2017, the Company announced that its common stock was approved for listing on the NASDAQ Capital Market, effective
March 13, 2017, under the symbol AKTS.

Acquisition of Assets

On June 26, 2017, pursuant to a Definitive Asset Purchase Agreement and Definitive Real Property Purchase Agreement (collectively, the
“Agreements”)  with  The  Research  Foundation  for  the  State  University  of  New  York  (“RF-SUNY”)  and  Fuller  Road  Management
Corporation  (“FRMC”),  an  affiliate  of  RF-SUNY,  respectively,  the  Company  completed  the  acquisition  of  certain  specified  assets,
including  STC-MEMS,  a  semiconductor  wafer-manufacturing  operation  and  microelectromechanical  systems  (“MEMS”)  business  with
associated wafer-manufacturing tools, as well as the real estate and improvements associated with the facility located in Canandaigua, New
York, which is used in the operation of STC-MEMS (the assets and real estate and improvements referred to together herein as the “STC-
MEMS  Business”), which  was  created  in  2010  by  RF-SUNY  as  an  economic  development  project.  The  purpose  of  the  initiative  was  to
explore different technology opportunities with the goal of being a vertically integrated provider of foundry services that would offer its
customers  the  capacity,  infrastructure  and  operational  capabilities  of  semiconductor  and  advanced  manufacturing  for  aerospace,
biomedical, communications, defense, and energy markets. Post-acquisition date, the Company also agreed to assume substantially all the
on-going  obligations  of  STC  incurred  in  the  ordinary  course  of  business  including  with  respect  to  the  29  employees  employed  by  RF-
SUNY.

The  Company  acquired  the  STC-MEMS  Business  through  its  wholly-owned  subsidiary,  Akoustis  Manufacturing  New  York,  Inc.,
(“Akoustis NY”), a Delaware corporation.

See Note 4 for a detailed description of the transaction. 

 F-7

 
 
 
 
 
 
 
 
 
 
 
The 2016-2017 Offering

The  Company  sold  a  total  of  2,142,000  shares  of  its  common  stock,  par  value  $0.001  per  share  (the  “Common  Stock”)  in  a  private
placement offering (the “2016-2017 Offering”) at a fixed purchase price of $5.00 per share (the “2016-2017 Offering Price”), with closings
in each of November and December 2016 and January and February 2017. The Company also sold a total of 663,000 shares of Common
Stock in a private placement offering (the “2017 Offering” and together with the 2016-2017 Offering, the “Offerings”) at a fixed purchase
price of $9.00 per share (the “2017 Offering Price”), with closings in May 2017. Aggregate gross proceeds from the Offerings totaled $16.7
million  before  deducting  commissions  and  expenses  of  approximately  $1.3  million.  In  connection  with  the  2016-2017  Offering,  the
Company also issued to the placement agents warrants to purchase an aggregate 205,126 shares of Common Stock with a term of five years
and an exercise price of $5.00 per share, and in connection with the 2017 Offering, the Company issued to the placement agents warrants to
purchase an aggregate 46,410 shares of Common Stock with a term of five years and an exercise price of $9.00 per share. In accordance
with the terms of the subscription agreements executed by the Company and each of the investors, if the Company issues additional shares
of Common Stock or Common Stock equivalents (subject to customary exceptions, including but not limited to issuances of awards under
Company  employee  stock  incentive  programs  and  certain  issuances  in  connection  with  credit  arrangements,  equipment  financings,  lease
arrangements,  or  similar  transactions)  between  November  25,  2016  and  September  4,  2017  (with  respect  to  the  2016-2017  Offering),  or
between May 1, 2017 and May 1, 2019 (with respect to the 2017 Offering), for a consideration per share less than the 2016-2017 Offering
Price  or  the  2017  Offering  Price,  as  applicable  (as  adjusted  for  any  subsequent  stock  dividend,  stock  split,  distribution,  recapitalization,
reclassification, reorganization, or similar event) (the “Lower Price”), each investor will be entitled to receive from the Company additional
shares  of  Common  Stock  in  an  amount  such  that,  when  added  to  the  number  of  shares  of  Common  Stock  initially  purchased  by  such
investor,  will  equal  the  number  of  shares  of  Common  Stock  that  such  Investor’s  investment  in  the  applicable  offering  would  have
purchased at the Lower Price.

The March 2016 and April 2016 Offerings

On March 10, 2016, the Company held a closing  of  a  private  placement  offering  (the  “March  2016  Offering”)  in  which  it  sold  494,125
shares of Common Stock at a fixed purchase price of $1.60 per share (the “2016 Offering Price”), for aggregate gross proceeds of $790,600
(before deducting legal expenses of $20,913 for the March 2016 Offering). 

On April  14,  2016,  the  Company  held  closings  of  a  private  placement  offering  (the  “April  2016  Offering”)  in  which  the  Company  sold
1,741,185 shares of Common Stock at a fixed purchase price of $1.60 per share (the “2016 Offering Price”), for aggregate gross proceeds
of $2,785,896 (before deducting expenses of $223,000 for legal services and agent commissions of the April 2016 Offering).

Investors in the shares were given anti-dilution protection with respect to the shares of Common Stock sold in the April 2016 Offering such
that if, during the period from the closing of the April 2016 Offering until 90 days after the date on which the registration statement that the
Company is required to file under a Registration Rights Agreement with the  investors is declared effective by the SEC, the Company shall
issue  additional  shares  of  Common  Stock  or  Common  Stock  equivalents  (subject  to  customary  exceptions,  including  but  not  limited  to
issuances  of  awards  under  the  Company’s  2015  Equity  Incentive  Plan  and  certain  issuances  of  securities  in  connection  with  credit
arrangements, equipment financings, lease arrangements or similar transactions) for a consideration per share less than the 2016 Offering
Price  (as  adjusted  for  any  subsequent  stock  dividend,  stock  split,  distribution,  recapitalization,  reclassification,  reorganization  or  similar
event) (the “2016 Lower Price”), each such investor will be entitled to receive from the Company additional shares of Common Stock in an
amount such that, when added to the number of shares of Common Stock initially purchased by such investor, will equal the number of
shares  of  Common  Stock  that  such  investor’s  Offering  subscription  amount  would  have  purchased  at  the  2016  Lower  Price. As  of  mid-
October 2016, the anti-dilution rights expired.

In  connection  with  the April  2016  Offering,  the  Company  agreed  to  pay  the  placement  agents  a  cash  commission  of  8%  of  the  gross
proceeds  raised  from  investors  first  contacted  by  the  placement  agents  in  the  2016  Offering.  In  addition,  the  placement  agents  received
warrants to purchase a number of shares of Common Stock equal to 10% of the number of shares of Common Stock sold in the April 2016
Offering, with a term of five (5) years and an exercise price of $1.60 per share (the “2016 Placement Agent Warrants”). Any sub-agent of
the placement agents that introduced investors to the 2016 April Offering was entitled to share in the cash fees and warrants attributable to
those investors as described above.

 F-8

 
 
 
 
 
 
 
 
 
Note 2. Going Concern and Management Plans

The  accompanying  condensed  consolidated  financial  statements  have  been  prepared  on  a  going  concern  basis,  which  contemplates  the
realization  of  assets  and  the  satisfaction  of  liabilities  in  the  normal  course  of  business. As  of  June  30,  2017,  the  Company  had  working
capital of $8.7 million and an accumulated deficit of $15.8 million. Since inception, the Company has recorded approximately $892,000 of
revenue from contract research and government grants. As of June 30, 2017, the Company had cash and cash equivalents of $9.6 million
which  the  Company  believes  is  sufficient  to  fund  its  current  operations  through  December  2017. As  a  result,  we  will  need  to  obtain
additional capital through the sale of additional equity securities, debt and additional grants, or otherwise, to fund operations past that date.
The  Company  is  actively  managing  and  controlling  the  Company’s  cash  outflows  to  mitigate  these  risks,  these  matters  raise  substantial
doubt about the Company’s ability to continue as a going concern.  The consolidated financial statements do not include any adjustments
relating  to  the  recoverability  and  classification  of  asset  amounts  or  the  classification  of  liabilities  that  might  be  necessary  should  the
Company be unable to continue as a going concern. The Company had $6.7 million of cash and cash equivalents on hand as of September
8, 2017 to fund its business.

There is no assurance that the Company’s projections and estimates are accurate. The Company’s primary sources of funds for operations
since  inception  have  been  private  equity,  note  financings  and  grants.  The  Company  needs  to  obtain  additional  capital  to  accomplish  its
business  plan  objectives  and  will  continue  its  efforts  to  secure  additional  funds  through  issuance  of  debt  or  equity  instruments  and/or
receipts  of  grants  as  appropriate.  However,  the  amount  of  funds  raised,  if  any,  may  not  be  sufficient  to  enable  the  Company  to  attain
profitable operations. To the extent that the Company is unsuccessful in obtaining additional financing, the Company may need to curtail or
cease  its  operations  and  implement  a  plan  to  extend  payables  or  reduce  overhead  until  sufficient  additional  capital  is  raised  to  support
further operations. There can be no assurance that such a plan will be successful.

Note 3. Summary of significant accounting policies

Basis of presentation

The Company’s consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the
United States of America (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”). 

Principles of Consolidation

The  accompanying  consolidated  financial  statements  include  the  accounts  of  the  Company  and  its  wholly-owned  subsidiaries, Akoustis,
Inc.  and  Akoustis  Manufacturing  New  York,  Inc.  All  significant  intercompany  accounts  and  transactions  have  been  eliminated  in
consolidation.

Use of estimates and assumptions

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date(s) of the financial statements and the
reported amounts of revenues and expenses during the reporting period(s).

Critical accounting estimates are estimates for which (a) the nature of the estimate is material due to the levels of subjectivity and judgment
necessary  to  account  for  highly  uncertain  matters  or  the  susceptibility  of  such  matters  to  change  and  (b)  the  impact  of  the  estimate  on
financial  condition  or  operating  performance  is  material.  The  Company’s  critical  accounting  estimates  and  assumptions  affecting  the
financial statements were:

(1) Fair value of long–lived assets: Fair value is generally determined using the asset’s expected future discounted cash flows or
market  value,  if  readily  determinable.  If  long–lived  assets  are  determined  to  be  recoverable,  but  the  newly  determined
remaining  estimated  useful  lives  are  shorter  than  originally  estimated,  the  net  book  values  of  the  long–lived  assets  are
depreciated  over  the  newly  determined  remaining  estimated  useful  lives.  The  Company  considers  the  following  to  be  some
examples of important indicators that may trigger an impairment review: (i) significant under–performance or losses of assets
relative to expected historical or projected future operating results; (ii) significant changes in the manner or use of assets or in
the Company’s overall strategy with respect to the manner or use of the acquired assets or changes in the Company’s overall
business strategy; (iii) significant negative industry or economic trends; (iv) increased competitive pressures; (v) a significant
decline  in  the  Company’s  stock  price  for  a  sustained  period  of  time;  and  (vi)  regulatory  changes.  The  Company  evaluates
acquired assets for potential impairment indicators at least annually and more frequently upon the occurrence of such events.

 F-9

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(2) Valuation allowance for deferred tax assets: Management assumes that the realization of the Company’s net deferred tax assets
resulting from its net operating loss (“NOL”) carry–forwards for Federal income tax purposes that may be offset against future
taxable income was not considered more likely than not and accordingly, the potential tax benefits of the NOL carry–forwards
are offset by a full valuation allowance. Management made this assumption based on (a) the Company’s incurrence of losses,
(b) general economic conditions, and (c) other factors.

(3) Estimates and assumptions used in valuation of equity instruments: Management estimates expected term of share options and
similar instruments, expected volatility of the Company’s common shares and the method used to estimate it, expected annual
rate of quarterly dividends, and risk-free rate(s) to value share options and similar instruments.

(4) Estimates  and  assumptions  used  in  valuation  of  derivative  liability:  Management  utilizes  a  binomial  option  pricing  model  to
estimate  the  fair  value  of  derivative  liabilities.  The  model  includes  subjective  assumptions  that  can  materially  affect  the  fair
value estimates.

(5) Estimates and assumptions used in business combinations:  The  accounting  for  business  combinations  requires  estimates  and
judgments  as  to  expectations  for  future  cash  flows  of  the  acquired  business,  and  the  allocation  of  those  cash  flows  to
identifiable  intangible  assets,  in  determining  the  estimated  fair  value  for  assets  and  liabilities  acquired.  The  fair
value measurement is highly sensitive to significant changes in the unobservable inputs and significant increases (decreases) in
discount  rate  or  decreases  (increases)  in  price/earnings  multiples  would  result  in  a  significantly  lower  (higher)  fair
value  measurement.  The  fair  values  assigned  to  tangible  and  intangible  assets  acquired  and  liabilities  assumed  are  based  on
management’s estimates and assumptions, including valuations that utilize customary valuation procedures and techniques. If
the  actual  results  differ  from  the  estimates  and  judgments  used  in  these  estimates,  the  amounts  recorded  in  the  financial
statements could result in a possible impairment of the acquired assets. 

These significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to these
estimates or assumptions, and certain estimates or assumptions are difficult to measure or value.

Management bases its estimates on various assumptions that are believed to be reasonable in relation to the financial statements taken as a
whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities
that are not readily apparent from other sources. Actual results could differ from those estimates.

Cash and Cash Equivalents

The  Company  considers  all  highly  liquid  investments  with  an  original  maturity  of  three  months  or  less  when  purchased  to  be  cash
equivalents. Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash deposits.
The Company maintains its cash in institutions insured by the Federal Deposit Insurance Corporation (“FDIC”). At times, the Company’s
cash  and  cash  equivalent  balances  may  be  uninsured  or  in  amounts  that  exceed  the  FDIC  insurance  limits;  as  of  June  30,  2017
approximately $9.4 million was uninsured.

 F-10

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inventory

Inventory  is  stated  at  the  lower  of  cost  or  market  using  the  first-in,  first-out  (FIFO)  valuation  method.  Inventory  was  comprised  of  the
following at June 30, 2017 and 2016:

Finished goods held for resale
Raw materials

Property and equipment, net

June 30, 2017

June 30, 2016

  $

  $

49,374    $
139,102     
188,476    $

43,544 
— 
43,544 

Property and equipment are stated at cost less accumulated depreciation. Depreciation is calculated using the straight–line method on the
various  asset  classes  over  their  estimated  useful  lives,  which  range  from  three  to  ten  years.  Expenditures  for  major  renewals
and betterments that extend the useful lives of property and equipment are capitalized. Expenditures for maintenance and repairs, which do
not extend the economic useful life of the related assets, are charged to operations as incurred.

Intangible assets, net

Intangible  assets  consist  of  patents  and  trademarks. Applicable  long–lived  assets  are  amortized  or  depreciated  over  the  shorter  of  their
estimated useful lives, the estimated period that the assets will generate revenue, or the statutory or contractual term in the case of patents.
Estimates  of  useful  lives  and  periods  of  expected  revenue  generation  are  reviewed  periodically  for  appropriateness  and  are  based  upon
management’s judgment. Patents are amortized on the straight-line method over their useful lives of 15 years.

Impairment of Long-Lived Assets

The  Company  assesses  the  recoverability  of  its  long-lived  assets,  including  property  and  equipment,  when  there  are  indications  that  the
assets might be impaired. When evaluating assets for potential impairment, the Company compares the carrying value of the asset to its
estimated  undiscounted  future  cash  flows.    If  an  asset’s  carrying  value  exceeds  such  estimated  undiscounted  cash  flows,  the  Company
records an impairment charge for the difference between the carrying amount of the asset and its fair value.

Based on its assessments, the Company did not record any impairment charges for the years ended June 30, 2017 and 2016.

Fair Value of Financial Instruments

The  carrying  amounts  of  cash  and  cash  equivalents  and  accounts  payable  approximate  fair  value  due  to  the  short-term  nature  of  these
instruments.

The Company measures the fair value of financial assets and liabilities based on the guidance of ASC 820, “ Fair Value Measurements and
Disclosures,”  which  defines  fair  value,  establishes  a  framework  for  measuring  fair  value,  and  expands  disclosures  about  fair  value
measurements. 

ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the
principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement
date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the
use of unobservable inputs when measuring fair value.

 F-11

 
 
 
 
 
 
   
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
Fair value measurements are categorized using a valuation hierarchy for disclosure of the inputs used to measure fair value, which prioritize
the inputs into three broad levels:

Level 1 - Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in
which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis.

Level 2 - Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable
as of the reported date, and include those financial instruments that are valued using models or other valuation methodologies.

Level 3 - Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with
internally developed methodologies that result in management’s best estimate of fair value.

Derivative Liability

The Company evaluates its options, warrants or other contracts, if any, to determine if those contracts or embedded components of those
contracts  qualify  as  derivatives  to  be  separately  accounted  for  in  accordance  with  paragraph  815-10-05-4  and  Section  815-40-25  of  the
FASB Accounting  Standards  Codification.  The  result  of  this  accounting  treatment  is  that  the  fair  value  of  the  embedded  derivative  is
marked-to-market  each  balance  sheet  date  and  recorded  as  either  an  asset  or  a  liability.  The  change  in  fair  value  is  recorded  in  the
consolidated statement of operations as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the
instrument is marked to fair value at the date of conversion, exercise or cancellation and then the related fair value is reclassified to equity.

In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other
embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are
accounted for as a single, compound derivative instrument.

The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed
at  the  end  of  each  reporting  period.  Equity  instruments  that  are  initially  classified  as  equity  that  become  subject  to  reclassification  are
reclassified to liability at the fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in
the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12
months of the balance sheet date.

The Company adopted Section 815-40-15 of the FASB Accounting Standards Codification (“Section 815-40-15”)  to determine whether an
instrument (or an embedded feature) is indexed to the Company’s own stock.  Section 815-40-15 provides that an entity should use a two-
step  approach  to  evaluate  whether  an  equity-linked  financial  instrument  (or  embedded  feature)  is  indexed  to  its  own  stock,  including
evaluating the instrument’s contingent exercise and settlement provisions.

The Company utilizes a binomial option pricing model to compute the fair value of the derivative and to mark to market the fair value of
the derivative at each balance sheet date. The Company records the change in the fair value of the derivative as other income or expense in
the consolidated statements of operations.

Revenue Recognition

Change in Accounting Policy for Revenue Recognition

Effective October 1, 2016, the Company changed its accounting policy for the recognition of grant revenue. The Company believes this
change in accounting policy is preferable due to the fact that grant revenue is viewed as an ongoing function of its intended operations. This
change in accounting policy also enhances the comparability of the Company’s financial statements with many of its industry peers. The
adoption of this accounting policy change has been applied retrospectively to all prior periods presented in this Annual Report on Form 10-
K and has had no impact on net loss per share.

 F-12

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contract Research and Government Grants

The  Company  may  generate  revenue  from  product  sales,  license  agreements,  collaborative  research  and  development  arrangements,  and
government grants. To date the Company’s principal source of revenue consists of government research grants. The Company recognizes
nonrefundable grant revenue when it is received and reports this revenue as “Contract research and government grants” on the condensed
consolidated statements of operations. Contracts executed and monies received prior to the recognition of revenue are recorded as deferred
revenue.

Engineering Review Services

The  Company  records  Engineering  Review  Services  revenue  (“ERS”)  which  is  for  providing  one  time  design  and  development  services
whereby the Company’s R&D personnel deliver simulations/models and demonstration units (low volume) for evaluation by the customers.
The Company recognizes revenue when there is persuasive evidence of an arrangement, the service has been provided to the customer, the
amount of fees to be paid by the customer is fixed or determinable, and the collection of fees is reasonably assured. Total ERS revenue to
date is approximately $14,500.

Revenue Recognition for Facility Rental Income

Effective  June  26,  2017,  the  Company  records  rental  income  for  the  tenants  at  the  Company’s  NY  fabrication  facility.  The  Company
recognizes rental income in the period the rental services are delivered to the lessee; rent is received on a monthly, straight-line basis.

Research and Development

Research and development expenses are charged to operations as incurred.

Equity–based compensation

The  Company  recognizes  compensation  expense  for  all  equity–based  payments  in  accordance  with ASC  718  “Compensation  –  Stock
Compensation”.  Under  fair  value  recognition  provisions,  the  Company  recognizes  equity–based  compensation  net  of  an  estimated
forfeiture rate and recognizes compensation cost only for those shares expected to vest over the requisite service period of the award.

Restricted  stock  awards  are  granted  at  the  discretion  of  the  Company.  These  awards  are  restricted  as  to  the  transfer  of  ownership  and
generally vest over the requisite service periods, typically over a four-year period (generally vesting either ratably over the first four years
or on a tier basis of 50% on the second anniversary of the effective date and 25% on the third and fourth anniversary dates). The fair value
of a stock award is equal to the fair market value of a share of Company stock on the grant date.

The fair value of an option award is estimated on the date of grant using the Black–Scholes option valuation model. The Black–Scholes
option  valuation  model  requires  the  development  of  assumptions  that  are  inputs  into  the  model.  These  assumptions  are  the  value  of  the
underlying  share,  the  expected  stock  volatility,  the  risk–free  interest  rate,  the  expected  life  of  the  option,  the  dividend  yield  on  the
underlying stock and the expected forfeiture rate. Expected volatility is benchmarked against similar companies in a similar industry over
the expected option life and other appropriate factors. Risk–free interest rates are calculated based on continuously compounded risk–free
rates for the appropriate term. The dividend yield is assumed to be zero as the Company has never paid or declared any cash dividends on
its  Common  stock  and  does  not  intend  to  pay  dividends  on  its  Common  stock  in  the  foreseeable  future.  The  expected  forfeiture  rate  is
estimated based on management’s best estimate.

 F-13

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Determining  the  appropriate  fair  value  model  and  calculating  the  fair  value  of  equity–based  payment  awards  requires  the  input  of  the
subjective  assumptions  described  above.  The  assumptions  used  in  calculating  the  fair  value  of  equity–based  payment  awards  represent
management’s best estimates, which involve inherent uncertainties and the application of management’s judgment. As a result, if factors
change and the Company uses different assumptions, equity–based compensation could be materially different in the future. In addition, the
Company  is  required  to  estimate  the  expected  forfeiture  rate  and  recognize  expense  only  for  those  shares  expected  to  vest.  If  the
Company’s actual forfeiture rate is materially different from its estimate, the equity–based compensation could be significantly different
from what the Company has recorded in the current period.

The Company accounts for share–based payments granted to non–employees in accordance with ASC 505-40, “Equity Based Payments to
Non–Employees”. The Company determines the fair value of the stock–based payment as either the fair value of the consideration received
or the fair value of the equity instruments issued, whichever is more reliably measurable. If the fair value of the equity instruments issued
is  used,  it  is  measured  using  the  stock  price  and  other  measurement  assumptions  as  of  the  earlier  of  either  (1)  the  date  at  which  a
commitment  for  performance  by  the  counterparty  to  earn  the  equity  instruments  is  reached,  or  (2)  the  date  at  which  the  counterparty’s
performance is complete. The fair value of the equity instruments is re-measured each reporting period over the requisite service period.

Income taxes

The Company applies the elements of ASC 740–10 “Income Taxes” regarding accounting for uncertainty in income taxes. This clarifies the
accounting for uncertainty in income taxes recognized in financial statements and requires the impact of a tax position to be recognized in
the financial statements if that position is more likely than not of being sustained by the taxing authority. As of March 31, 2017, no liability
for unrecognized tax benefits was required to be reported. The Company does not expect that the amount of unrecognized tax benefits will
significantly increase or decrease within the next twelve months. The Company’s policy is to recognize interest and penalties related to tax
matters in the income tax provision on the Statement of Operations. There was no interest and penalties for the years ended June 30, 2017
and 2016.

Deferred taxes are computed based on the tax liability or benefit in future years of the reversal of temporary differences in the recognition
of  income  or  deduction  of  expenses  between  financial  and  tax  reporting  purposes.  The  net  difference,  if  any,  between  the  provision  for
taxes  and  taxes  currently  payable  is  reflected  in  the  balance  sheet  as  deferred  taxes.  Deferred  tax  assets  and/or  liabilities,  if  any,  are
classified as current and non–current based on the classification of the related asset or liability for financial reporting purposes, or based on
the  expected  reversal  date  for  deferred  taxes  that  are  not  related  to  an  asset  or  liability.  Valuation  allowances  are  recorded  to  reduce
deferred tax assets to that amount which is more likely than not to be realized. 

Loss Per Share

Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of
common  shares  outstanding  during  the  period.  Diluted  net  loss  per  common  share  is  determined  using  the  weighted-average  number  of
common  shares  outstanding  during  the  period,  adjusted  for  the  dilutive  effect  of  common  stock  equivalents.  In  periods  when  losses  are
reported, which is the case for the years ended June 30, 2017 and 2016 presented in these consolidated financial statements, the weighted-
average number of common shares outstanding excludes common stock equivalents because their inclusion would be anti-dilutive.

The Company had the following common stock equivalents at June 30, 2017 and 2016:

Options
Warrants
Totals

June 30, 2017    

160,000     
612,165     
772,165     

June 30, 2016  
160,000 
471,697 
631,697 

 F-14

 
 
 
 
 
 
 
 
 
 
 
   
     
     
     
 
Shares Outstanding

Shares  outstanding  include  shares  of  restricted  stock  with  respect  to  which  restrictions  have  not  lapsed.  Restricted  stock  included  in
reportable shares outstanding was 1,646,965 shares and 1,361,055 shares as of June 30, 2017 and 2016, respectively. Shares of restricted
stock are included in the calculation of weighted average shares outstanding.

Reclassification

Certain prior period amounts have been reclassified to conform to current period presentation. The reclassifications did not have an impact
on net loss as previously reported.

Recently Issued Accounting Pronouncements

In  July  2015,  the  Financial Accounting  Standards  Board  (FASB)  issued  the  FASB Accounting  Standards  Update  (ASU)  No.  2015-11
“Inventory (Topic 330): Simplifying  the  Measurement  of  Inventory”  (“ASU  2015-11”).  The  amendments  in  this  Update  do  not  apply  to
inventory  that  is  measured  using  last-in,  first-out  (LIFO)  or  the  retail  inventory  method.  The  amendments  apply  to  all  other  inventory,
which includes inventory that is measured using first-in, first-out (FIFO) or average cost. An entity should measure inventory within the
scope of this update at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course
of  business,  less  reasonably  predictable  costs  of  completion,  disposal,  and  transportation.  Subsequent  measurement  is  unchanged  for
inventory measured using LIFO or the retail inventory method. For public business entities, the amendments in this update are effective for
fiscal years beginning after December 15, 2016, including interim periods within those fiscal years. The Company is currently evaluating
the effects of ASU 2015-11 on the consolidated financial statements.  

In November 2015, the FASB issued ASU No. 2015-17, “ Balance Sheet Classification of Deferred Taxes”, which will require entities to
present deferred tax assets and deferred tax liabilities as noncurrent in a classified balance sheet. The ASU simplifies the current guidance,
which requires entities to separately present deferred tax assets and deferred tax liabilities as current and noncurrent in a classified balance
sheet.  The ASU  may  be  applied  either  prospectively  or  retrospectively.  The  amendments  in  this ASU  are  effective  for  annual  reporting
periods  beginning  after  December  15,  2016  and  interim  periods  within  those  annual  periods.  Earlier  application  is  permitted  as  of  the
beginning of an interim or annual period. The Company is currently evaluating the effects of ASU 2015-17 on the consolidated financial
statements.

In January 2016, the FASB issued ASU No. 2016-01, “ Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement
of  Financial  Assets  and  Financial  Liabilities”.  The  update  addresses  certain  aspects  of  recognition,  measurement,  presentation  and
disclosure of financial instruments. For public business entities, the amendments in this update are effective for fiscal years beginning after
December 15, 2017, including interim periods within those fiscal years. Early adoption is permitted only for certain portions of the ASU
related to financial liabilities. The Company is currently evaluating the impact of the provisions of this new standard on the consolidated
financial statements. 

In February 2016, the FASB issued ASU No. 2016-02, “ Leases” (Topic 842). The FASB issued this update to increase transparency and
comparability  among  organizations  by  recognizing  lease  assets  and  lease  liabilities  on  the  balance  sheet  and  disclosing  key  information
about  leasing  arrangements.  The  updated  guidance  is  effective  for  annual  periods  beginning  after  December  15,  2018,  including  interim
periods within those fiscal years. Early adoption of the update is permitted. The Company is currently evaluating the impact of the new
standard.

In April 2016, the FASB issued ASU No. 2016-09, “ Compensation – Stock Compensation” (Topic 718). The FASB issued this update to
improve  the  accounting  for  employee  share-based  payments  and  affect  all  organizations  that  issue  share-based  payment  awards  to  their
employees.  Several  aspects  of  the  accounting  for  share-based  payment  award  transactions  are  simplified,  including:  (a)  income  tax
consequences; (b) classification of awards as either equity or liabilities; and (c) classification on the statement of cash flows. The updated
guidance  is  effective  for  annual  periods  beginning  after  December  15,  2016,  including  interim  periods  within  those  fiscal  years.  Early
adoption of the update is permitted. The Company is currently evaluating the impact of the new standard.

 F-15

 
 
 
 
 
 
 
 
 
 
 
 
In April 2016, the FASB issued ASU No. 2016-10,  “Revenue from Contracts with Customers: Identifying Performance Obligations and
Licensing (Topic 606)”.  In March 2016, the FASB issued ASU No. 2016-08, “Revenue from Contracts with Customers: Principal versus
Agent  Considerations  (Reporting  Revenue  Gross  verses  Net)  (Topic  606)”.  These  amendments  provide  additional  clarification  and
implementation  guidance  on  the  previously  issued ASU  2014-09,  “Revenue  from  Contracts  with  Customers”.  The  amendments  in ASU
2016-10 provide clarifying guidance on materiality of performance obligations; evaluating distinct performance obligations; treatment of
shipping and handling costs; and determining whether an entity’s promise to grant a license provides a customer with either a right to use an
entity’s intellectual property or a right to access an entity’s intellectual property. The amendments in ASU 2016-08 clarify how an entity
should  identify  the  specified  good  or  service  for  the  principal  versus  agent  evaluation  and  how  it  should  apply  the  control  principle  to
certain types of arrangements. The adoption of ASU 2016-10 and ASU 2016-08 is to coincide with an entity’s adoption of ASU 2014-09,
which the Company intends to adopt for interim and annual reporting periods beginning after December 15, 2017. The Company is in the
process of evaluating the standard and does not expect the adoption will have a material effect on its consolidated financial statements and
disclosures.

In May 2016, the FASB issued ASU No. 2016-12,  “Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements
and  Practical  Expedients”, which  narrowly  amended  the  revenue  recognition  guidance  regarding  collectability,  noncash  consideration,
presentation of sales tax and transition and is effective during the same period as ASU 2014-09. The Company is currently evaluating the
standard and does not expect the adoption will have a material effect on its consolidated financial statements and disclosures.

In August  2016,  the  FASB  issued ASU  2016-15,  “ Classification  of  Certain  Cash  Receipts  and  Cash  Payments” .  This  update  provides
guidance on how to record eight specific cash flow issues. This update is effective for fiscal years beginning after December 15, 2017, and
interim  periods  within  those  fiscal  years.  Early  adoption  is  permitted  and  a  retrospective  transition  method  to  each  period  should  be
presented. The Company is currently evaluating the effect of this update on its consolidated financial statements.

In November 2016, the FASB issued ASU 2016-18,  “Statement of Cash Flows (Topic 230)”,  requiring  that  the  statement  of  cash  flows
explain the change in the total cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. This
guidance  is  effective  for  fiscal  years,  and  interim  reporting  periods  therein,  beginning  after  December  15,  2017  with  early  adoption
permitted. The provisions of this guidance are to be applied using a retrospective approach which requires application of the guidance for
all periods presented. The Company is currently evaluating the impact of the new standard. 

In  May  2017,  the  FASB  issued ASU  2017-09,  “ Compensation—Stock  Compensation  (Topic  718):  Scope  of  Modification  Accounting,”
which  provides  guidance  about  which  changes  to  the  terms  or  conditions  of  a  share-based  payment  award  require  an  entity  to  apply
modification  accounting  in  Topic  718.  This  standard  is  required  to  be  adopted  in  the  first  quarter  of  2018.  The  Company  is  currently
evaluating the impact this guidance will have on its consolidated financial statements and related disclosures.

In July 2017, the FASB issued ASU 2017-11, “ Earnings Per Share (Topic 260),  Distinguishing  Liabilities  from  Equity  (Topic  480)  and
Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features; II. Replacement of the
Indefinite  Deferral  for  Mandatorily  Redeemable  Financial  Instruments  of  Certain  Nonpublic  Entities  and  Certain  Mandatorily
Redeemable  Noncontrolling  Interests  with  a  Scope  Exception”.  Part  I  of  this  update  addresses  the  complexity  of  accounting  for  certain
financial  instruments  with  down  round  features.  Down  round  features  are  features  of  certain  equity-linked  instruments  (or  embedded
features)  that  result  in  the  strike  price  being  reduced  on  the  basis  of  the  pricing  of  future  equity  offerings.  Current  accounting  guidance
creates  cost  and  complexity  for  entities  that  issue  financial  instruments  (such  as  warrants  and  convertible  instruments)  with  down  round
features that require fair value measurement of the entire instrument or conversion option. Part II of this update addresses the difficulty of
navigating  Topic  480,  Distinguishing  Liabilities  from  Equity,  because  of  the  existence  of  extensive  pending  content  in  the  FASB
Accounting  Standards  Codification.  This  pending  content  is  the  result  of  the  indefinite  deferral  of  accounting  requirements  about
mandatorily  redeemable  financial  instruments  of  certain  nonpublic  entities  and  certain  mandatorily  redeemable  noncontrolling  interests.
The amendments in Part II of this update do not have an accounting effect. This ASU is effective for fiscal years, and interim periods within
those  years,  beginning  after  December  15,  2018.  The  Company  is  evaluating  the  effect  that  ASU  2017-11  will  have  on  its  financial
statements and related disclosures.

 F-16

 
 
 
 
 
 
 
 
Note 4. Acquisition of STC-MEMS

Acquisition of STC-MEMS

On March 23, 2017, the Company entered into the Agreements with  RF-SUNY, a New York State education corporation, on behalf of The
State  University  of  New  York  Polytechnic  Institute,  and  FRMC,  an  affiliate  of  RF-SUNY  to  acquire  the  STC-MEMS  Business.  The
acquisition  will  allow  the  Company  to  internalize  manufacturing,  increase  capacity  and  control  its  wafer  supply  chain  for  single  crystal
BAW RF filters. Akoustis will utilize the NY Facility to consolidate all aspects of wafer manufacturing for its high-band RF filters.

Smart Systems Technology & Commercialization Center (STC-MEMS) was created in 2010 to form a vertically integrated “one-stop-shop”
in  smart  system  and  smart-device  innovation  and  manufacturing.  The  facility  was  designed  to  provide  its  customers  the  capacity,
infrastructure and operational capabilities in all areas of semiconductor and advanced manufacturing, while covering a diverse number of
markets  including  aerospace,  biomedical,  communications,  defense,  and  energy.  Located  in  Canandaigua,  New  York,  just  outside  of
Rochester,  the  STC-MEMS  facility  includes  certified  cleanroom  manufacturing,  advanced  test  and  metrology,  as  well  as  a  MEMS  and
optoelectronic packaging facility.

The Company acquired the STC-MEMS Business through its Akoustis NY, a Delaware corporation. Post-acquisition date, the Company
also agreed to assume substantially all the on-going obligations of the STC-MEMS Business incurred in the ordinary course of business,
including with respect to the 29 employees employed by RF-SUNY.  The purchase closed on June 26, 2017.

Acquisition Price

The  purchase  price  paid  for  the  transaction  was  an  aggregate  of  approximately  $4.58  million  consisting  of  (i)  $2.75  million  in  cash
consideration, (ii) $96,000 in inventory, and (iii) a contingent real estate liability of approximately $1.73 million.

Recognizing and measuring the identifiable assets acquired, the liabilities assumed, and any non-controlling interest in the acquiree

The  fair  value  of  the  purchase  consideration  issued  to  the  sellers  of  the  STC-MEMS  Business  was  allocated  to  the  net  tangible  and
intangible assets acquired. The Company accounted for the STC-MEMS Business acquisition as the purchase of a business under GAAP
under the acquisition method of accounting, as specified in ASC 805 “Business Combinations”, and the assets and liabilities acquired were
recorded as of the acquisition date, at their respective fair values and consolidated with those of the Company. The fair value of the net
assets acquired was approximately $6.3 million. The excess of the aggregate fair value of the net tangible and intangible assets over the
consideration paid has been treated as a gain on bargain purchase in accordance with ASC 805. The purchase price allocation was based, in
part, on management’s knowledge of the STC-MEMS Business and the results of a third-party appraisal commissioned by management.

The Company utilized the services of an independent appraisal company to assist it in assessing the fair value of the assets and liabilities
acquired. This assessment included an evaluation of the fair value of the real estate and fixed assets in addition to the intangibles acquired.
The real estate was valued utilizing a combination of the income and cost approaches.  The fixed assets were valued utilizing a combination
of the market and cost approaches.  The intangible asset, customer relationships, was valued utilizing the income approach. The valuation
process also included discussion with management regarding the history and business operations of the STC-MEMS Business, a study of
the economic and industry conditions in which the STC-MEMS Business competes and an analysis of the historical and projected financial
statements and other records and documents. 

Recognizing and measuring goodwill or a gain from a bargain purchase

Management reviewed the assets and liabilities acquired and the assumptions utilized in estimating their fair values. Further revisions to the
estimates were not deemed necessary and after identifying and valuing all assets and liabilities of the STC-MEMS Business, the Company
concluded that recording a bargain purchase gain was appropriate and required under GAAP.

 F-17

 
 
 
 
 
 
 
 
 
 
 
  
 
 
Purchase Consideration

Amount of consideration:

Assets acquired and liabilities assumed at fair value

Land
Building
STC-MEMS equipment
Inventory
Customer relationships

Net assets acquired

Total net assets acquired
Consideration paid
Gain on bargain purchase

  $

4,576,591 

  $

  $

  $

  $

1,000,000 
3,000,000 
2,124,650 
96,049 
81,773 
6,302,472 

6,302,472 
4,576,591 
1,725,881 

Prior to this transaction, none of the parties negotiating on behalf of the Company had met any of the individuals negotiating on behalf of
the sellers. Further, there were no agreements signed with any individuals negotiating this deal. Additionally, there were no related parties
associated with this transaction.

The following presents the unaudited pro-forma combined results of operations of the Company with the STC-MEMS Business as if the
entities were combined on July 1, 2015.

Revenues, net
Net (loss) allocable to common shareholders
Net (loss) per share
Weighted average number of shares outstanding

Year Ended
June 30,
2017

    Year Ended  
June 30,
2016

4,195,374    $
(13,907,072)   $
(0.82)   $
16,990,536     

5,314,499 
(7,613,100)
(0.57)
13,349,482 

  $
  $
  $

The unaudited pro-forma results of operations are presented for information purposes only. The unaudited pro-forma results of operations
are not intended to present actual results that would have been attained had the acquisitions been completed as of July 1, 2015 or to project
potential operating results as of any future date or for any future periods.

 F-18

 
 
 
  
 
 
  
 
   
  
   
  
   
   
   
   
 
   
  
   
 
 
 
 
 
 
 
   
 
 
 
   
 
   
 
 
The  estimated  useful  life  remaining  on  equipment  and  building  acquired  with  the  STC-MEMS  Business  is  3  to  5  years  and  11  years,
respectively.

The Company consolidated Akoustis NY as of the closing date of the agreement, and the results of operations of the Company include that
of Akoustis NY. The Company recognized net revenues attributable to Akoustis NY of $0 and recognized net losses of $171,000 during
the period June 26, 2017 through June 30, 2017; driven by wages and fringe benefits of $126,000.

 F-19

 
 
 
 
Note 5. Property and equipment

Property and equipment consisted of the following:

Land
Research and development equipment
Computer equipment
Furniture and fixtures
STC-MEMS equipment
Building
Leasehold improvements

Less: Accumulated depreciation
Total

Estimated
Useful Life
n/a
3 – 10 years
5 years
5 – 10 years
3 – 5 years
11 years
*

June 30,
2017

June 30,
2016

  $

  $

1,000,000    $
1,851,427     
16,783     
3,725     
2,124,650     
3,000,000     
3,240     
7,999,825     
(146,011)    
7,853,814    $

— 
226,372 
16,783 
3,725 
— 
— 
3,240 
250,120 
(43,135)
206,985 

(*) Amortized on a straight-line basis over the term of the lease or the estimated useful lives, whichever is shorter.

The Company recorded depreciation expense of $102,876 and $34,828 for the years ended June 30, 2017 and 2016, respectively.

As of June 30, 2017, research and development fixed assets totaling $1,062,496 were not placed in service and therefore not depreciated
during the period. 

Note 6. Intangible assets

The Company’s intangible assets consisted of the following:

Patents
Customer relationships
Less: Accumulated amortization
Subtotal
Trademarks
Intangible assets, net

15 years    $
14 years   

—     

     $

135,291    $
81,773   
(12,097)  
204,967   
1,560   
206,527    $

June 30, 2016  
74,562 
— 
(4,889)
69,673 
1,560 
71,233 

Estimated 
useful life

June 30, 2017    

The Company recorded amortization expense of $7,208 and $3,339 for the year ended June 30, 2017 and 2016, respectively.

The following table outlines estimated future annual amortization expense for the next five years and thereafter:

June 30,
2018
2019
2020
2021
2022
Thereafter
Total

    $

    $

14,811 
14,811 
14,811 
14,811 
14,811 
130,912 
204,967 

F-20 

 
 
 
 
 
 
 
   
 
 
 
   
 
   
 
   
 
   
 
   
 
   
 
 
 
   
 
 
   
 
 
  
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
    
 
 
 
 
    
 
 
 
 
 
 
 
 
 
 
 
   
  
     
     
     
     
     
 
      
  
  
Note 7. Accounts payable and accrued expenses

Accounts payable and accrued expenses consisted of the following at June 30, 2017 and June 30, 2016: 

June 30, 2017    

Accounts payable
Accrued salaries and benefits
Accrued bonuses
Accrued stock-based compensation
Other accrued expenses
Totals

Note 8. Derivative Liabilities

  $

  $

494,515    $
274,050   
—   
399,157   
168,646   
1,336,368    $

June 30, 2016  
73,400 
21,376 
126,575 
179,079 
143,216 
543,646 

Upon closing of private placements on May 22, 2015 and June 9, 2015, the Company issued 298,551 and 26,099 warrants, respectively, to
purchase the same number of shares of Common Stock with an exercise price of $1.50 and a five-year term to the placement agent. Upon
closing of a private placement in April 2016, the Company issued 153,713 warrants to purchase the same number of shares of Common
Stock with an exercise price of $1.60 and a five-year term to the placement agent. The Company identified certain put features embedded in
the warrants that potentially could result in a net cash settlement, requiring the Company to classify the warrants as a derivative liability.

During  the  year  ended  June  30,  2017,  the  Company  amended  the  existing  warrant  agreements  to  eliminate  the  derivative  feature.  Upon
execution of the revised agreements, a total of 471,697 warrants with a fair value of $2,200,219 were reclassified from liability to equity.

Level 3 Financial Liabilities – Derivative warrant liabilities

Financial assets and liabilities measured at fair value on a recurring basis are summarized below and disclosed on the consolidated balance
sheet as of June 30, 2017:

Carrying
Value

Fair Value Measurement Using

Level 1

Level 2

Level 3

Total

Derivative warrant liabilities

  $

     $

—    $

—    $

—    $

— 

Financial  assets  and  liabilities  measured  at  fair  value  on  a  recurring  basis  are  summarized  below  and  disclosed  on  the  condensed
consolidated balance sheet as of June 30, 2016:

Carrying
Value

Fair Value Measurement Using

Level 1

Level 2

Level 3

Total

Derivative warrant liabilities

  $

1,322,729    $

—    $

—    $

1,322,729    $

1,322,729 

F-21 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
   
   
   
   
 
 
   
      
      
      
      
  
 
 
 
 
   
 
 
 
   
   
   
   
 
 
   
      
      
      
      
  
 
The table below provides a summary of the changes in fair value, including net transfers in and/or out, of all financial assets and liabilities
measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the year ended June 30, 2017 and 2016:

Balance, July 1, 2015
Issuance of derivative warrants
Change in fair value of derivative warrant liabilities
Reclassification of Derivative liability to Additional Paid in Capital
Balance, June 30, 2016
Change in fair value of derivative warrant liabilities
Reclassification of Derivative liability to Additional Paid in Capital
Balance, June 30, 2017

Fair Value
Measurement
Using Level 3
Inputs
Total

  $

  $

  $

205,144 
165,719 
968,840 
(16,974)
1,322,729 
877,490 
(2,200,219)
— 

The fair value of the derivative feature of the warrants on the issuance dates, at the balance sheet date and on the date of reclassification to
equity were calculated using a binomial option model valued with the following weighted average assumptions: 

Risk free interest rate
Dividend yield
Expected volatility
Remaining term (years)

April 14,
2016

June 30,
2016

January 19, 
2017

1.04% 
0.00% 
41% 

4.15 - 4.19 

1.08% 
0.00% 
44% 
5.0 

1.01%
0.00%
39%

3.89 - 4.79 

Risk-free interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Note with a similar term on the date of the grant.

Dividend yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate
declaring dividends in the near future.

Volatility: The Company calculates the expected volatility of the stock price based on the corresponding volatility of the Company’s peer
group stock price for a period consistent with the warrant’s expected term.

Remaining term: The Company’s remaining term is based on the remaining contractual maturity of the warrants.

During the years ended June 30, 2017 and 2016, the Company marked the derivative feature of the warrants to fair value and recorded a
loss of $877,490 and $968,840, respectively, relating to the change in fair value.

F-22 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note 9.  Concentrations

For  the  year  ended  June  30,  2017,  one  vendor  represented  11%  of  the  Company’s  purchases.  For  the  year  ended  June  30,  2016,  two
vendors represented 28% and 14% of the Company’s purchases.

Note 10. Stockholders’ Equity

On  December  15,  2016,  in  connection  with  the  Company’s  reincorporation  from  the  State  of  Nevada  to  the  State  of  Delaware,  the
Company  filed  a  Certificate  of  Incorporation  with  the  State  of  Delaware,  which,  among  other  things,  reduced  the  number  of  authorized
shares  of  capital  stock  of  the  Company  from  310,000,000  total  shares  consisting  of  (a)  300,000,000  shares  of  Common  Stock  and  (b)
10,000,000 of $0.001 par value “blank check” preferred stock to 50,000,000 total shares consisting of (a) 45,000,000 shares of Common
Stock and (b) 5,000,000 shares of “blank check” preferred stock.

As of June 30, 2017 and 2016, there were no shares of preferred stock issued and outstanding. 

The Company recorded stock-based compensation expense for the shares issued to consultants that have vested, which is a component of
operating expenses in the Consolidated Statement of Operations as follows:

Month of Original Grant

Shares
Issued

Stock-Based Compensation

For the Year Ended

June 30,
2017

June 30,
2016

December 2015
March 2016
August 2016
January 2017

230,000    $
60,000     
40,000     
50,000     
380,000    $

945,189    $
261,214     
147,600     
194,776     
1,548,779    $

342,811 
71,786 
— 
— 
414,597 

On March 10, 2016, the Company held a closing  of  a  private  placement  offering  (the  “March  2016  Offering”)  in  which  it  sold  494,125
shares of Common Stock at a fixed purchase price of $1.60 per share (the “2016 Offering Price”), for aggregate gross proceeds of $790,600
(before deducting legal expenses of the March 2016 Offering).

On April  14,  2016,  the  Company  held  closings  of  a  private  placement  offering  (the  “April  2016  Offering”)  in  which  the  Company  sold
1,741,185 shares of Common Stock at a fixed purchase price of $1.60 per share (the “2016 Offering Price”), for aggregate gross proceeds
of $2,785,896 (before deducting expenses for legal services and agent commissions of the April 2016 Offering).

The Company sold a total of 2,142,000 shares of its Common Stock at the 2016-2017 Offering Price, with closings in each of November
and December 2016 and January and February 2017, as well as 663,000 shares of Common Stock at the 2017 Offering Price, for aggregate
gross proceeds were $16.7 million before deducting commissions and expenses of approximately $1.3 million.

F-23 

 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
   
 
   
 
 
 
 
 
   
 
 
   
   
 
   
   
   
   
    
 
 
 
 
Stock incentive plans

2015 Equity Incentive Plan

On May 22, 2015, the Board of Directors adopted, and on the same date the stockholders approved, the 2015 Equity Incentive Plan (the
“2015 Plan”), which reserved a total of 1,200,000 shares of Common Stock for issuance under the 2015 Plan. The 2015 Plan authorized the
grant  to  participants  of  nonqualified  stock  options,  incentive  stock  options,  restricted  stock  awards,  restricted  stock  units,  performance
grants.  No  additional  shares  will  be  issued  under  the  2015  Plan.  Effective  December  15,  2016,  equity  awards  are  granted  under  the
Company’s 2016 Stock Incentive Plan, which was approved stockholders on the same date.

In addition, the number of shares of our Common Stock subject to the 2016 Plan, any number of shares subject to any numerical limit in the
2016  Plan,  and  the  number  of  shares  and  terms  of  any  incentive  award  are  expected  to  be  adjusted  in  the  event  of  any  change  in  our
outstanding  Common  Stock  by  reason  of  any  stock  dividend,  spin-off,  split-up,  stock  split,  reverse  stock  split,  recapitalization,
reclassification, merger, consolidation, liquidation, business combination or exchange of shares or similar transaction.

Options granted under the 2015 Plan vest as determined by the Company’s board of directors and expire over varying terms, but not more
than seven years from the date of grant. In the case of an Incentive Stock Option that is granted to a 10% shareholder on the date of grant,
such Option shall not be exercisable after the expiration of five years from the date of grant. Options for 160,000 shares of Common Stock
were issued under the 2015 Plan to four non-employee directors in May 2015. No options have been awarded under the 2016 Plan.

The  fair  values  of  the  Company’s  options  were  estimated  at  the  dates  of  grant  using  a  Black-Scholes  option  pricing  model  with  the
following weighted average assumptions:

Expected term (years)
Risk-free interest rate
Volatility
Dividend yield

6.25 
1.29%
47%
0%

Expected  term:  The  Company’s  expected  term  is  based  on  the  period  the  options  are  expected  to  remain  outstanding.  The  Company
estimated this amount utilizing the “Simplified Method” in that the Company does not have sufficient historical experience to provide a
reasonable basis to estimate an expected term.

Risk-free interest rate: The Company uses the risk-free interest rate of a U.S. Treasury Note with a similar term on the date of the grant.

Volatility: The Company calculates the expected volatility of the stock price based on the corresponding volatility of the Company’s peer
group stock price for a period consistent with the options’ expected term.

Dividend yield: The Company uses a 0% expected dividend yield as the Company has not paid dividends to date and does not anticipate
declaring dividends in the near future. 

The following is a summary of the option activity:

Outstanding – July 1, 2015
Exercisable – July 1, 2015
Granted
Exercised
Forfeited/Cancelled
Outstanding – June 30, 2016
Exercisable – June 30, 2016
Granted
Exercised
Forfeited/Cancelled
Outstanding – June 30, 2017
Exercisable – June 30, 2017

F-24 

Weighted
Average
Exercise 
Price

Options

160,000    $
—    $
—     
—     
—     
160,000     
40,000     
—     
—     
—     
160,000    $
80,000    $

1.50 
— 
— 
— 
— 
1.50 
1.50 
— 
— 
— 
1.50 
1.50 

 
 
 
 
 
 
 
 
   
   
   
   
 
 
 
 
 
 
 
 
   
 
   
   
   
   
   
   
   
   
   
   
   
   
 
As of June 30, 2017, the total intrinsic value of options outstanding and exercisable was $1,158,400 and $579,200, respectively. As of June
30, 2017, the Company has $52,800 in unrecognized stock-based compensation expense attributable to the outstanding options, which will
be amortized over a period of 2.14 years.

For  the  years  ended  June  30,  2017  and  2016,  the  Company  recorded  $27,932  and  $28,008,  respectively,  in  stock-based  compensation
related to stock options, which is reflected in the consolidated statements of operations.

Issuance of restricted shares – employees and consultants

Restricted  stock  awards  are  considered  outstanding  at  the  time  of  execution  by  the  Company  and  the  recipient  of  a  restricted  stock
agreement, as the stock award holders are entitled to dividend and voting rights. As of June 30, 2017, the number of  shares  granted  for
which the restrictions have not lapsed was 1,352,265 shares.

The  Company  recognizes  the  compensation  expense  for  all  share-based  compensation  granted  based  on  the  grant  date  fair  value  for
directors and employees and the reporting period remeasured fair value for consultants. The fair value of the award is recorded as share–
based compensation expense over the respective restriction period. Any portion of the grant awarded to consultants, directors, employees,
and other service providers as to which the repurchase option has not lapsed is accrued on the Balance Sheet as a component of accounts
payable  and  accrued  expenses.  As  of  June  30,  2017  and  2016,  the  accrued  stock-based  compensation  was  $399,157  and  $179,079,
respectively.  The  Company  has  the  right  to  repurchase  some  or  all  of  such  shares  in  certain  circumstances  upon  termination  of  the
recipient’s service with the Company, for up to 60 months from the date of termination (“repurchase option”). The shares as to which the
repurchase option has not lapsed are subject to forfeiture upon termination of consulting and employment relationships.

In September 2015, the Company amended the original restricted stock agreement for certain award recipients. Pursuant to the amendment,
75% of the shares as to which the repurchase option had not lapsed as of September 30, 2015 will be released from the repurchase option
on  the  third  anniversary  of  the  original  effective  date  of  the  agreement.  The  remaining  25%  of  the  shares  will  be  released  from  the
repurchase option on the fourth anniversary of the original effective date.   

The following is a summary of restricted shares:

Grant Date

Shares
Issued

Fair
Value (1)

Shares
Vested

June 2014
July 2014
August 2014
September 2014
March 2015
October 2015
November 2015
December 2015
January 2016
March 2016
June 2016
August 2016
January 2017
February 2017
March 2017

307,876    $
32,408     
81,020     
129,633     
72,918     
293,000     
36,200     
300,000     
40,000     
60,000     
118,000     
351,000     
192,000     
110,000     
20,000     
2,144,055    $

1,294,029     
48,612     
326,323     
352,282     
401,717     
439,500     
54,300     
1,393,000     
68,000     
333,000     
535,809     
1,489,247     
1,165,122     
697,500     
135,000     
8,733,441     

121,530 
23,791 
8,102 
13,667 
— 
— 
— 
230,000 
— 
60,000 
— 
40,000 
— 
— 
— 
497,090 

F-25 

 
 
 
 
 
 
 
 
 
 
   
   
 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
 
   
 
(1) – The fair value of the restricted stock awards as shown above is based on either the balance sheet date for consultants or grant date

for employees.

In  relation  to  the  above  restricted  stock  agreements  for  the  year  ended  June  30,  2017  and  2016,  the  Company  recorded  stock-based
compensation expense for the shares that have vested of $3,223,398 and $821,617, respectively.

As of June 30, 2017, the Company had $3,966,899 in unrecognized stock-based compensation expense related to the unvested shares. 

Note 11. Commitments and contingencies

Employment agreements

On  June  15,  2015,  the  Company  entered  into  a  three-year  employment  agreement  with  the  Chief  Executive  Officer  (“CEO”). After  the
initial three-year term, the agreement will be automatically renewed for successive one-year periods unless terminated by either party on at
least 30 days’ written notice prior to the end of the then-current term. The CEO’s annual base salary is $150,000 and is subject to increase
or decrease on each anniversary as determined by the Board of Directors. The CEO is eligible, at the discretion of our Board of Directors,
to  receive  an  annual  cash  bonus  of  up  to  100%  of  his  annual  base  salary,  which  may  be  based  on  the  Company  achieving  certain
operational,  financial  or  other  milestones  (the  “Milestones”)  that  may  be  established  by  the  Board  of  Directors.  The  CEO  is  entitled  to
receive stock options or other equity incentive awards under the 2016 Plan as and when determined by the Board, and is entitled to receive
perquisites  and  other  fringe  benefits  that  may  be  provided  to,  and  is  eligible  to  participate  in  any  other  bonus  or  incentive  program
established by the Company, for the executives. The CEO and his dependents are also entitled to participate in any of the employee benefit
plans subject to the same terms and conditions applicable to other employees. The CEO will be entitled to be reimbursed for all reasonable
travel,  entertainment  and  other  expenses  incurred  or  paid  by  him  in  connection  with,  or  related  to,  the  performance  of  his  duties,
responsibilities  or  services  under  his  employment  agreement,  in  accordance  with  policies  and  procedures,  and  subject  to  limitations,
adopted by us from time to time. In the event that the CEO is terminated by the Company without Cause (as defined in his employment
agreement) or he resigns for Good Reason (as defined in his employment agreement) during the term of his employment agreement, the
CEO would be entitled to (x) an amount equal to his annual base salary then in effect (payable in accordance with the Company’s normal
payroll practices) for a period of 24 months commencing on the effective date of his termination (the “Severance Period”) (in the case of
termination by the executive for Good Reason, reduced by any cash remuneration paid to him because of any other employment or self-
employment  during  the  Severance  Period),  and  (y)  if  and  to  the  extent  the  Milestones  are  achieved  for  the  annual  bonus  for  the  year  in
which  the  Severance  Period  commences  (or,  in  the  absence  of  Milestones,  the  Board  of  Directors  has,  in  its  sole  discretion,  otherwise
determined an amount of the CEO’s annual bonus for such year), an amount equal to such annual bonus pro-rated for the portion of the
performance year completed before the CEO employment terminated, (z) any unvested stock options, restricted stock or similar incentive
equity  instruments  will  vest  immediately.  For  the  duration  of  the  Severance  Period,  the  CEO  will  also  be  eligible  to  participate  in  our
benefit  plans  or  programs,  provided  the  CEO  was  participating  in  such  plan  or  program  immediately  prior  to  the  date  of  employment
termination,  to  the  extent  permitted  under  the  terms  of  such  plan  or  program  (collectively,  the  “Termination  Benefits”).  If  the  CEO’s
employment is terminated during the term of his employment agreement by the Company for Cause, by the CEO for any reason other than
Good  Reason  or  due  to  his  death,  then  he  will  not  be  entitled  to  receive  the  Termination  Benefits,  and  shall  only  be  entitled  to  the
compensation and benefits which shall have accrued as of the date of such termination (other than with respect to certain benefits that may
be available to the CEO as a result of a Permanent Disability (as defined in his employment agreement).

On  June  15,  2015,  the  Company  also  entered  into  two-year  employment  agreements  with  each  of  the  Vice  President  of  Business
Development,  the  Vice  President  of  Operations,  and  the  then  Chief  Financial  Officer.  Each  of  these  employment  agreements  had
substantially the same terms as that of the CEO described above. These employment agreements expired on June 15, 2017.

On  July  14,  2017,  the  Board  named  a  new  Chief  Financial  Officer  who  would  also  serve  as  the  Company’s  Chief Accounting  Officer,
effective as of the same date.

F-26 

 
 
 
 
 
 
 
 
 
 
In  connection  with  the  election  of  the  new  Chief  Financial  Officer  of  the  Company,  the  Company  entered  into  a  one-year  employment
agreement, dated July 14, 2017 (the “Employment Agreement”), with the Chief Financial Officer with essentially the same terms as the
Chief Executive Officer employment agreement described above with the exception of the following:

- Monthly living expenses of $1,600.
-

Target annual bonus each fiscal year equal to 70% of his annual base salary, based on certain Company  operation,  financial,  and
other milestones set by the Board and/or its Compensation Committee.

- A  restricted  a  stock  award  for  100,000  shares  of  Common  Stock  and  options  for  75,000  shares of  Common  Stock  to  be  granted
during the Company’s next open trading window. The  Awards will be granted under the 2016 Plan and will vest 25% on each of the
first,  second, third,  and  fourth  anniversaries  of  the  grant  date,  subject  to  the  CFO’s  continued  employment  and  the  terms  and
conditions of the 2016 Plan and the applicable award agreements.

The  term  of  the  Employment Agreement  extends  through  July  31,  2018,  and  the  Employment Agreement  will  automatically  renew  for
successive one- year periods unless either party gives at least 30 days written notice of non-renewal to the other party prior to the end of the
then applicable term.

Operating leases

The Company leases office space in Huntersville, NC pursuant to a three-year lease agreement. The operating lease provides for annual real
estate  tax  and  cost  of  living  increases  and  contains  predetermined  increases  in  the  rentals  payable  during  the  term  of  the  lease.  The
aggregate rent expense is recognized on a straight-line basis over the lease term. The total lease rental expense was $56,808 and $55,186
for the years ended June 30, 2017 and 2016, respectively. The future minimum payments under this lease are $40,314.

The Company leases equipment for its Canandaigua, NY facility pursuant to a three-month lease agreement beginning on June 16, 2017.
The aggregate rent expense is recognized on a straight-line basis over the lease term. The total lease rental expense was $8,125 and $0 for
the  years  ended  June  30,  2017  and  2016,  respectively.  The  future  minimum  payments  under  this  lease  are  $44,375.  The  Company
anticipates renewing the lease for another three months and in process of finalizing terms and conditions.

Real Estate Contingent Liability

In  connection  with  the  acquisition  of  the  STC-MEMS  Business,  the  Company  agreed  to  pay  to  Fuller  Road  Management  Corporation  a
penalty, as set forth below, if the Company sells the property subject to the related Definitive Real Property Purchase Agreement within
three  (3)  years  after  the  date  of  such  agreement  for  an  amount  in  excess  of  $1,750,000,  subject  to  certain  enumerated  exceptions.  The
penalty  imposed  shall  be  equivalent  to  the  amount  that  the  sales  price  of  the  property  exceeds  $1,750,000  up  to  the  maximum  penalty
(“Maximum Penalty”) defined below:

Year 1
Year 2
Year 3

    Maximum Penalty  
5,960,000 
    $
3,973,333 
    $
1,986,667 
    $

The fair value of the contingent liability was calculated by an independent third-party appraisal firm, utilizing a present value calculation
based  on  the  probability  the  Company  sells  the  property  triggering  the  contingent  penalty  and  a  discount  rate  of  14.1%.  The  14.1%
discount rate was derived from a weighted average cost of capital, modified to include the effects of the bargain purchase price. As of June
30, 2017, the balance of the contingent liability was $1,730,542.

F-27 

 
 
 
 
 
 
 
 
 
 
 
 
 
Note 12. Related Party Transactions

Consulting Services

AEG Consulting, a firm owned by one of the Company’s Co-Chairmen, received $15,195 and $10,238 for consulting fees for the years
ended June 30, 2017 and 2016, respectively.

The Company’s CEO and Vice President of Engineering participated in the closing of the 2016-2017 Offering that occurred on November
25,  2016  where  they  each  purchased  20,000  shares  of  Common  Stock  at  a  price  of  $5.00  per  share.  The  Company’s  Vice-President  of
Operations  also  purchased  2,000  shares  of  Common  Stock  in  the  closing  at  an  aggregate  purchase  price  of  $10,000.  One  of  the  Co-
Chairmen of the Company’s Board purchased 200,000 shares of Common Stock at a price of $5.00 per share at an aggregate purchase price
of  $1,000,000.  The  brother  of  the  CEO  purchased  14,000  shares  of  Common  Stock  in  the  closing  at  an  aggregate  purchase  price  of
$70,000.

The Company’s second Co-Chairman participated in the closing of the 2016-2017 Offering that occurred on December 27, 2016 where he
purchased 2,000 shares of Common Stock at a price of $5.00 per share for an aggregate purchase price of $10,000. A second brother of the
CEO purchased 20,000 shares of Common Stock in the closing at an aggregate purchase price of $100,000.

Inventory Purchase

In  March  2016,  the  Company  purchased  inventory  from  Big  Red  LLC  (“Big  Red”),  a  company  formed  by  the  CEO,  the  brother  of  the
Company’s CEO, the Vice President of Operations and one additional party. The transaction for $43,544 was executed so the Company
could pursue commercialization of the amplifier inventory purchased. The Company will utilize this inventory and related technology to
process and sell the amplifiers. The CEO and Vice President of Operations assigned their interests in Big Red to other parties in March of
2016.

License Agreement

In April  2016,  the  Company  entered  into  a  license  agreement  with  Big  Red.  The  license  agreement  was  executed  so  that  the  Company
could pursue commercialization of amplifier inventory purchased from Big Red in March 2016. The Company will utilize this inventory
and related technology to process and sell the amplifiers. Future revenue from sales utilizing the amplifier technology will result in a license
fee paid to Big Red according to the following schedule:

Net Sales
$0 - $500,000
$500,000 - $1,000,000
$1,000,000 - $2,000,000
$2,000,000 – $5,000,000
$5,000,001 and over

Note 13. Income Taxes

Royalty Percentage  

5.00%
4.00%
3.50%
3.00%
2.00%

The Company had no income tax expense due to operating losses incurred for the years ended June 30, 2017 and 2016.

F-28 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The provision for/(benefit from) income tax differs from the amount computed by applying the statutory federal income tax rate to income
before the provision for/(benefit from) income taxes. The sources and tax effects of the differences are as follows: 

Income taxes at Federal statutory rate
State income taxes, net of Federal income tax
benefit
Permanent differences
Other
Change in Valuation Allowance
State tax rate change
Income Tax Provision

For the
Year Ended
June 30,
2017

For the
Year Ended
June 30,
2016

(34.00)%  

(34.00)%

(2.63)%  
(6.36)%  
6.49%  
36.50%  
0.00%  
0.00%  

(2.60)%
0.22%
— 
36.09%
0.29%
0.00%

The tax effects of temporary differences that give rise to the Company’s deferred tax assets and liabilities are as follows:

Net Operating Loss Carryforwards
Share-based compensation
Derivative liability
Other

Valuation Allowance
Net Deferred Tax Assets

June 30, 2017  
5,352,238 
406,498 
— 
(33,028)
5,725,708 
(5,725,708)
— 

June 30, 2016  
1,711,488 
396,264 
315,205 
(22,365) 
2,400,592 
(2,400,592)
— 

  $

  $

  $

  $

At June 30, 2017, the Company had approximately $14,600,000 of Federal and state NOL carryovers that may be available to offset future
taxable income.

The NOL carry overs, if not utilized, will expire in stages beginning 2035.

Based  on  a  history  of  cumulative  losses  at  the  Company  and  the  results  of  operations  for  the  years  ended  June  30,  2017  and  2016,  the
Company determined that it is more likely than not it will not realize benefits from the deferred tax assets. The Company will not record
income tax benefits in the financial statements until it is determined that it is more likely than not that the Company will generate sufficient
taxable  income  to  realize  the  deferred  income  tax  assets.  As  a  result  of  the  analysis,  the  Company  determined  that  a  full  valuation
allowance against the deferred tax assets is required. The net change in the valuation allowance during the year ended June 30, 2017 was
an increase of approximately $3,325,000.

As a result of the reverse merger that occurred on May 22, 2015, the Company’s previous NOL may be significantly limited. The Company
has not performed a detailed analysis to determine whether an ownership change under IRC Section 382 or similar rules has occurred. The
effect of an ownership change would be the imposition of annual limitation on the use of NOL carryforwards attributable to periods before
the change which total approximately $421,000. Any limitation may result in expiration of a portion of the NOL before utilization. The
Company recognizes interest and penalties related to uncertain tax positions in selling, general and administrative expenses. The Company
has not identified any uncertain tax positions requiring a reserve as of June 30, 2017.

Note 14. Subsequent Events

In July 2017, 9,533 placement agent warrants issued in connection with the 2016-2017 private placement offering, each having a term of
five years and an exercise price of $5.00, were exercised.

F-29 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
   
 
 
   
 
 
 
   
 
 
   
 
 
 
 
  
 
  
Exhibit
Number

Description

 EXHIBIT INDEX

2.1

2.2

2.3

3.1

3.2

3.3

3.4

  Plan of Conversion, dated December 15, 2016 (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on

Form 8-K filed with the SEC on December 16, 2016)

  Definitive Asset Purchase Agreement dated March 23, 2017 by and between The Research Foundation for the State University
of New York and the Company (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed
with the SEC on March 24, 2017)

  Definitive Real Property Purchase Agreement dated March 23, 2017, by and between Fuller Road Management Corporation
and the Company (incorporated by reference to Exhibit 2.2 to the Company’s Current Report on Form 8-K filed with the SEC
on March 24, 2017)

  Articles of Conversion of the Company, as filed with the Nevada Secretary of State on December 15, 2016  (incorporated by

reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the SEC on December 16, 2016)

  Certificate of Conversion of the Company, as filed with the Delaware Secretary of State on December 15, 2016  (incorporated

by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed with the SEC on December 15, 2016)

  Certificate of Incorporation, as filed with the Delaware Secretary of State on December 15, 2016 (incorporated by reference to

Exhibit 3.3 to the Company’s Current Report on Form 8-K filed with the SEC on December 15, 2016)

  Bylaws of the Company (incorporated by reference to Exhibit 3.4 to the Company’s Current Report on Form 8-K filed with

the SEC on December 15, 2016)

10.1.1†

  Akoustis, Inc. 2014 Stock Plan (incorporated by reference to Exhibit 10.10 to the Company’s Transition Report on Form 10-K

filed with the SEC on October 31, 2016)

10.1.2†

10.1.3†

10.2

10.3

10.4

  Form of Restricted Stock Purchase Agreement under the 2014 Stock Plan between the Company (as assignee of Akoustis, Inc.)
and  each  of  Steve  DenBaars,  Mark  Boomgarden  and  Arthur  Geiss (incorporated  by  reference  to  Exhibit  10.12  to  the
Company’s Current Report on Form 8-K filed with the SEC on May 29, 2015)

  Form of Amendment to Restricted Stock Purchase Agreement under the 2014 Stock Plan between the Company and each of
Steve DenBaars and Mark Boomgarden (incorporated by reference to Exhibit 10.18 to the Company’s Annual Report on Form
10-K filed with the SEC on June 29, 2016)

Joint Development Agreement, dated February 27, 2015, between Akoustis, Inc. and Global Communication Semiconductors,
LLC (incorporated by reference to Exhibit 10.13 to the Company’s Current Report on Form 8-K filed with the SEC on May
29, 2015)

  Foundry  Agreement,  dated  February  27,  2015,  between  Akoustis,  Inc.  and  Global  Communication  Semiconductors,
LLC (incorporated by reference to Exhibit 10.14 to the Company’s Current Report on Form 8-K filed with the SEC on May
29, 2015)

  Form of 2015 Placement Agent Warrant for Common Stock of the Company in connection with the Company’s 2015 private
placement  offering (incorporated by reference to Exhibit 10.8 to the Company’s Current Report on Form 8-K filed with the
SEC on May 29, 2015)

59 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.5

  Form of 2015 Registration Rights Agreement (incorporated by reference to Exhibit 10.9 to the Company’s Current Report on

Form 8-K filed with the SEC on May 29, 2015)

10.6.1†

  Akoustis Technologies, Inc. 2015 Equity Incentive Plan (incorporated by reference to Exhibit 10.10 to the Company’s Current

Report on Form 8-K filed with the SEC on May 29, 2015)

10.6.2†

  Form  of  Stock  Option  Agreement  under  the  Akoustis  Technologies,  Inc.  2015  Equity  Incentive  Plan  (incorporated  by

reference to Exhibit 10.11 to the Company’s Current Report on Form 8-K filed with the SEC on May 29, 2015)

10.6.3†

  Form  of  Restricted  Stock  Agreement,  under  the  Akoustis  Technologies,  Inc.  2015  Equity  Incentive  Plan,  between  the
Company and each of Mark Boomgarden, Dave Aichele and Cindy Payne (incorporated by reference to Exhibit 10.17 to the
Company’s Annual Report on Form 10-K filed with the SEC on June 29, 2016)

10.7†

  Employment Agreement  between  the  Company  and  Jeffrey  Shealy  dated  as  of  June  15,  2015  (incorporated  by  reference  to

Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on June 19, 2015)

10.8.1†

  Employment Agreement between the Company and David M. Aichele dated as of June 15, 2015  (incorporated by reference to

Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on June 19, 2015)

10.8.2†

  Offer  Letter  from  the  Company  to  David  M. Aichele  (incorporated  by  reference  to  Exhibit  10.1  to  the  Company’s  Current

Report on Form 8-K filed with the SEC on May 30, 2017)

10.9.1†

  Employment Agreement between the Company and Mark Boomgarden dated as of June 15, 2015  (incorporated by reference

to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed with the SEC on June 19, 2015)

10.9.2†

  Offer Letter from the Company to Mark D. Boomgarden (incorporated by reference to Exhibit 10.2 to the Company’s Current

Report on Form 8-K filed with the SEC on May 30, 2017)

10.10.1†

  Employment Agreement between the Company and Cindy C. Payne dated as of June 15, 2015 (incorporated by reference to

Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the SEC on June 19, 2015)

10.10.2†

  Offer  Letter  from  the  Company  to  Cindy  C.  Payne (incorporated  by  reference  to  Exhibit  10.1  to  the  Company’s  Current

Report on Form 8-K filed with the SEC on May 26, 2017)

10.11

  Form  of  2016  Subscription Agreement  between  the  Company  and  the  investors  party  thereto  (incorporated  by  reference  to

Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on April 20, 2016)

10.12

  Form of 2016 Placement Agent Warrant for Common Stock of the Company in connection with the Company’s 2016 private
placement  offering (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the
SEC on April 20, 2016)

10.13

  Form of 2016 Registration Rights Agreement (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on

Form 8-K filed with the SEC on March 11, 2016)

10.14.1

  Form  of  Registration  Rights  Agreement  by  and  among  the  Company  and  the  investors  in  the  2016-2017  Offering
(incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on November 25,
2016)

60 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.14.2

  Amendment No. 1 to Registration Rights Agreement by and among the Company and the investors in the 2016-2017 Offering
(incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed with the SEC on December 28,
2016)

10.15

  Form  of  Placement Agent  Warrant  in  the  2016-2017  Offering  (incorporated  by  reference  to  Exhibit  10.3  to  the  Company’s

Current Report on Form 8-K filed with the SEC on December 28, 2016)

10.16.1

  Form of Subscription Agreement by and among the Company and the investors in the 2016-2017 Offering  (incorporated by

reference to Exhibit 10.6 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on February 14, 2017)

10.16.2

10.17.1

10.17.2

10.18.1

  Form  of  Amended  Subscription  Agreement  by  and  among  the  Company  and  the  investors  in  the  2016-2017  Offering
(incorporated by reference to Exhibit 10.7 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on February
14, 2017)

  Placement  Agent  Agreement,  dated  December  8,  2016,  by  and  between  the  Company  and  Katalyst  Securities  LLC  in
connection  with  the  2016-2017  Offering (incorporated  by  reference  to  Exhibit  10.8  to  the  Company’s  Quarterly  Report  on
Form 10-Q filed with the SEC on February 14, 2017)

  Amendment to Placement Agent Agreement, dated May 8, 2017, by and between the Company and Katalyst Securities LLC
(incorporated by reference to Exhibit 10.40 to the Company’s Registration Statement on Form S-1 (SEC File No. 333-218245)
filed with the SEC on May 25, 2017)

  Placement  Agent  Agreement,  dated  December  12,  2016,  by  and  between  the  Company  and  Drexel  Hamilton,  LLC  in
connection  with  the  2016-2017  Offering (incorporated  by  reference  to  Exhibit  10.9  to  the  Company’s  Quarterly  Report  on
Form 10-Q filed with the SEC on February 14, 2017)

10.18.2

  Amendment  to  Placement  Agent  Agreement  by  and  between  the  Company  and  Drexel  Hamilton  LLC  (incorporated  by
reference to Exhibit 10.39 to the Company’s Registration Statement on Form S-1 (SEC File No. 333-218245) filed with the
SEC on May 25, 2017)

10.19

10.20

10.21

  Placement Agent Agreement,  dated  December  14,  2016,  by  and  between  the  Company  and  Joseph  Gunnar  &  Co.,  LLC  in
connection  with  the  2016-2017  Offering (incorporated by reference to Exhibit 10.11 to the Company’s Quarterly Report on
Form 10-Q filed with the SEC on February 14, 2017)

  Placement  Agent  Agreement,  dated  December  19,  2016,  by  and  between  the  Company  and  Northland  Securities,  Inc.  in
connection  with  the  2016-2017  Offering (incorporated by reference to Exhibit 10.10 to the Company’s Quarterly Report on
Form 10-Q filed with the SEC on February 14, 2017)

  Form  of  Amended  and  Restated  Placement  Agent  Warrant  for  Common  Stock  of  the  Company  in  connection  with  the
Company’s 2015 private placement offering and 2016 private placement offering  (incorporated by reference to Exhibit 10.12
to the Company’s Quarterly Report on Form 10-Q filed with the SEC on February 14, 2017)

10.22.1†

  Akoustis Technologies, Inc. 2016 Stock Incentive Plan  (incorporated by reference to Exhibit 10.1 to the Company’s Current

Report on Form 8-K filed with the SEC on December 16, 2016)

10.22.2†

  Form of Restricted Stock Award Agreement under the Akoustis Technologies, Inc. 2016 Stock Incentive Plan  (incorporated

by reference to Exhibit 10.2 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on February 14, 2017)

10.22.3†

  Revised  Form  of  Restricted  Stock  Award  Agreement  under  the  Akoustis  Technologies,  Inc.  2016  Stock  Incentive  Plan
(incorporated  by  reference  to  Exhibit  10.1  to  the  Company’s  Current  Report  on  Form  8-K  filed  with  the  SEC  on  June  23,
2017)

61 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10.23.1

10.23.2

10.24

  Form  of  Subscription  Agreement  by  and  among  the  Company  and  the  investors  in  the  2017  Offering  (incorporated  by
reference to Exhibit 10.35 to the Company’s Registration Statement on Form S-1 (SEC File No. 333-218245) filed with the
SEC on May 25, 2017)

  Form of Amended Subscription Agreement by and among the Company and the investors in the 2017 Offering  (incorporated
by reference to Exhibit 10.36 to the Company’s Registration Statement on Form S-1 (SEC File No. 333-218245) filed with the
SEC on May 25, 2017)

  Form of Registration Rights Agreement by and among the Company and the investors in the 2017 Offering  (incorporated by
reference to Exhibit 10.37 to the Company’s Registration Statement on Form S-1 (SEC File No. 333-218245) filed with the
SEC on May 25, 2017)

10.25

  Form  of  Placement  Agent  Warrant  in  the  2017  Offering  (incorporated  by  reference  to  Exhibit  10.38  to  the  Company’s

Registration Statement on Form S-1 (SEC File No. 333-218245) filed with the SEC on May 25, 2017)

10.26

  Purchase Order for Deposition Tool (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K

filed with the SEC on June 20, 2017)

10.27.1†

  Employment Agreement by and between John T. Kurtzweil and the Company, dated July 14, 2017  (incorporated by reference

to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on July 17, 2017)

10.27.2†

  Form  of  Restricted  Stock  Award  Agreement  to  be  entered  into  by  and  between  John  T.  Kurtzweil  and  the  Company  in
connection with Mr. Kurtzweil’s employment  (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on
Form 8-K filed with the SEC on July 17, 2017)

10.27.3†

  Form  of  Option Agreement  to  be  entered  into  by  and  between  John  T.  Kurtzweil  and  the  Company  in  connection  with  Mr.
Kurtzweil’s employment (incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on July
17, 2017)

21.1

  Subsidiaries of the Company (incorporated by reference to Exhibit 21.1 to the Company’s Registration Statement on Form S-1

(SEC File No. 333-218245) filed with the SEC on May 25, 2017)

31.1*

  Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Executive Officer

31.2*

  Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Financial and Accounting Officer

32.1*

  Section 1350 Certification of Principal Executive Officer

32.2*

  Section 1350 Certification of Principal Financial and Accounting Officer

62 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
101§*

Interactive Data Files of Financial Statements and Notes.

101.ins*

Instant Document

101.sch*

  XBRL Taxonomy Schema Document

101.cal*

  XBRL Taxonomy Calculation Linkbase Document

101.def*

  XBRL Taxonomy Definition Linkbase Document

101.lab*

  XBRL Taxonomy Label Linkbase Document

101.pre*

  XBRL Taxonomy Presentation Linkbase Document

*       Filed herewith

†       Management contract or compensatory plan or arrangement

63

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exhibit 31.1

CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934

I, Jeffrey B. Shealy, certify that:

1.

I have reviewed this Annual Report on Form 10-K of Akoustis Technologies, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to
make  the  statements  made,  in  light  of  the  circumstances  under  which  such  statements  were  made,  not  misleading  with  respect  to  the
period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed  such  disclosure  controls  and  procedures,  or  caused  such  disclosure  controls  and  procedures  to  be  designed  under  our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to
us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our  supervision,  to  provide  reasonable  assurance  regarding  the  reliability  of  financial  reporting  and  the  preparation  of  financial
statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about
the  effectiveness  of  the  disclosure  controls  and  procedures,  as  of  the  end  of  the  period  covered  by  this  report  based  on  such
evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's
most  recent  fiscal  quarter  (the  registrant's  fourth  fiscal  quarter  in  the  case  of  an  annual  report)  that  has  materially  affected,  or  is
reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent
functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any  fraud,  whether  or  not  material,  that  involves  management  or  other  employees  who  have  a  significant  role  in  the  registrant's

internal control over financial reporting.

Date: September 19, 2017

/s/ Jeffrey B. Shealy
Jeffrey B. Shealy
President and Chief Executive Officer
(Principal Executive Officer)

 
 
 
 
 
 
 
 
 
 
 
Exhibit 31.2

CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934

I, John T. Kurtzweil, certify that:

1.

I have reviewed this Annual Report on Form 10-K of Akoustis Technologies, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to
make  the  statements  made,  in  light  of  the  circumstances  under  which  such  statements  were  made,  not  misleading  with  respect  to  the
period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed  such  disclosure  controls  and  procedures,  or  caused  such  disclosure  controls  and  procedures  to  be  designed  under  our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to
us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our  supervision,  to  provide  reasonable  assurance  regarding  the  reliability  of  financial  reporting  and  the  preparation  of  financial
statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about
the  effectiveness  of  the  disclosure  controls  and  procedures,  as  of  the  end  of  the  period  covered  by  this  report  based  on  such
evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's
most  recent  fiscal  quarter  (the  registrant's  fourth  fiscal  quarter  in  the  case  of  an  annual  report)  that  has  materially  affected,  or  is
reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent
functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any  fraud,  whether  or  not  material,  that  involves  management  or  other  employees  who  have  a  significant  role  in  the  registrant's

internal control over financial reporting.

Date: September 19, 2017

/s/ John T. Kurtzweil
John T. Kurtzweil
Chief Financial Officer
(Principal Financial and Accounting Officer)

 
 
 
 
 
 
 
 
 
 
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 32.1

In connection with the Annual Report of Akoustis Technologies, Inc. (the “Company”) on Form 10-K for the fiscal year ended June 30,
2017,  as  filed  with  the  Securities  and  Exchange  Commission  on  the  date  hereof  (the  “Report”),  I,  Jeffrey  B.  Shealy,  Chief  Executive
Officer  of  the  Company,  certify,  pursuant  to  18  U.S.C.  Section  1350,  as  adopted  pursuant  to  Section  906  of  the  Sarbanes-Oxley Act  of
2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of

the Company.

Date: September 19, 2017

/s/ Jeffrey B. Shealy
Jeffrey B. Shealy
President and Chief Executive Officer
(Principal Executive Officer)

A  signed  original  of  this  written  statement  required  by  Section  906,  or  other  document  authenticating,  acknowledging,  or  otherwise
adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been
provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon
request.

 
 
 
 
 
 
 
 
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Exhibit 32.2

In connection with the Annual Report of Akoustis Technologies, Inc. (the “Company”) on Form 10-K for the fiscal year ended June 30,
2017,  as  filed  with  the  Securities  and  Exchange  Commission  on  the  date  hereof  (the  “Report”),  I,  John  T.  Kurtzweil,  Chief  Financial
Officer  of  the  Company,  certify,  pursuant  to  18  U.S.C.  Section  1350,  as  adopted  pursuant  to  Section  906  of  the  Sarbanes-Oxley Act  of
2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of

the Company.

Date: September 19, 2017

/s/ John T. Kurtzweil
John T. Kurtzweil
Chief Financial Officer
(Principal Financial and Accounting Officer)

A  signed  original  of  this  written  statement  required  by  Section  906,  or  other  document  authenticating,  acknowledging,  or  otherwise
adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been
provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon
request.